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Despite reductions in worldwide child mortality rates, 6.3 million children still die each year, 
the vast majority of them in low- and middle-income countries (LMICs), often from easily 
preventable and treatable diseases.  This dissertation explores how a child survival strategy 
called integrated community case management of childhood illness (iCCM) was developed at 
the global level and adopted and implemented in Niger, drawing upon qualitative methods 
(in-depth interviews, document analysis), quantitative methods (citation network analysis), 
and contextual analysis of historical, political, economic and social trends. 
The results show that the development of effective policies depends on far more that 
synthesizing relevant research evidence – particularly when “evidence” is narrowly defined as 
the scientific literature.  Policy processes at both the global and national (Nigerien) levels 
were determined by (geo-) political factors, power structures, distributions of resources and 
economic and financial incentives, which influenced policy decisions of individuals and 
groups of actors.   
At the global level (Chapter 4), an “epistemic community” of mid- to upper-level technical 
officers in global health norm-setting bodies, implementing agencies, funders and academic 
groups used sophisticated scientific analyses to develop and promote iCCM; however, their 
narrow technical focus created blind spots, for example about service delivery implications in 
countries with weak health systems.   
In Niger, political economy factors and internal power relationships were crucial 
determinants of key policy decisions underlying iCCM, such as the President’s creation of 
the policy’s underlying health infrastructure (the “health huts”) as a way to distribute rents to 
client networks (Chapter 5).  In terms of the use of evidence in the development of iCCM in 
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Niger (Chapter 6), technical expertise was concentrated among actors from multi-lateral and 
bilateral agencies who packaged and delivered scientific arguments supportive of iCCM to 
Nigerien policymakers, whose input was limited mainly to operational decisions.   
This dissertation sheds light on determinants of policy-making processes that have been less 
frequently examined in the scholarly literature, notably how contextual factors shape policy 
content and determine whether policies are adopted and implemented at the country level.  
These issues merit further research, for while policy development processes remain as yet 
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The work presented in this dissertation reflects my attachment to founding principles in 
public health that have recently come back into vogue, namely the Vichrowian conception of 
the field as a social science – an activist science – whose findings have both practical and 
moral implications for the organization of our societies.   
As a student at JHSPH, my academic instruction in these principles needed no further 
practical illustration than the bus I took each day from my apartment in clean, bright Mount 
Vernon to the bleak, impoverished neighborhoods surrounding the School of Public Health, 
areas separated by a ten-minute drive – and a ten-year difference in life expectancy.  The 
reason for the difference in life expectancy?  Chronic ailments such as diabetes and heart 
disease, elevated child mortality, accidents and violence – these are some proximate causes.  
But what of deep structural inequalities like East Baltimore’s economic deprivation, 
inadequate and degraded housing, political voicelessness, locally funded (or rather under-
funded) schools and ongoing cycles of incarceration and criminality?  Aren’t these causes in 
some truer sense?  And while these circumstances are “bad” in themselves, that ten-year 
difference life expectancy seems the purest measure of the injustice: on average, people from 
the right side of the tracks in Baltimore, my side of the tracks, get an additional decade of 
time on Earth.   
This way of framing public health’s central issues led me to “look upstream” and seek to 
identify the most powerful, far-reaching, and consequential determinants of health at the 
population level.  For the purposes of this dissertation, I landed on policies – the ways 
societies allocate necessary or desirable goods and direct resources to specific population 
groups – and the political incentives driving policy decisions, the availability and 
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mobilization of resources to finance them, and social forces affecting what gets put in them 
in first place.   
Why Niger?  Though I have since become attached to the country’s people, culture and 
languages, I was shocked by the materiality of its poverty when I first landed there as a 
Master’s student in 2006.  With historically very high child mortality rates, it was not unusual 
when asking a Nigerien about his children to learn that he had “three living, two deceased,” 
or some such reply.  The burden of disease is also a burden of sorrow.  Thus, when the 
opportunity came to work on a policy analysis of child survival in Niger with a set of 
excellent researchers at JHSPH, I signed up without hesitation.   
I hope this dissertation will contribute to emerging understandings about the connections 
between structural phenomena and population health – most especially the health of the 
world’s poor, whose exposure to pathologies is as outsized as their access to basic care is 
disproportionately low.  Generating knowledge about these links is a necessary first step to 
addressing them – tasks whose urgency cannot be overstated.   
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Chapter 1. Introduction 
1.1 Introduction 
Globally, despite widespread declines in child mortality rates in recent years, an estimated 6.3 
million children under 5 died in 2013, of which three of the top causes were pneumonia 
(15% of deaths), diarrhea (9%), and malaria (7%) (You, Hug et al. 2014).  Each of these 
pathologies can be prevented and treated with simple and affordable interventions, 
explaining why the vast majority of these deaths occur in low- and middle-income countries 
(LMICs) among populations with limited access to health services.   
Policy advances to address this disparity could affect the life chances of millions of children 
worldwide.  Since the 1970s, selective primary health care using community-level service 
delivery has been recognized as a solution for reaching poor, rural populations and 
preventing child deaths, though the full promise of this policy has yet to be realized.  One 
recent version of this policy, Integrated Community Case Management (iCCM), has received 
the full endorsement of the global health policy community in the form of a joint statement 
by WHO and Unicef (WHO/UNICEF 2012) and support from major bilateral and multi-
lateral agencies.  The iCCM strategy encompasses curative treatment for malaria, pneumonia, 
and diarrhea in children under five by community health workers (CHWs).  Positioned by 
global actors as an “evidence-based policy,” iCCM rests on studies showing that 
interventions carried out by CHWs for each of these pathologies can reduce under-5 
mortality rates, with fairly pronounced effects when curative treatments (anti-malarials and 
antibiotics) are included (Christopher, Le May et al. 2011).   
The scholarly literature on health policy in LMICs  remains underdeveloped, despite the high 
political, economic and human stakes of policy choices (Gilson and Raphaely 2008).  For 
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example, there are only a few published studies on processes of policy change for malaria 
treatment policies, despite this disease’s considerable ravages on health and well-being in 
LMICs, particularly in Africa (Williams, Vincent-Mark et al. 2009; Woelk, Daniels et al. 2009; 
Cliff, Lewin et al. 2010).  What studies do exist on policy development in LMICs tend to 
focus more on policy implementation than formulation (Gilson and Raphaely 2008).  The 
paucity of the literature is compounded by the fact that many studies are mainly descriptive, 
lacking a strong theoretical basis, and furthermore put an undue focus on technocratic 
aspects of policy-creation by relying on a “rational” model of evidence use that fails to take 
into account that policy reform is inevitably political: it seeks to change who gets valued 
goods in society (Reich 1995).   While it is recognized that political, economic and social 
factors influence health through multiple pathways, insufficient attention has been paid to 
their impact on policy development at the global and national level. 
Niger was one of the first countries to fully adopt and implement iCCM, which alongside 
other interventions contributed to a 43% reduction in the country’s child mortality rate, 
from 226 deaths per 1000 live births in 1998 to 128 deaths in 2009 (Amouzou, Habi et al. 
2012).  After examining how the policy was developed at the global level, this dissertation 
will illuminate the process of iCCM policy development at the national level in Niger, tracing 
the path of a globally-produced strategy to its application to Niger’s stringent demographic, 
epidemiological and economic challenges, and drawing lessons on the reasons for its success.   
1.2 Study objectives   
This dissertation explores the development of health policy using the example of iCCM at 
the global level and in Niger, focusing on the social and structural (political, economic, and 
historical) determinants of policy-making processes and the use of evidence in policy 
3 
 
adoption.  I use case study methodology based on a range of qualitative and quantitative 
methods described in detail in each of the substantive chapters (Chapters 4-6).  
Understanding factors that support or inhibit the formulation of pro-poor policies, and the 
globalized policy environment they operate in, is a precursor to removing barriers to putting 
evidence-based policies in place and ultimately improving health outcomes for disadvantaged 
populations.  In all papers, I strive to provide historical context for policy decisions and take 
a long view of the policy development process (at least two decades).  This study provides 
new contributions to the scholarly literature on how health policy is created at the global and 
national levels in LMICs, and responds to previous calls by scholars to provide a stronger 
theoretical basis for policy decisions, as well as the sources and exercise of power in policy 
development at these levels. 
Each paper included in the dissertation has its own specific aim.  The first paper (Chapter 4) 
aims to describe the origins of iCCM policy at the global level and provide a theoretical 
explanation for how it came to the fore of child survival efforts using the “epistemic 
communities” framework first described by Haas (1994).  The second paper (Chapter 5) 
examines iCCM policy development at the national level in Niger, focusing on the role of 
power in the policy’s successful adoption and implementation, extending a political economy 
view of power to the health policy domain by incorporating technical expertise as one of its 
components.  Finally, in the third paper (Chapter 6), I provide a case study of the processes 
of knowledge translation and research utilization during iCCM policy development processes 
in Niger and identify relevant theoretical categories of knowledge and practice, also with an 




1.3 Conceptual framework 
This dissertation draws on ideas from three theoretical perspectives, which were used to 
inform research questions, data collection and analysis methods, and interpretations of 
results:  1) policy analysis theories from the public health and public policy literatures, 2) 
political economy theories pertaining to African states, and 3) social constructionism.  These 
theoretical perspectives inflect the substantive chapters of this dissertation to varying 
degrees, as is reflected in each chapter’s section on theory. 
1.3.1 Theories of policy analysis 
This dissertation examines policy development processes at both the global level and the 
national level in Niger.  At the global level, the determinants affecting the selection of 
particular health policies or priorities over others are not well understood.  Aside from the 
fact that policy change is a profoundly political process (Reich 1995), “we know little about 
the sources of variance in priority levels afforded to global health initiatives” despite the 
massive sums mobilized on their behalf (Shiffman and Smith 2007).  And though improved 
analytical tools allow for increasingly precise estimates of the impact of specific interventions 
on disease burden, health policy choices, both globally and at the national level, cannot not 
be explained by “material factors” such as disease burdens and the availability of cost-
effective interventions (Reich 1995; Reichenbach 2002).  
In the early 1990s there were calls for a new approach to health policy analysis, which 
theretofore had focused almost exclusively on Western countries (Walt and Gilson 1994; 
Reich 1995; Reich 1995).  Furthermore, previous studies focused on technical content and 
design and not on “politics, process and power,” as these authors now urged (Gilson and 
Raphaely 2008).  As a heuristic for analyzing these issues, Walt and Gilson proposed a 
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“policy triangle” (Figure 1) that would subsequently become the most commonly used 
framework in policy analyses in LMICs: in the “policy triangle,” actors negotiate policy content, 
policy-making processes, and the overall institutional, political and social context (Walt and 
Gilson 1994; Gilson and Raphaely 2008).  This simple framework provides the basis of this 
dissertation’s “nuts and bolts” analytical work; that is, producing a thorough, precise, and in-
depth description of iCCM policy development at the global level and in Niger.  While the 
“policy triangle” does have the benefit of simplicity, each category contains multitudes; this 
dissertation’s emphasis on political and contextual determinants of policy choices will no 
doubt nourish the reflection on policy context. 
Figure 1 : Walt and Gilson’s model for policy analysis (Walt and Gilson 1994) 
 
 
The first and only systematic review of health policy analysis in LMICs, covering the years 
1994-2007 (n=164 articles), described its four main characteristics as “small size, diversity, 
fragmentation, and domination by authors based in northern organizations” (Gilson and 
Raphaely 2008).  The vast majority of these articles was based on one country case (just 7% 
included more than one country) and only 23% of studies focused exclusively on policy 
development (as opposed to implementation). Despite these limitations, some conclusions 
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could still be drawn from the pool of articles, notably that policy change is always contested 
and that policy is socially “constructed, wrapped up in and influenced by the meanings 
different actors attribute to policy content or goals.”  Of particular pertinence to the creation 
of iCCM policy, the review also found that equity-oriented policy reforms can be hindered 
by resistance from powerful stakeholders, and that intended beneficiaries are often excluded 
from even local-level policy making processes.   
In intervening years, studies have examined barriers to using research in policy development 
(Woelk, Daniels et al. 2009; Cruz and Walt 2013; Deeming 2013), even though policymakers 
in LMICs nearly universally cite evidence as being crucial to making good policy decisions 
(Burchett, Mounier-Jack et al. 2012).  Yet one clear finding in the health policy literature on 
LMICs (and in Western settings) is that evidence alone is not sufficient for rational policies 
to be put in place, even when coupled with international donor prioritization and resource 
availability (Shiffman 2007).  A comparison of prioritization for breast and cervical cancer in 
Ghana, for example, reported that “political attention essentially trumped available scientific 
and economic evidence in terms of the priority given to breast cancer rather than cervical 
cancer” (Reichenbach 2002).  Still, actor groups such as professional groups exercise 
authority in the policy process on the basis of their expertise in understanding research and 
interpreting scientific evidence; in highly technical domains such as health, experts can 
exercise considerable power (Rose and Miller 1992) 
At the national level, there are a host of structural and historical factors that can affect policy 
formulation in LMICs.  In a study of CCM policy formulation and implementation in 
Nicaragua, international support was a facilitator to policy development, but so were a 
national history of community participation, government commitment to reaching the poor, 
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public sector decentralization, and resource constraints (George, Menotti et al. 2010).  Even 
when programs are shown to be successfully implemented, effects have been observed to 
taper off after declines in political and financial support, as was the case for a Gambian 
malaria prevention program (Hill, MacLeod et al. 2000). Other important evolutions in the 
national political arena can include decentralization, democratization and major political 
transitions, which influence health policy outcomes by distributing power and altering 
processes by which policies are made and implemented (Shiffman 2007).  Finally, 
interactions between state actors and international agencies, including bilateral and multi-
lateral agencies, aid and lending institutions, and NGOs are a significant feature of health 
policy-making in LMICs, yet the influence of global elites, international policy decisions, and 
resource flows on national policy remains to be fully elaborated, even though regional and 
international links can be “crucial” in policy decision making (Cliff, Walt et al. 2004).   
1.3.2 African health policy environments in political economy perspective 
The political economy literature offers clues on features of African states with the potential 
to impact decisions made throughout the policy cycle, including 1) governance types, 2) 
political participation, 3) economic and fiscal factors, and 4) relationships with external 
actors.  In this section, we will focus on characteristics of neo-patrimonial states, a strongly 
executive form of rule characteristic of many African countries, including this study’s main 
study site, Niger. 
Governance types 
Governance types are closely linked to policy because they condition the relationship 
between ruler and ruled and determining the location of power within the state, including as 
this relates to health policy.  In terms of the relationship between ruler and ruler, African 
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states often operate according to clientelist mechanisms making extensive use of state resources 
for political purposes.  Systems of patronage, rooted in colonial and pre-colonial patterns, 
undergird many African states, although these are cloaked in the appearance of Western-style 
bureaucracy (van de Walle 2001).   
Power in these types of regimes operates under powerful distributive pressures, yet “is 
concentrated and personalized, entailing discretionary control over broad realms of public 
life” (Lewis 1996).   African neo-patrimonial governance often follows a presidential system, 
dominated by a strong executive branch:  in policy areas, there is often little delegation to 
technocratic groups, and the executive leads (Lewis 2002).  For health policy, this could have 
a number of implications:  technocratic elements have less power to promote life-saving 
policies, but the president’s whim could go a long way.   
In electoral regimes, there is also evidence of persistent patronage politics – a system of 
functioning that may clash with donor policies or modalities and affect which policies are 
selected, depending on the identities of the regime’s clients (Bienen and Herbst 1996).  In 
democratic regimes such as those of Niger over the past two decades, populist coalitions have 
often formed, which may include, beyond clients of senior officials, state employees, labor 
groups, and recipients of subsidies or protections on manufacturing (Lewis 2002).  However, 
as Meddi Mugyeni argues, “electability is not the same as capability in handling public policy 
and management. ... Elected politicians tend to be populist, but development decision-
making tends to be technical” (Mugyeni 1988).  
Political participation 
For policies such as iCCM, designed to benefit poor, disempowered groups, it is interesting 
to consider the potential role of political participation was important in claiming the right to 
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health care or demanding reductions in child mortality rates.  Theorists have long 
distinguished between “procedural forms of democracy, where a minimum set of democratic 
rules and rights are observed, and substantive democracy, in which citizens are broadly included 
in the political arena and the populace exercises an effective voice” (Lewis 2002).  In Africa, 
“illiberal” electoral democracies have tended to succeed authoritarian regimes, failing to fully 
develop government accountability, overarching rights and liberties, and the inclusion of 
marginal groups (Diamond, Linz et al. 1996).  In a related observation, the region’s political 
parties often fail to advance forceful policy ideas (Bienen and Herbst 1996).  
Limited political participation in these types of states means that policy decisions are often 
decided by a small elite, whose members overlap considerably from regime to regime (Bienen 
and Herbst 1996).  In a country like Niger, with a highly rural, poor and illiterate population, 
membership in the elite is likely highly concentrated (e.g. Niamey’s “fifty families”).  Indeed, 
urban bias is a recognized feature of post-colonial African states and economies, beginning 
with Bates’ classic analysis of agricultural policy, which showed the extent to which policy 
choices disfavored residents of rural areas (Bates 2005).  African governments are often 
based almost entirely in the capital city, whereas rural constituencies have trouble organizing 
–elections have little affected this divide (Bienen and Herbst 1996).  Ruling coalitions thus 
tend to be made up predominantly of urban dwellers, largely excluding the rural constituents 
who would benefit from policies resembling iCCM (van de Walle 2001).   
Economic and fiscal factors 
The economic outlook for Africa has significantly improved over the past decade, with GDP 
growth returning to an average of 2.6% per year between 2000 and 2008 (Moss 2011).  This 
follows a two-decades’ long growth crisis with only a few states spared (Botswana, Mauritius) 
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from virtual devastation:  in the 1980s, average incomes declined at 1% per year and in the 
1990s at 0.4% per year (Moss 2011).  Declining terms of trade and external shocks in the 
form of the oil crisis made a bad situation worse; in international trade, Africa’s position was 
significantly marginalized, leaving it with little say in international economic institutions such 
as the WTO, which set the “rules of the game” (Collier 1995).  Thus many African states are 
emerging from a period of internal economic weakness and a position of weakness in the 
international economic system.  Decades of economic decline, and the ensuing debt crisis, 
have left many states in a precarious fiscal position, with effects for health spending.  Generally, 
spending in neopatrimonial regimes tends to be regressive, reinforcing inequitable social 
divisions, upon ethic or class lines, which would suggest an obstacle for iCCM policy (Lewis 
2002).  
Relationships with external actors 
Although policymakers themselves often inhabit national and transnational roles 
simultaneously, an understanding of the relationship between state and non-state actors and 
institutions is particularly warranted given the colonial and post-colonial legacy of the state in 
Africa, whose governing apparatus is transplanted from the West rather than organic.  As a 
result, some analysts argue state actors’ power derives largely from their position as 
interlocutors of privilege with outside actors, hence the term “gatekeeper” states (Cooper 
2002; Englebert 2009).  Due to their low capacity, these states have difficulty extending their 
power within their borders:  “their survival [depends] precisely on the fact that formal 
sovereignty was recognized from outside, and that resources, such as foreign aid and military 
assistance, came to governments for that reason” (Cooper 2002).   
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Indeed, in many African nations, ever-larger aid international aid flows have taken over many of 
the state’s essential functions (van de Walle 2001).  Representatives of international aid 
agencies thus have a strong voice in negotiations on the provision of public goods and 
services, not least in the area of health.  Such massive aide flows have created a situation of 
“dynamic dependency,” binding states to donors’ agendas and withering capacity (Naudet 
1999).  This “dependency,” however, is not entirely one-sided, as industry workers depend 
on ongoing development work for their livelihoods (Ellis 2011).   
Putting countries’ relationships with external donors in historical perspective, it is important 
to evoke the trauma of structural adjustment, remembered by all parties as a painful failure, 
though the reasons for the failure remain controversial.  It has been widely documented that 
structural adjustment policies progressively eroded state capacity due to years of non-reform, 
coinciding with a persistent economic crisis that forced states to cut back social programs 
and other offerings (van de Walle 2001).   
Finally, states may also be subject to political interference.  Former French colonies such as 
Niger have been subject to significant outside political interventionism from France in the 
years since independence (Moss 2011).  Under General de Gaulle and his successors, and 
continuing until late in the 20th century, the French state operated a system with “striking 
similarities to formal colonial control in political, economic, military and financial matters.” 
The grip of this system, known as Françafrique, finally began to relax after a series of 
unfortunate events in the 1990s, including France’s implication in the Rwandan genocide 
(the so-called “genocide fax”), the devaluation of the CFA currency and the death in 1993 of 
Ivoirian President Félix-Houphouët-Boigny (Ellis 2011).  Even today, European if not 
French actors still have a direct influence on monetary policy in the CFA zone:  the 
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currency, used by a dozen countries in West Africa, is pegged to the euro, in continuity with 
the colonial past of monetary control from abroad (Nubukpo 2007).   
1.3.3. Social constructionism 
Lastly, the social constructionist lens is particularly well suited to the production and use of 
evidence in policy-making processes.  Social constructionism emerged in 1960s and 1970s 
from works such as Berger and Luckman’s “The Social Construction of Reality” (1967), and 
focuses on the role of society in creating “reality” and holds that meaning and understanding 
are produced by individuals acting in concert with each other, exchanging interpretations and 
knowledge in a dynamic process.  The notion that science, or the creation of knowledge, is 
determined by social processes was famously advanced by Thomas Kuhn, who argued that 
scientific inquiry itself was shaped by socially constructed categories (Kuhn 1970).   
Several studies have applied concepts from social constructionism to the study of health 
policy at the global level and in LMICs, notably Shiffman’s work on issue attention 
(sometimes also called prioritization) in global public health (Shiffman and Smith 2007), 
issue attention regarding newborn health (Shiffman 2010), and structural factors affecting 
maternal mortality outcomes (Shiffman and Garcés del Valle 2006).  Shiffman argues social 
constructionism can explain the choice of policies, which are predicated on social contexts 
and norms that are continually being reconstructed and renegotiated.  As he explains, “those 
issues that attract attention may be the ones in which policy community members have 
discovered frames – ways of positioning an issue – that resonate with global and national 
political elites…” (Shiffman 2009).  As such, issues take can on high symbolic value, as 
observed in a previous study of cancer prioritization in Ghana, where the social construction 
of the breast as a symbol of maternal caring provided enhanced support to policies 
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combatting breast cancer compared to cervical cancer, despite the latter pathology’s greater 
public health importance in terms of incidence in LMICs (Reichenbach 2002).   In more 
recent work, Shiffman has simplified his earlier frameworks, proposing a “social explanation 
for the rise and fall of global health issues,” based on actors’ perceptions of the health 
problem as severe and neglected and its solution as tractable and beneficial (Shiffman 2009).  This 
explanatory model places particular importance on communication between actors, who 
interact to frame the issue, debate and interact, and ideally find solutions to the problem at 
hand.     
1.4 Organization of the dissertation 
Beginning in Chapter 2, I provide background information related to the history of global 
child survival initiatives leading up to iCCM and the evidence base for iCCM policy found in 
the existing scientific literature.  In Chapter 3, I give context on the main study site, Niger, 
providing an overview of the country’s recent political history and political, economic and 
social features, particularly as they relate to Niger’s health system and health policy decision-
making. 
Starting with Chapter 4, I present three manuscripts, the first two of which have been 
submitted the journal Health Policy & Planning for inclusion in an upcoming supplement on 
iCCM (both articles were accepted with revisions and have been re-submitted in their 
current form).  Chapter 4 describes the policy formulation process for iCCM at the global 
level, using the “epistemic communities” conceptual framework to explain how this policy 
came to the fore as a child survival initiative.  Chapter 5 examines how iCCM and supporting 
policies were adopted at the national level in Niger, focusing on the role of power in terms 
of political authority, financial resources and technical expertise.  Chapter 6 focuses on the 
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processes of knowledge translation and research utilization in the iCCM policy formulation 
process in Niger. 
Finally, the conclusion (Chapter 7) offers a summary of results, discusses the dissertation’s 
strengths and limitations, and suggests directions for future research on structural 




Chapter 2. Literature review 
2.1 Brief history of global child survival initiatives  
In the past 50 years of global health policy, institutional support for providing care at 
household or community levels has waxed and waned, tracing a policy cycle that is now once 
more in ascendance.  At all times, community-level programs have been justified as 
extending coverage of basic health services and improving equity and access to care.  Already 
in the late 1960s and early 1970s when the movement for primary health care emerged, 
works such as John Bryant’s Health and the Developing World (1971) criticized the 
transplantation of the hospital-based health care system to developing countries (Cueto 
2004).  At the same time, Carl Taylor of the Johns Hopkins School of Public Health was 
promoting the Indian rural health care system as a model for reaching populations 
marginalized by the facility-based health care system; in Communist China, “barefoot 
doctors” aimed to achieve the same end.  Various models using auxiliary health workers 
were discussed in Health by the People (1975), a WHO publication including a chapter on 
Niger’s village health teams, consisting of a CHW and a midwife (Fournier and Djermakoye 
1975).  Given their experience with village workers inside communities, Christian 
missionaries were also influential in the intellectual movement in favor of policies using 
community health workers, and in 1974, the collaboration was formalized between WHO 
and the Christian Medical Commission (Cueto 2004).  Two years previously, WHO had 
created the Division of Strengthening Health Services, which focused on providing and 
more “basic health services” projects.  In 1975, the debate was further stocked by the joint 
WHO-Unicef publication Alternative Approaches to Meeting Basic Health Needs in Developing 
Countries, which criticized facility based strategies as a “failure” (Djukanovic and Mach 1975).   
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The WHO’s conference in Alma-Ata in 1978 in many ways capped off the consensus that 
had already been built around primary health care and community-level approaches.  The 
conference’s declaration emphasized the construction of health posts in poor rural and 
urban areas and promoted the empowerment of communities (WHO 1978).  However, little 
guidance was provided as to how to operationalize these recommendations.  Alma-Ata was 
criticized for being too broad and idealistic; in response, the 1979 Bellagio conference 
proposed the next iteration of the idea:  selective primary health care.  The conference was 
organized around an article calling for an evidence-based attack on specific diseases, notably 
including malaria, pneumonia, and diarrhea (Walsh and Warren 1979), and its attendance 
included influential persons such as Robert S. McNamara, head of the World Bank and 
former U.S. secretary of defense, as well as top officials from USAID and the Canadian 
International Development Agency (CIDA) (now the Department of Foreign Affairs and 
Trade and Development, DFATD).  The selective approach to primary health care was 
justified by concerns of expediency:  “The goal set at Alma Ata is beyond reproach, yet its 
very scope makes it unattainable because of the cost and numbers of trained personnel 
required” (Walsh and Warren 1979).   
In the following years, programming increasingly tended to follow the route of selective 
primary health care, usually according to the Growth Monitoring, Oral Rehydration, 
Breastfeeding and Immunization (GOBI) framework of priority interventions.  GOBI was 
notably promoted by James Grant, Unicef’s charismatic leader, and while supporters of 
primary health care continued to influence the debate, the selective approach received added 
support after the successful eradication of smallpox in the 1980s, following the creation of 
WHO’s Expanded Program on Immunization (EPI) program in 1974.  U.S. agencies, the 
World Bank, and Unicef all created programs that prioritized certain components of GOBI 
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(especially immunization and oral rehydration therapy), creating noted tension between 
Unicef and WHO, which remained a center of support for a holistic vision of primary health 
care (Cueto 2004).  Nonetheless, WHO programming followed suit with the creation of 
programs specifically targeting acute respiratory infections (ARI) and diarrheal diseases, 
Control of Diarrhoeal Disease (CDD). The priorities encapsulated by GOBI include some 
key components of iCCM policy; however, in the 1980s, hospital-based approaches to health 
care were ascendant, despite the enthusiasm for community participation expressed a decade 
earlier.  At the same time, the first field trials of community-level approaches suffered from 
implementation problems, such as inadequate supervision, a lack of ongoing training, and 
poor logistical and financial support, leading to poor quality of care (Heggenhougen, 
Muhondwa et al. 1987; Walt 1990; Frankel 1992) (Berman, Gwatkin et al. 1987).   As a result 
of these political and scientific factors, community-based approaches were temporarily set 
aside.   
Meanwhile, advocates for child health were becoming increasingly  prominent in the global 
health policy world, notably including those at Unicef, which “became extraordinarily 
successful in mobilizing its own organization and others in support of the ‘child survival 
revolution.’” (Reich 1995).  Under Unicef’s James Grant, the Task Force on Child Survival’s 
promotion of child health as a top-priority issue has been noted as a particularly effective 
advocacy instrument (Shiffman and Smith 2007).  (Task Force members included Unicef, 
UNDP, WHO, the World Bank, the Rockefeller Foundation and the Carter Center.)  Such 
an overwhelming impetus to improve outcomes in child health, in a period following the 
evidence gathering fomented by GOBI, laid the foundations for the advent of the Integrated 
Management of Childhood Illness (IMCI) algorithm in 1995, which organized case 
management for the most common and devastating childhood illnesses in the developing 
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world.   Beginning with Tanzania and Uganda in 1996, IMCI was introduced to over 100 
countries in the next decade, and the IMCI algorithm was widely hailed as a successful policy 
in hospital settings (Chopra, Binkin et al. 2012).   
But while the IMCI program as articulated by WHO had three components (case 
management in facilities, health systems strengthening, and community-level care), the early 
focus of most country programs remained on the clinical management of childhood illness.  
The community-based component of IMCI (community IMCI or C-IMCI) was officially 
launched at the First IMCI Global Review and Coordination Meeting in Santo Domingo 
(D.R.) in September 1997, where attendees advocated for appropriate management of 
childhood illness at household and community levels (WHO 1997).  At this same meeting, 
Unicef was appointed lead agency on C-IMCI, but internal disagreements hindered progress, 
and a 2005 evaluation of IMCI showed that implementation of C-IMCI had been slow to 
nonexistent in most countries (Bryce, Victora et al. 2005).  Around the same time, a review 
of IMCI published by WHO pointed to other problems with the design of C-IMCI, such as 
its reliance on health workers on government facilities, despite their low rates of utilization 
(WHO, UNICEF et al. 2003).   
While C-IMCI was struggling to get off the ground, policymakers worldwide were taking 
note of promising results in studies with community health workers.  In the late 1990s and 
early 2000s, the potential contributions of community health workers were being positively 
reevaluated, in part due to the growing recognition of the ravages wrought by HIV/AIDS 
on health services’ human resources and discussions on “task shifting” (Lehmann, Van 
Damme et al. 2009), as well as the effects of the brain drain.  By 2004, researchers had 
established a body of scientific evidence substantial enough for a WHO/Unicef joint 
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statement on the management of pneumonia in community settings (WHO/UNICEF 2004).  
The home or community-level treatment of diarrhea using ORT, later combined with zinc, 
was at this time already widely accepted, and home management of malaria (HMM) was also 
proving efficacious (see the section below on the evidence for iCCM for further details).  
Further accrual of the evidence resulted in another WHO/Unicef joint statement in June 
2012, promoting iCCM according to the definition used in this proposal:  community-level 
treatment of malaria, diarrhea, pneumonia, malnutrition and newborn conditions by trained 
CHWs (WHO/UNICEF 2012).  Implementation of iCCM is not yet widespread on the 
African continent, although many countries are moving toward adopting iCCM or policies 
that resemble it.   
2.2 The evidence base for iCCM  
In July 2012, WHO and Unicef issued a joint statement promoting iCCM, “an equity-
focused strategy to improve access to essential treatment services for children” 
(WHO/UNICEF 2012).  This announcement followed upon previous joint statements on 
home visits for newborns and pneumonia treatment, which presented a strong case for the 
effectiveness of community-based care from CHWs (WHO/UNICEF 2004; 
WHO/UNICEF 2004).  Currently, the full heft of the international policy arena is squarely 
behind iCCM based on an accumulation of research over two decades, as indeed iCCM was 
selected from a number of available models for managing childhood illness at the household 
or community level.  Several of these models use CHWs for tasks including basic 
surveillance with facilitated referral (CHWs sometimes provide first dose of antibiotics or 
ACTs), CHW-directed fever management using a simple algorithm, home management of 
malaria (HMM), case management of pneumonia by CHWs, and integrated multiple disease 
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case management (essentially iCCM), each of which include a constellation of clinical tools 
(antibiotics, RDTs, ACTs) (Winch, Gilroy et al. 2005).   
In the mid-2000s, evidence of a mortality impact of these programs existed only for 
pneumonia case management by CHWs (hence the WHO/Unicef joint statement in 2004) 
and family-directed fever management, which did not use CHWs.  Today, CCM programs 
have greater evidentiary support, although there is still relatively little evidence of the 
effectiveness of integrated, community-level treatment policies with the specific 
characteristics of iCCM.  A 2011 review article evaluated the scientific evidence for programs 
delivering curative treatments for malaria, diarrhea and pneumonia in Africa, and found that 
large and significant reductions in under-5 mortality were reported, though only six studies 
were conducted in sub-Saharan Africa between 1995 and 2005, all in West African countries 
(Benin, Ghana, The Gambia) (Christopher, Le May et al. 2011).  The programs under study 
included both nationwide programs and small-scale interventions initiated for research 
purposes, but none included fully integrated care or the full array of curative treatments 
included under iCCM (antibiotics, ACTs, and ORS with zinc).  Indeed, while the integration 
of health services is intuitively appealing, there is still a paucity of evidence as to whether 
integration actually improves outcomes and access to services (Shigayeva, Atun et al. 2010). 
The notion of integration has roots in organizational theory, and has been found to reduce 
fragmentation and duplication and improve the sustainability of communicable disease 
programs; however, the impact of integrated policies on patient outcomes remains under-
studied.  
Nonetheless, there have been some tests of integrated programs for child illness, including a 
community-based trial in Zambia piloting the use of CHWs to treat uncomplicated malaria 
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with artemether-lumefantrine and nonsevere pneumonia with amoxicillin.  Of children with 
non-severe pneumonia (N=3,125), 68.2% in the intervention arm received early and 
appropriate treatment compared to 13.3% in the control arm (RR 5.32, 95% CI: 2.19-8.94) 
(Yeboah-Antwi, Pilingana et al. 2010).  Study authors concluded that the approach might 
help reduce overuse of ACTs as well as provide early and appropriate treatment to sick 
children. Furthermore, though the symptoms of malaria and pneumonia overlap significantly  
(Kallander, Nsungwa-Sabiiti et al. 2004), CHWs have been shown to be able to distinguish 
between them using clinical criteria, agreeing with a pediatrician’s breath readings 85% of the 
time and prescribing anti-malarials in 96% of children with a positive RDT, in a Ugandan 
study (Kallander, Nsungwa-Sabiiti et al. 2004; Mukanga, Babirye et al. 2011)  At least one 
earlier study also suggested that broader (i.e. integrated) roles for CHWs, with the treatment 
of diarrhea, pneumonia, and malnutrition, improved utilization of CHW services (Curtale, 
Siwakoti et al. 1995) 
In contrast, a large body of evidence buttresses iCCM from the direction of each individual 
pathology and its management at the community level.  Various studies have shown that 
CHWs can detect pneumonia using a watch; for example, in a study of 96 CHWs in eastern 
Uganda, CHWs were able to identify rapid breathing in under-5 children with a sensitivity of 
75% and specificity of 83% (Källander, Tomson et al. 2006).  In a community trial of 28 
randomized clusters testing community case management of severe pneumonia by lady 
health workers, the intervention group received full treatment with instructions to mothers, 
while the control group received the first dose antibiotics with referral to a health center 
(Bari, Sadruddin et al. 2011).  Cluster-adjusted treatment failure rates by day 6 were 
significantly reduced in the intervention clusters with a risk difference of 8.9% (95% CI –
12.4 to –5.4); barriers to obtaining care included transportation, cost, and distance to a health 
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center. Furthermore, the positive results of this first rigorous randomized trial of community 
case management of pneumonia are consistent with other sources of evidence, such as 
Nepal’s 20 years of experience with the community-based management of childhood 
pneumonia (Dawson, Pradhan et al. 2008).   
The inclusion of diarrhea in models of home- or community-based care has been more easily 
accepted than pneumonia or neonatal conditions, in large part because its treatment requires 
no medicines whose power to prescribe is reserved for higher-level actors in the health 
system, usually doctors. Indeed, simple oral rehydration solutions have been recommended 
since the 1970s to reduce deaths from diarrhea within the community, though in many ways 
it remains a neglected area today.  A 2010 systematic review of the evidence for ORS use in 
the home included no fewer than 169 studies, and used meta-analysis to estimate that home 
ORS use can prevent 93% of deaths from diarrhea (Munos, Walker et al. 2010).  The 
addition of zinc, which has been shown to reduce the duration and severity of diarrhea, has 
been recommended by WHO since 2004 (Walker and Black 2010). 
The status of home- or community-based treatment programs for malaria have changed in 
recent years with the introduction of ACTs, a much more expensive class of drugs than the 
previous generation (chloroquine, sulfadoxine/pyrimethamine).  Furthermore, the 
emergence of resistance to ACTs is greatly to be feared, as there are no other drugs currently 
available, a situation which can make policymakers reluctant to put these drugs in the hands 
of lesser-trained cadres of health workers.  There are numerous programmatic examples of 
community-level programs to treat malaria (Winch, Bagayoko et al. 2003), as well as lessons 
from the home management of malaria (HMM) (Gyapong and Garshong 2007), though 
many of these studies pre-date the era of ACTs.  A review of CHW models found that 
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programs for presumptive treatment of malaria for children with fever had the potential to 
increase the correct administration of treatment regimens at home, decrease malaria 
morbidity, and improve referral when facilitated referral mechanisms are included (Winch, 
Gilroy et al. 2005).  In any case, the high malaria burden in many countries of sub-Saharan 
Africa strongly motivates its inclusion in integrated approaches to childhood illness. 
There remain a number of worries about iCCM policy, less about the clinical benefits of 
integrating care than regarding the use of CHWs, about which some policy-makers remain 
circumspect.  For example, although there is a growing body of literature presenting 
evidence in favor of allowing CHWs to treat sick children for pneumonia with antibiotics, 
this aspect of iCCM is among the least supported by policymakers (Winch, Gilroy et al. 
2005; Dawson 2008) and indeed a recent review questioned how well community level 
treatment of childhood pneumonia can work in sub-Saharan African countries, which differs 
from Asian countries in their malaria burden and less developed community health 
infrastructure (Druetz, Ridde et al. 2014).  The most commonly cited concern about CHWs 
providing treatment with antibiotics is potential misuse of the drugs leading to antibiotic 
resistance; however there is little evidence either to support or disprove this notion.  
However, worries may be warranted given findings on iCCM programs showing that 
consistent, accurate treatment remains a challenge (Cardemil, Gilroy et al. 2012; Mukanga, 
Tiono et al. 2012), especially in the absence of effective supervision (Laínez, Wittcoff et al. 
2012). 
Finally, while a 2007 follow-up to the World Health Report 2006 (Working Together for Health) 
cited “robust evidence” that CHWs could contribute to improved outcomes in child health, 
the report also noted that the positive impact of CHW programs was not consistent and the 
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quality of services was sometimes poor (Sanders and Lehmann 2007).  According to the 
report’s authors, these problems can be overcome by the proper selection, training, support, 
and supervision of CHWs, the absence of which have unnecessarily undermined the 
credibility of CHW programs, due to “unrealistic expectations, poor planning and an 
underestimation of the effort and input required to make them work.”  Thus, questions 
remain about the sustainability of such programs and their long term effects on quality of 
care for the poor, rural populations they serve (Haines, Sanders et al. 2007).  Nonetheless, 
movement is being made toward providing further guidance in task-shifting as a system-level 
intervention, for example with WHO’s guide to task-shifting to optimize maternal and 
newborn interventions (WHO 2012). 
In sum, the scientific evidence in favor of CCM programs is not insubstantial; however, 
there is still relatively little evidence of the effectiveness of integrated, community-level 
treatment policies with the specific characteristics of iCCM.  This situation will doubtless 




Chapter 3. Study site: Niger  
3.1 Niger’s socio-historical context 
Niger is a relatively young state in the international order if not in sub-Saharan Africa, 
gaining independence from France in 1960 and experiencing alternating periods of autocratic 
rule and, for the past two decades, democratic governance, punctuated by coups d’état in 1996, 
1999 and 2010.  It is also a particularly weak state, ranking at the bottom of international 
indices for “political stability and absence of violence” and “control of corruption” 
(Kaufman, Kraay et al. 2008).  Niger’s pressing challenges also include a demographic 
context of high population growth, while natural resources and arable farmland are being 
diminished by global warming and desertification.  Niger’s long history of food crises, with 
20th-century famines named “poitrine large” and “vendre les enfants” (“large belly,” “sell the 
children”), continues in the present, with major food crises in 2005-2006 and 2010, and will 
likely worsen if current ecological and demographic trends continue. 
Over the past two decades Niger suffered several periods of instability, beginning with the 
coup ending the Third Republic in January 1996 by Colonel Ibrahim Barre, who assumed 
the presidency in July of the same year but was assassinated in 1999. The constitution of the 
Fifth Republic was approved by voters in July 1999, who then elected President Mamadou 
Tandja, who was later to create the network of rural health posts that served as the basis for 
implementing iCCM in Niger. Aside from the second Tuareg rebellion in 2007-2008, the 
next ten years of Tandja’s rule were relatively quiet, until his efforts in 2009 to extend his 
term by amending the constitution known as Tazartché. A coup in February 2010 led to the 
establishment of the Supreme Council for the Restoration of Democracy under Salou Djibo, 
followed by the election of current President Mahamadou Issoufou in April 2011 in a 
process deemed in accordance with international electoral standards.  However, Issoufou’s 
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presidency has thus far been beset by significant threats to national security, including the 
fall of Muammar Gaddafi’s regime in Libya, violent attacks by Boko Haram in northern 
Nigeria (and recently in Bosso, Niger), and the coup d’état in Mali in April 2012, which sent 
waves of refugees into western Niger.   
The structural adjustment era has had long-lasting effects on the Nigerian economy and 
technocratic cadre; its privations were particularly unwelcome as they coincided with the end 
of high uranium prices in the early 1980s.  As in other countries, adjustment had the effect 
of re-orienting priorities toward the short term, in part by privileging Finance Ministries over 
Planning Ministries (Lavigne Delville and Abdelkader 2010).  Furthermore, the IMF and the 
World Bank had a heavy hand in policy choices, and critics have pointed out donors’ 
tendency to bypass institutions and favor ad hoc over systematic solutions.  These 
circumstances lead to a “dramatic degradation of the capacities of planning and leadership 
… in large part the result of restructuring imposed by outside funders, at a time when ‘less 
government’ was ascendant” (Polet 2009).  A socio-anthropological study of international 
aid in Niger based on qualitative interviews with government figures reported a consensus 
that the state was significantly weakened or even crumbled during this period (Lavigne 
Delville and Abdelkader 2010).   
The same study, tellingly titled “Don’t Look a Gift Horse in the Mouth” (“A cheval donné on 
ne regarde pas les dents”), describes a “vicious cycle” in Niger which state passivity stimulates 
donor action, and vice versa, with the result that national policymakers tend to renounce 
responsibility or initiative (Lavigne Delville and Abdelkader 2010).  Outside donors remain 
very powerful in Niger given the country’s few technical and financial resources; Niger 
received approximately $400 million in aid in 2008, representing 50% of its public 
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expenditure (EURODAD 2008).  Since 2000, there has been a greater tendency for donors 
to follow countries’ direction regarding national strategies, a principle enshrined in the 2005 
Declaration of Paris, but the power dynamics have not been modified:  multi- and bi-lateral 
organizations can “finance human, technical, institutional, and political resources to 
standards that are quite far from those accessible using the State’s own resources” (Lavigne 
Delville and Abdelkader 2010).   
The characteristics of the Nigerien state as described by Lavigne Delville and Abdelkader 
dovetail with descriptions of the neopatrimonial state outlined above, including its lack of 
strategy and direction, the fact that is not well anchored in society, and the prominence of 
clientelistic relations.  The rural sector remains neglected, for example in Niger’s Poverty 
Reduction Strategy, the writing of which the World Bank is said to have participated in 
extensively.  Furthermore, the “President’s Special Program” (Programme spécial du Président), 
which funded President’s Tandja’s project of rural health posts (cases de santé) involved in 
iCCM, was singled out by respondents as an “extreme case of the personalization of public 
funds” used to achieve political ends (Lavigne Delville and Abdelkader 2010).   
3.2 Nigerien health system in historical perspective 
With one of the world’s least dense populations (only 12.5 people/sq. km in 2010), and 
extremely scarce human resources in health (0.03 physicians per 1,000 population), Niger is 
challenged with providing even basic care to a far-flung population (WHO-AFRO 2006).  
Niger also has the world’s highest birth rate, 7.6 children per woman (DHS 2012).  The child 
mortality rate has dropped significantly in recent years, from 226 deaths per 1000 live births 
in 1998 to 128 deaths in 2009:  according to estimates using the Lives Saved Tool (LiST), the 
main causes of this reduction were the introduction of insecticide-treated bednets (25% of 
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the decrease); care-seeking for malaria, diarrhea, and pneumonia (22%); and improvements 
in nutritional status (19%) (Amouzou, Habi et al. 2012).  Still, the current child mortality rate 
remains high even for the region, and the top causes of death are pneumonia (18%), malaria 
(15%), diarrhea (15%), with neonatal deaths equal to 25% of all deaths (WHO/UNICEF 
2012).    
It is useful to put Niger’s health system in historical perspective.  The first community-based 
approaches in Niger date to the 1960s, with the creation of village health teams (équipes de 
santé villageoises) whose members, called secouristes-hygiénistes, provided basic preventive and 
curative care in their home communities. This program included at-cost payment for drugs 
to allow the secouristes to renew their supplies; however, services were provided for free.  In 
1974, there were 780 secouristes in 396 villages (Fournier and Djermakoye 1975) and program 
was reinforced by Niger’s adhesion to the Declaration of Alma-Ata in 1978, which called for 
expanding access to primary health care and collaboration with communities.  However, the 
village health teams began to fade during the 1980s, finally disappearing in the 1990s 
following a “lack of results obtained in comparison to the resources expended” (MSP 2008).   
The 1987 Bamako Initiative, calling for community financing as a mechanism to achieve 
universal access to primary health care, was influential in Francophone African countries 
including Niger (Gilson 1997).  Following political upheavals in the early 1990s, the Nigerien 
government decided to generalize the Bamako Initiative in 1995 in a reform process that 
included the implementation of user fees, alongside enhanced community participation and 
utilization of essential medicines.  However, subsequently, service utilization remained 
extremely low, as the state had reduced its financial contribution and not all patients had the 
means to pay (Ridde and Diarra 2009).  In the Tillabéri region, the creation of a cost 
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recovery program resulted in a 41% reduction in the number of patients in the eight health 
centers followed in the study (Meuwissen 2002).   
The cost recovery regime persisted until 2006, at which point 85% of private health 
expenditure on health was out-of-pocket (Ridde and Diarra 2009).  In April 2006, Nigerien 
President Mamadou Tandja announced the removal of user fees for health services first for 
pregnant women, and then for children under five.  In the years since, studies of the 
reform’s effects have been generally positive:  the number of consultations by children under 
5 increased “suddenly and immediately” after the policy change by 10,427 consultations per 
quarter, equivalent to a 98% increase in utilization by target groups (Lagarde, Barroy et al. 
2012) and health services workers found the change in policy “noble and beneficial” (Ridde, 
Diarra et al. 2011).  In this sense, the policy has been a success; however, the state’s 
reimbursement system is in arrears up to 6 billion CFA (US$12 million) and is highly 
dysfunctional, leading to fears about the system’s immediate, not to speak of long-term, 
sustainability (Ousseini 2011; Lagarde, Barroy et al. 2012; Ridde and Olivier de Sardan 2012). 
With respect to child survival approaches, a number of strategies have been implemented in 
recent years to address consistently high child mortality rates.  In 1994, the USAID program 
BASICS began testing early integrated approaches called “combined case management” 
(CCM), including community-based interventions, which paved the way for the arrival of 
IMCI in 1996 (Legros, Tawfik et al. 2002).  However, while implementation of IMCI had 
begun in 1997, it focused on the first two components of this policy (clinical management of 
childhood illness and health systems strengthening) and not the third component 
(community-level care).  Indeed, a 2001 review of IMCI, which reported that little progress 
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had been made on this front (Konate and Zataka 2004).  Implementation of the community-
based IMCI (C-IMCI) began in 2003-2004 and proceeded slowly.   
At the same time, infrastructural improvements were underway in the Nigerien health 
system.  A new cadre of CHWs (called agents de santé communautaire) began to be trained and 
placed in a network of rural health posts (cases de santé).  CHWs were trained for 6 months 
and legally permitted to prescribe antibiotics, ACTs, and ORS, though supplies were highly 
inadequate (Degbey 2004).  Funds to pay the CHWs’ salaries and construct the rural health 
posts were provided by President Tandja’s Programme spécial beginning in 2001 (Bensaid and 
Mistycki May 2011).  By 2003, there were already 1,201 health posts, though few were yet 
fully staffed and operational (MSP 2005); today there are over 2,500, representing the health 
infrastructure that would form the basis of iCCM.  
In sum, the Nigerien health system has made significant improvements in recent years, 
becoming much more financially and geographically accessible to poor, rural populations.  
However, the system remains fragile and chronically underfinanced, as it competes for 
government and aid funds with the many other pressing priorities in one of the world’s 
poorest countries.    
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Chapter 4. Epistemic communities in global health and the 
development of child survival policy: a case study of iCCM 
4.1 Abstract 
Nearly all African countries have recently implemented some form of integrated community 
case management of childhood illness (iCCM), a strategy aimed at reducing child mortality 
by providing curative care for common yet fatal childhood illnesses. This case study 
describes the evolution of iCCM at the global level using the theory of epistemic 
communities first outlined by Haas, which explains how international policy coordination on 
technical issues takes place via transnational expert networks. We draw from in-depth 
interviews with global policy-makers (n=25), a document review (n=72) and co-authorship 
network analysis of scientific articles on iCCM. We find that members of the iCCM 
epistemic community were mainly mid- to upper-level technical officers working in the 
headquarters of large norm-setting bodies, implementing partners, funders and 
academic/research groups in global health.  Already linked by pre-existing relationships, the 
epistemic community was consolidated as conflicts were overcome through structural 
changes in the network (including or excluding some members), changes in the state of 
technology or scientific evidence, shifting funding considerations, and the development of 
consensus through argument, legitimation and other means.  Next, the epistemic community 
positioned iCCM as a preferred solution via three causal dynamics outlined by Haas: 1) 
responding to decision-makers’ uncertainty about how to reduce child mortality after 
previous policies proved insufficient, 2) using sophisticated analytic tools to link the problem 
of child mortality to iCCM as a solution, and 3) gaining buy-in from major norm-setting 
bodies and financial and institutional support from large implementing agencies.  Applying 
the epistemic communities framework to the iCCM case study reveals the strengths and 
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weaknesses of a focused policy enterprise with highly specialized and homogenous 
disciplinary origins, which allows for efficient sharing of complex, high-level scientific 
information, but may exclude voices from relevant methodological areas, operational actors 
or country-level stakeholders.   
 
4.2 Introduction & Background 
In 2013, an estimated 6.3 million children under five died worldwide, with almost a third 
dying from pneumonia, diarrhea and malaria, a percentage that rises to nearly 40% in sub-
Saharan Africa (You, Hug et al. 2014). Integrated community case management of childhood 
illness (iCCM) is a strategy to expand access to life-saving curative care for children with 
these diseases using community health workers (Figure 2).  Designed by a transnational 
network of technical experts and leading to a WHO/Unicef Joint Statement 
(WHO/UNICEF 2012), iCCM was subsequently showcased in a 2012 supplement in the 
American Journal of Tropical Medicine and Hygiene (Young, Wolfheim et al. 2012). ICCM 
has been promoted by prominent stakeholders in child health at the global level, including 
WHO, Unicef, USAID and others, with funding provided by bi- and multi-lateral agencies 
and private foundations.  To date, nearly all African countries have adopted some form of 
iCCM, including CCM for malaria, diarrhea or pneumonia or some combination thereof 
(Rasanathan, Muñiz et al. 2014).   
Figure 2 Definition of iCCM 
The provision by community health workers (CHWs) of integrated diagnosis and treatment 
for children under five of: 
(i) pneumonia with oral antibiotics, 
(ii) diarrhea with zinc and oral rehydration salts (ORS),  
(iii) malaria with artemisinin combination therapy (ACTs) and other antimalarials.   
 
Source:  Adapted from WHO/Unicef Joint Statement: Integrated community case management (2012)  
33 
 
Preventable child deaths have long been a focus of global health policy-makers, whose 
proposed interventions consistently target malaria, diarrhea and pneumonia, among other 
illnesses.  Campaigns in the 1960s and 1970s such as malaria eradication, as well as the 
primary health care movement epitomized by the Alma Ata conference in 1978, represented 
major efforts to reduce deaths from these diseases (WHO 1978).  These initiatives faltered as 
the 1980s ushered a sustained financial crisis, whose effects on health systems in LMICs 
were aggravated by fiscal austerity measures instituted under structural adjustment.  Global 
health policy-makers shifted to more targeted approaches such as selective primary health 
care, as in Unicef’s GOBI strategy (growth monitoring, oral rehydration, breastfeeding, 
immunization) (Walsh and Warren 1979; Cueto 2004).  Later in the 1990s, WHO came out 
with Integrated Management of Childhood Illness (IMCI), a diagnostic and treatment 
algorithm for malaria, diarrhea, pneumonia, measles and malnutrition (WHO 1997).  First 
introduced in Tanzania and Uganda in 1996, IMCI was adopted in over 100 countries. 
However, expected reductions in child mortality subsequently failed to materialize, as IMCI’s 
impact was limited mainly to facilities and not community settings where most child deaths 
occurred (Bryce, Victora et al. 2005). 
The articulation of the Millennium Development Goals in 2001 further focused global 
policy-makers’ attention on reducing child mortality. Discussions variously emphasized 
interventions for specific pathologies (malaria, HIV/AIDS, pneumonia); a renewed 
emphasis on vaccine-preventable diseases following the development of vaccines against 
Haemophilus influenzae type b (Hib), pneumococcal disease and rotavirus; and the perennial 
problems of under-nutrition and malnutrition.  Concurrently, the universe of health policy 
actors grew institutionally broader (Glass, Guttmacher et al. 2012).  With respect to child 
health, U.N. agencies (primarily WHO and Unicef) increasingly shared the stage with 
34 
 
bilateral aid agencies, private foundations and non-governmental organizations (NGOs) 
(WHO, UNICEF et al. 2003). Among policy discussions within and across these multiple 
policy networks, iCCM would emerge as a global strategy highly endorsed by international 
actors as a means to address child survival in Africa. 
This study describes the origins of iCCM policy and is linked to a policy analysis of iCCM in 
six countries in sub-Saharan Africa.  We aimed to examine underlying causal determinants of 
iCCM’s rise to prominence at the global level and identify processes facilitating network 
formation and reasons for the network’s effectiveness.  The case study takes as its endpoint 
the issuance of iCCM policy, defined as the 2012 WHO/Unicef Joint Statement on iCCM 
(WHO/UNICEF 2012) and preceding implementation guidelines issued by USAID and the 
CORE Group (USAID, CORE_Group et al. 2010).  We first present our methodology for 
data collection and multi-stage analysis, then present results using the epistemic communities 
framework to show how the iCCM policy community initially formed, how members 
resolved internal conflicts about specific points of policy and how they positioned iCCM as a 
preferred policy solution.  Finally we review our findings and draw lessons from this case 
study with resonance for global health policy-making more broadly.   
Epistemic communities framework 
Various theoretical frameworks have been proposed to analyze the networks of individuals 
responsible for national and global policy, which is increasingly made by diverse sets of 
actors connected through non-traditional governance arrangements (Ostrom, Tiebout et al. 
1961). The range, diversity, and fluidity of actors working on policy issues is captured by the 
concept of policy networks, which have variously been described as issue networks (Heclo 
1974), policy communities (Wright 1988; Coleman and Skogstad 1990), global and 
35 
 
transnational policy networks (Slaughter 1997; Walt, Lush et al. 2004; Stone 2008), advocacy 
networks (Keck and Sikkink 1998), and epistemic communities (Haas 1992).  Policy network 
theory, in addition to providing a helpful heuristic to describe who participates in 
policymaking (Atkinson and Coleman 1992), can also be used to explain policy outcomes 
through examinations of network structure (Howlett 2002; Provan, Fish et al. 2007; 
Sandström and Carlsson 2008).  
In his seminal 1992 article, Haas proposed “epistemic communities” as agents of policy 
change in a framework bringing together elements of structural, institutional and normative 
theories (Haas 1992). Epistemic communities are networks of technical professionals who 
gather, synthesize and interpret technical bodies of knowledge and as such play a strong role 
in determining which policies are selected in highly specialized policy arenas.  Under Haas’ 
framework, epistemic communities are defined by the fact that their members hold shared 1) 
values / normative beliefs, 2) causal beliefs, 3) notions of validity, and 4) a common policy 
enterprise, or set of common practices associated with specific policy problems (Haas 1992). 
Epistemic communities influence change by articulating problems and potential solutions, 
framing the issues for debate, proposing policies and sometimes offering funding (Haas 
1992; Hafner and Shiffman 2013).  In so doing, members of epistemic communities 
promote the solutions they favor via three causal mechanisms: 1) by relieving decision-
makers’ uncertainty about which policies best address complex issues; 2) by engaging in 
interpretation of so-called raw data or observations, filtering them through worldviews, 
disciplinary perspectives, and stated and unstated beliefs; and 3) by seeking to institutionalize 
their preferred policy solutions (Haas 1992).   
36 
 
The epistemic communities approach is well-adapted to analyzing policy networks like the 
one around iCCM, whose transnational membership of technocrats and researchers of 
diverse national origin was nonetheless homogenous in terms of educational status 
(including many medical doctors and PhDs), disciplinary background or area of 
specialization (usually medicine or public health), and socio-professional profile.  Together, 
these actors were, or were in dialogue with, policy-makers in global health agencies, donor 
organizations, and research universities, and were thus positioned to relieve their uncertainty 
about policy options, interpret data and institutionalize policy solutions, following the causal 
mechanisms driving epistemic communities.  The epistemic communities framework is also 
highly relevant to global public health policy making because it examines power dynamics 
deriving from experts’ authority on technical matters and explores how large organizations 
broker the creation of far-reaching policies.   
4.3 Methods 
Data collection took place from May to August 2013 and included a document review 
(N=72 documents, Table 1) and semi-structured in-depth interviews (N=25, Table 2).  We 
used initial purposive selection of respondents followed by a snowball approach, targeting 
key informants involved in or knowledgeable about iCCM policy formulation, including 
technical officials working at major international agencies, bilateral aid agencies, non-
governmental organizations (NGOs), private foundations and academic/research 
organizations.  Interviewees were associated with policy communities focusing on specific 
pathologies including malaria, pneumonia (often linked with diarrhea and/or the broader 
child survival community), and more rarely nutrition or health systems issues.  Interviews 
were conducted mainly by telephone and lasted approximately 45 minutes; these were audio 
recorded and transcribed verbatim.   
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Table 1 Contents of document review 
 
 
Number of documents 
Global policy (guidelines, recommendations, strategic plans) 15 
Meetings (conference reports, meeting minutes, PowerPoint presentations) 19 
Scientific journal articles 16 
Programmatic documents (program evaluations, working papers, operational  research, calls 
for proposals) 
8 
Implementation tools (guides, training manuals, planning documents) 9 
Public communications (websites, fact sheets, declarations of support) 5 
TOTAL 72 
 
Table 2 Organizational membership of interview respondents 
 Number of interviews 
Multi-lateral agencies  11 
Bilateral agencies  7 
NGOs/private foundations  3 
Academic/research organizations  4 
TOTAL 25 
 
Preliminary data analysis began with the document review, which we used to populate a 
timeline capturing key events in iCCM global policy creation and compare how iCCM policy 
and related topics were framed by individuals, groups, and institutions in terms of themes, 
reasoning, and interpretation of the data, as well as underlying values, principles, and causal 
beliefs (Eyles, Robinson et al. 2009).  For interviews, we performed primary thematic 
analysis using NVivo 9 software to apply codes on the origins of iCCM; policy content; 
policy-making processes; actors; and the types and uses of scientific evidence (QSR 2010).  
Emerging themes and links to theory (including policy network theories and the epistemic 
communities frameworks) were documented and discussed by research team members as 
data collection was ongoing.  The epistemic communities approach was selected as best 
according with observations that actors were mostly technical and acted in a transnational 
policy space; the framework also captured the interplay between ideas and institutions better 




We then applied the epistemic communities approach to emerging understandings of policy 
creation, refining our analysis to define the epistemic community’s membership and using 
the theory’s three causal dynamics – uncertainty, interpretation and institutionalization – to 
explain how iCCM came to the fore in the policy sphere.  To obtain greater clarity about the 
shape and structure of the epistemic community, we used co-authorship network analysis to 
examine how authors formed a larger network structure. Relevant publications were 
retrieved using the search terms “community case management” in ISI Web of Science, 
excluding irrelevant categories (e.g. GERONTOLOGY). Abstracts were read to exclude 
studies in high-income countries, resulting in 62 publications and 276 unique authors from 
2005-2013 (no lower limit for search dates; upper limit of June 2013). Network analyses were 
performed using Science of Science (Sci2) software, version 1.0 (Indiana University). 
This study was deemed exempt from ethical review by the Johns Hopkins Bloomberg 
School of Public Health. 
Study limitations 
It was not possible to interview all targeted key informants. Approximately 35 people were 
contacted, resulting in 25 interviews. A comparison of respondents and non-respondents 
found no significant differences in the profile of these two groups. As in many types of 
qualitative research, respondents may have sought to reflect well on themselves or the group 
they represent. We mitigated this bias by triangulating among data types and sources. Finally, 
the authors of this analysis are or have been affiliated with organizations involved in iCCM 
policy development.  To improve the trustworthiness of the findings, we prioritized 
viewpoints from data sources not associated with these organizations in matters involving 
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them, and checked emerging analyses against possible social desirability bias and other 
biases. 
4.4 Results 
In this section, we describe how the epistemic community around iCCM coalesced and how 
members reached consensus by resolving conflicts over values/normative beliefs, causal 
beliefs, notions of validity, and a common policy enterprise.  We then describe how the 
epistemic community used the dynamics of uncertainty, interpretation and 
institutionalization to promote iCCM as a favored solution in the global health policy sphere. 
Figure 3 presents an overall timeline of events and accompanying policy documents 
important in the creation of iCCM. 
 




4.4.1 An epistemic community forms around iCCM 
Over the course of a decade or more, actors working on different facets of child survival 
came together to form an epistemic community that would design iCCM as a way to meet 
the Millennium Development Goal (MDG) on child survival.   After giving an overview of 
the child survival policy landscape and iCCM policy community that emerged out of it, we 
attempt to understand this process using co-authorship analysis to describe the growth of 
linkages, and use interview data to describe the qualitative nature of ties among epistemic 
community members. 
First, networks of policy actors working on child survival in the late 1990s and early 2000s 
were organized along a number of axes, including specific pathologies, (malaria, diarrhea and 
pneumonia, nutrition), child survival programs (notably IMCI and C-IMCI), and broader 
issue areas such as child survival, health systems and community health workers (CHWs).  
These networks had varying degrees of overlap and spanned different organizations and 
departments, for example in the case of the malaria network, which linked officials from 
WHO (Global Malaria Programme, Tropical Disease Research Programme, Roll Back 
Malaria), USAID (PMI), and academic researchers working on malaria, among others.   
Institutionally, the main actors who would become involved in the creation of iCCM at the 
global level were located at WHO, Unicef, bilateral aid agencies (USAID and CIDA, now 
DFATD), private foundations (principally the Gates Foundation), NGOs such as Save the 
Children and other members of the CORE Group, and academics and researchers (Table 
3).  Actors were mainly mid- to upper-level technical officers working in the headquarters of 
these agencies and were often connected via coordinating mechanisms such as the CORE 
Group, the Child Health Epidemiology Research Group (CHERG), and more recently the 
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Partnership for Maternal, Neonatal and Child Health (PMNCH) and the Countdown to 
2015 Group (Table 4), as well as via meetings (such as an important 2001 Baltimore meeting 
on C-IMCI), evidence reviews (the 2002 Stockholm meeting on pneumonia) and global-level 
forums such as the Global Action Plan on Pneumonia (GAPP) process (see the timeline, 
Figure 2). 
In June 2008, following initial discussions at meetings under the GAPP process, members of 
WHO, Unicef, USAID, Save the Children, the CORE Group, Karolinska Institutet and the 
Johns Hopkins University, among other organizations formed the CCM Task Force as a 
forum for facilitating iCCM policy development (see Table 4 for details).  Members of the 
CCM Task Force were mid-level technical staff of diverse national origin (including from 
LMICs) working out of agency headquarters, as well as researchers affiliated with mainly 
Western institutions. These actors worked to formulate the specifics of iCCM policy through 
ongoing meetings, reviews and communication, with sharing and consultation facilitated by 
the creation of a website (CCM.org) in 2011.   
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Table 3 Main organizations involved in iCCM policy development 
 Early policy development (late 1990s – 2008) Later policy development (2008-2012) 
WHO - Child and Adolescent Health Dept. involved in creating early guidelines 
for community-level IMCI; 
- ARI program solicited ongoing research and evidence reviews but 
reluctant to push for CCM-pneumonia despite positive findings; 
- Co-authored Joint Statements on CCM for pneumonia and diarrhea; 
- Roll Back Malaria publishes its “Home Management of Malaria” strategy. 
- WHO-led GAPP process convenes actors, raises support for CCM-pneumonia; 
- Steering committee member of CCM Task Force; 
- Supported operational research for and evaluation of iCCM; 
- 2010 WHA resolution supported CCM for pneumonia ; 
- WHO-TDR and the Global Malaria Program joined discussions on iCCM; 
- GMP administered RAcE funding from CIDA for iCCM beginning in 2012. 
Unicef - Failed to provide leadership on C-IMCI despite its responsibility for this 
policy, partly due to leaderships emphasis on other priorities; 
- Implemented Accelerated Child Survival (ACSD) program in 11 West 
African countries (2001-2005), case management not emphasized; 
- Co-authored Joint Statements on CCM for pneumonia and diarrhea; 
- Renewed focus on child survival following 2005 change in leadership. 
- Main implementer of Catalytic Initiative to Save a Million Lives, including large-
scale iCCM programs in Africa (2008-2011); 
- Steering committee member of CCM Task Force; 
- Supported operational research for and evaluation of iCCM. 
USAID - Bureau for Global Health led BASICS program of child survival strategies, 
which initiates pilot studies of CCM approaches in a number African 
countries beginning in 2004; 
- Diffused CCM approaches throughout the African region in a series of 
meetings (Dakar 2005, DRC 2007, Madagascar 2008). 
- PMI (launched in 2005) brings enhanced funding possibilities after joining in later 
discussions of iCCM policy; 
- MCHIP (created in 2008 as USAID’s flagship maternal and child health project) 
served as the secretariat for the CCM Task Force. 
CIDA  - Funded more than half of the ASCD program testing child survival 
interventions in West Africa. 
- Provided major funding for the Catalytic Initiative (CI), insisting on evaluations 
that measured iCCM’s impact on mortality; 
- Required implementation of iCCM as a conditionality mid-way through CI;  
- Funded several NGOs to implement iCCM in multiple countries.  
Gates 
Foundation 
- Provided grants to JHSPH for the development of the LiST tool; 
- Provided support to PMNCH for advocacy on child survival issues. 
- Co-funded the Catalytic Initiative; 
- A Gates call for proposals coins the name ‘iCCM’; 
- Funded operational research for and evaluation of iCCM. 
Save the 
Children 
- Leadership role within CORE Group in early work on creating a 
framework for C-IMCI; 
- Organized pilot studies of CCM-like approaches in a number of countries. 
- Ongoing programmatic work on CCM with operations research;  
- Strong individual advocates for child survival; 
- Steering committee member of CCM Task Force; 
- Involved in preparing the AJTMH supplement. 
Academic 
actors  
- JHSPH contracted by USAID and CIDA to support child survival work, 
reviewing CHW profiles, participating in drafting of joint statements and 
guidelines; anchors CHERG; contracted to externally evaluate ACSD; 
- Karolinska Institutet provided research on symptom overlap of malaria 
and pneumonia and home management of malaria; 
- Boston University performed early studies on antibiotics regimens. 
- JHSPH contracted by  CIDA to externally evaluate Catalytic Initiative; 
- JHSPH review of ACSD points out need to focus on iCCM; 
- Karolinska wins one of several Gates funded iCCM implementation research 
protocols in collaboration with Malaria Consortium. 
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Table 4 Coordinating mechanisms’ involvement in iCCM policy development 
 Description Membership 
Early policy development  
(late 1990s – 2008) 
Later policy development  
(2008-2012) 
CORE Group A coalition of non-profit 
global health organizations 
created in 1997 and funded by 
USAID. 
- 70+ NGOs including Care, 
IRC, CRS, World Vision, 
PATH, Save the Children, 
several of which implement 
iCCM, among other child 
survival efforts; 
 
- Contributed to 
producing C-IMCI 
framework;  
- Provided a forum for 
implementers to 
communicate and share 
best practices. 
- Created guidelines and 
implement-ation tools for iCCM 
such as the “CCM Essentials” 
handbook (2010); 
- Member organizations 
implement iCCM under USAID 






Established in 2001 primarily 
by WHO as an independent 
source of technical expertise 
on child health estimates. 
- Technical experts from 
University of Toronto, 
JHSPH, London School of 
Hygiene and Tropical 
Medicine, UNC-Chapel Hill, 
etc. 
- Estimation of levels and 
causes of child mortality 
using Global Burden of 
Disease data. 
- Continued to highlight gaps in 
the coverage of evidence-based 
interventions and highlight 




and Child Health 
(PMNCH) 
Hosted by the WHO from 
2005 to allow partners to 
“share strategies, align 
objectives and resources, and 
agree on interventions.” 
- Academics; donors and 
foundations; health-care 
professionals; multilateral 
agencies; NGOs; partner 
countries; and the private 
sector. 
- Promotion of LiST as a 
tool to select 
interventions; 
- Created the Countdown 
to 2015 partnership in 
2005. 
- Supported implementation of 
iCCM with Gates Foundation 
funding as part of  the Catalytic 
Initiative. 




Established in late 2005 as a 
multi-institutional 
collaboration to speed 
progress toward MDGs 4 and 
5 on maternal & child health. 
- Academics (LSTMH, 
JHSPH, Harvard), the 
Lancet, WHO, UNICEF, 
World Bank, Gates 
Foundation; also 
implementing partners such 
as JHPIEGO and SCF. 
- Focused attention on the 
problem of access to 
health facilities and the 
major pathologies 
blocking progress on 
MDG4. 
- Creation of country scorecards/ 
dashboards linking core 
indicators to problems to be 
resolved. 
CCM Task Force Grew out of GAPP process in 
2007-08 to track iCCM policy 
change and program status. 
- Steering committee:  
UNICEF, WHO, USAID 
and Save the Children; 
- Other members:  MCHIP 
(Secretariat), CORE Group, 
MSH, PSI, URC, JSI, and 
others. 
N/A - Established CCM.org website; 
- Consolidated available research 
evidence and existing 
implementation tools for CCM 
for broader dissemination; 
- Used matrices of work in 




Co-authorship network analysis (Figure 4) demonstrates how the iCCM policy community, 
as represented by technical authors publishing in scientific journals from 2005 to 2012, were 
initially clustered by pathology, with distinct authorship communities linked to malaria (such 
as around K. Kallander, K. Yeboah-Antwi) and pneumonia (D. Marsh, K. Gilroy) visible as 
late as 2010 (network “A”).  By the following year, links had been established between 
authors of the first CCM study including both malaria and pneumonia (Yeboah-Antwi, 
Pilingana et al. 2010) and the larger malaria group working on HMM in Uganda via a shared 
publication with malaria expert F. Pagnoni (network “B”).  In 2012, many principal members 
of the iCCM policy network were linked through the publication of a 2012 supplement on 
iCCM in the American Journal of Tropical Medicine and Hygiene closely following the issue 
of the Joint Statement on iCCM in June of that year (network “C”).  Accounting for delays 
inherent to the publication process related to manuscript preparation and peer review, the 
analysis highlights the increasing consolidation of actors around iCCM as researchers 
focusing on different pathologies begin to collaborate and publish together, with the 
academic literature mirroring the shape of policy.  Although no specific “diarrhea” 
authorship community is visible, this is likely due to long-standing acceptance of CCM for 




Figure 4 Evolving co-authorship network of publications including the term "iCCM" 
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Co-authorship network analysis only documents formalized relationships and gives little 
indication of the depth, longevity or affective nature of ties between epistemic community 
members.  In interviews, however, several respondents discussed the importance of long-
standing ties among members of the iCCM epistemic community, created by actors’ 
movement across organizations and issue areas, in facilitating policy development:  
“[Y]ou have people that have known each other, worked together for 30 years. And 
you can talk about this stuff and agree on how to move forward … it certainly made 
[policy discussions] a lot more fun.” (GLO_2013-07-11, multi-lateral agency) 
“[I]t’s a small community. … Information circulated pretty fast. We knew each other. 
We had collaborated. So I don’t remember having had any problem of getting 
information from them. And I hope they never had any problem in getting 
information from me. For example, when I worked I used to see [a researcher] at 
least six times a year, maybe more. And we talk to each other almost weekly.” 
(GLO_2013-6-27, multi-lateral agency) 
While our data does not comprehensively reveal the extent of such ties or how they were 
clustered within the epistemic community, at least some core members of the iCCM 
epistemic community appear to have enjoyed substantial familiarity and collegial relations, 
creating an atmosphere of trust and facilitating collaborative work on iCCM.  Our research 
did not turn up evidence of pre-existing ties hindering progress on iCCM, although a few 
respondents reported professional disagreements that bordered on personal conflicts, such 
as in arguments over whether the existing evidence base was sufficient (discussed in greater 




4.4.2 Resolving conflicts within the epistemic community 
Epistemic communities are a sub-set of policy networks in which members hold shared 1) 
values/normative beliefs, 2) causal beliefs, 3) notions of validity, and 4) a common policy 
enterprise (Haas 1992).  Initially, policy actors had points of conflict across all four 
dimensions (Figure 5); indeed they agreed only on broad policy objectives.  These conflicts 
were resolved through structural changes in the network (i.e. including or excluding some 
members), changes in the state of technology or scientific evidence, shifting funding 
considerations, and the development of consensus through argument, legitimation and other 
means. 
Values/normative beliefs.  While actors agreed on the importance of addressing child survival 
and the acceptability of task-shifting in general, they held conflicting normative beliefs about 
the ability of lower-level health workers to safely and effectively administer antibiotics for 
the treatment of pneumonia.  Respondents said some policy actors (located mainly at WHO) 
were reluctant to accept CCM for pneumonia, voicing concerns about antimicrobial 
resistance, and indeed WHO lagged behind in advancing the policy even as countries began 
to implement it (GLO_2013-6-14, academic; GLO_2013-07-23, bilateral agency).  At a June 
2002 meeting in Stockholm on pneumonia care, researchers presented an updated meta-
analysis of pneumonia trials (Sazawal and Black 2003), which respondents described as a 
“wake-up” moment about the solidity of the evidence for scaling up CCM pneumonia.  
However, shortly thereafter, an earlier set of CCM guidelines from WHO’s ARI program 
was removed from the WHO website (GLO_2013-07-11-2, GLO_2013-07-23, bilateral 




Figure 5 Resolving conflicts within the iCCM epistemic community 
 Points of consensus Points of conflict Forces of reconciliation 





- More widespread access to 
curative care for sick 
children is needed;  
- Some degree of task shifting 
is an appropriate response 
to limited human resources 
for health. 
- Normative disagreement 
about allowing lower-level 
health workers to 
prescribe antibiotics; 
- Tradeoff between risk of 
antibiotic resistance and 
treating sick children now. 
 - High rates of child mortality 
require a forceful policy 
response based on scientific 
evidence; 
- Community-based workers can 
safely and effectively prescribe 
antibiotics. 
     
Causal beliefs - Most child deaths occur 
outside the health system; 
- A few common illnesses 
cause most preventable 
child deaths, and these 
including malaria, diarrhea 
and pneumonia. 
- Disagreement about 
whether pneumonia or 
malaria was the leading 
cause of child deaths in 
Africa. 
 - Pneumonia causes many more 
deaths in African children than 
was previously believed; 
- Malaria and pneumonia must 
both be targeted and in an 
integrated fashion. 
     
Notions of 
validity 
- Epidemiological evidence is 
the best basis for policy; 
- “Gold Standard” is large-
scale experimental designs 
testing the mortality impact 
of iCCM. 
- Debate on whether 
sufficient evidence existed 
to move forward or 
whether more evidence 
was needed. 
 
 - “Gold Standard” evidence for 
integrated CCM will not soon 
be available; 
- It is acceptable to extrapolate 
from evidence on single-
pathology CCM programs.  
     
Common policy 
enterprise 
- Find innovative solutions to 
advance on the child 
survival MDG; 
- Maintain up-to-date 
strategies & guidelines. 
- Sectoral vs. multi-sectoral; 
- Simple vs. complex 
interventions; 
- Integrated vs. separate; 
- Health promotion vs. 
preventive vs. curative. 
 - Create an integrated 
community case management 
strategy to reduce preventable 
child deaths from malaria, 
diarrhea and pneumonia. 
RDTs demonstrate prevalence of non-
malarial fever in Africa.  
 
Argument that action is needed, despite 
lack of “Gold Standard” evidence.  
 
Complex, multi-sectoral intervention  
      fall out of favor after C-IMCI; 
Fundraising incentivizes integration;  
Legitimation of task-shifting for 
      curative care. 
Accruing evidence on safety &                           
efficacy of CCM-pneumonia;  
Clinicians’ resistance overcome via argument? 
Opponents leave WHO? 
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 “Fifteen years ago or even 20 years ago there were research agendas around diarrhea 
and pneumonia management … Only some of those pieces of an agenda were 
actually advanced. …  [W]ith all due respect to our friends in Geneva, it was a 
process of incremental change.” (GLO_2013-07-23, bilateral agency) 
Advocates of allowing CHWs to prescribe antibiotics (who often had positive experiences 
with CHWs early in their careers) argued that evidence favoring the intervention had “been 
there for a very long time: community-based trials, not one, two but rather eight, nine trials 
in the early ‘80s” (GLO_2013-07-22-2, multi-lateral agency).  However, the issue was 
seemingly not over scientific evidence; as one respondent said, 
“I think [iCCM] is one of the most evidence driven areas of policy, perhaps with the 
possible exception of how much more difficult it’s been to push the pneumonia 
treatment.” (GLO_ 2013-07-02-3, NGO/private foundation) 
Rather, the conflict appears to have stemmed from an over-riding normative belief about the 
appropriateness of allowing CHWs to prescribe antibiotics.  Respondents provided 
conflicting accounts or were unable to fully articulate the reasons for this normative conflict:  
“I don’t know if it’s the pediatric mafia or the medical mafia that doesn’t want to put 
antibiotics in the hands of a paraprofessional cadre.  That’s what you hear.” 
(GLO_2013-07-02-2, NGO/private foundation) 
“There is something unique about the use of antibiotics in children that creates a 
certain dynamic … that makes it distinctly different from many of the other things 
we work on and … leads to a more conservative, cautious approach.” (GLO_2013-
07-23, bilateral agency) 
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This “conservative, cautious approach” to modifying or expanding professional norms was 
most common in “rarified policy circles,” said the same respondent, as opposed to actors 
with more field experience who had personally observed positive outcomes with CHWs or 
were perhaps more attuned to the extent of needs on the ground.   
The exact way this normative conflict over the appropriateness of CCM for pneumonia was 
resolved remains somewhat obscure in our data.  One respondent said the stalemate was 
eased when one or two stalwarts against allowing CHWs to prescribe antibiotics (at least 
pending further research) left WHO around the time the CCM Task Force was gaining 
momentum (GLO_2013-6-14, academic).  In any case, opponents of CCM for pneumonia 
began to cede ground following the advent of the Global Action Plan on Pneumonia 
(GAPP) process in 2007 (WHO, UNICEF et al. 2007), as further indicated by a 2008 WHO 
Bulletin article urging countries to adopt CCM for pneumonia (Marsh, Gilroy et al. 2008), 
and finally a 2010 World Health Assembly Resolution in favor of the policy (WHA 2010).   
Causal beliefs.  Actors in the iCCM policy network agreed on the broad outlines of what 
illnesses caused child deaths and under what conditions but initially held conflicting beliefs 
about the relative contribution of malaria and pneumonia to overall child mortality in Africa.  
The received wisdom that malaria was by far the primary etiology of fever was supported by 
high malaria mortality estimates, though these were derived from epidemiological data based 
mainly on clinical diagnosis, which is less precise than laboratory tests.  Actors with 
professional experience in Asia, where pneumonia was by the greater problem, suspected the 
disease also caused many deaths in Africa and separate programs for the two diseases did not 
make sense, especially given their overlapping clinical presentation.  Still,  in the early 2000s, 
global policy-makers moved forward on strategies for community level treatment of malaria 
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only, notably Home Malaria Management (HMM) (WHO/RBM and WHO/TDR 2004; 
WHO-TDR 2005), a tactic made possible by the ample availability of funding for malaria 
programs in the early 2000s.  In these years, malaria stakeholders at WHO offices (Global 
Malaria Programme, Tropical Disease Research Programme, Roll Back Malaria), the Global 
Fund and PMI/USAID tended to resist calls to integrate CCM for malaria with care for 
other diseases.   
In reality, many cases of pneumonia in Africa were being misclassified as malaria due to the 
reliance on clinical diagnosis and high degree of symptom overlap (Kallander, Nsungwa-
Sabiiti et al. 2004).  The widespread introduction of malaria rapid diagnostic tests (RDTs) in 
the mid-2000s “changed the picture substantially” by providing concrete evidence that many 
sick children did not have malaria (GLO_2013-06-14, academic): 
“The push [toward integrated case management] happened when the RDTs came 
and the powerful malaria group realized that there’s RDT negative fever.  That’s 
when we got the push.” (GLO-2013-08-15, academic) 
The new evidence from RDTs modified the causal beliefs of the malaria (and other) 
stakeholders, as the greater number of child deaths in Africa was likely caused by 
pneumonia, not malaria.  To further encourage a shift in thinking, non-malaria policy 
network members used arguments that were at once scientific and affective to convince 
malaria stakeholders that integrated CCM was a necessity:   
“How I wrote it up – and I stand by this – is that those children were being treated 
for malaria, and they were dying because they didn’t have malaria but they had 
symptoms that are very similar …. Malaria programs, if they don’t treat the other 
52 
 
diseases, would be creating really a catastrophe….” (GLO_2013-07-12, bilateral 
agency)  
Following the introduction of RDTs, malaria stakeholders fully adopted this reasoning, 
incorporating it into later working documents such as a 2010 WHO-TDR PowerPoint 
presentation which mentions the “obligation to manage patients with negative RDTs” 
(Pagnoni 2010). 
Notions of validity. While there was general consensus among actors on standards of validity 
used to judge scientific evidence, there was less agreement on the exact amount of evidence 
judged sufficient for advancing the iCCM policy agenda. The “Gold Standard” of evidence 
was agreed to be experimental designs that could assess mortality impacts, however, such 
trials are difficult to realize for practical, financial and ethical reasons. Actors disagreed on 
the validity of basing policy on existing studies, which mainly included evaluations of CCM 
for single pathologies and few large trials.  Indeed, many respondents said scientific support 
for iCCM was “weak” (GLO_2013-6-14 and GLO_2013-08-15, academics; GLO_2013-07-
22-2, and GLO_2013-07-26, multi-lateral agencies; GLO_2013-07-08-2, bilateral agency).  
One respondent, when asked whether there was strong evidence for iCCM, said, “No. 
<Laughter> … That evidence base is pending” (GLO_2013-07-02-2, NGO/private 
foundation).  The disagreement between actors had to do with pursuing further research 
versus proceeding with policy development and implementation:     
“[Some actors] were just about at each other’s throat[s] … [some] people were really 
interested in research only versus the practical and implementation, and that was 
really one thing that annoyed a lot of [actors].”(GLO-2013-08-13, bilateral agency) 
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As mentioned before, our data does not fully elucidate how these points of discord were 
resolved within the epistemic community.  One respondent said resolution came following 
the departure of a few key figures at WHO as previously mentioned, as well as change in 
personnel at CIDA, where advocates had focused the evidence agenda on mortality impacts 
(GLO_2013-06-14, academic).  In any case, as opposition faded, a prevailing view would 
emerge in the epistemic community: 
“[The 2012 Joint Statement on iCCM] summarizes the disease-specific efficacy and 
effectiveness trials, and that seemed enough to justify rolling it out.  Yes, it’s not the 
same when you combine all three [diseases] … but, you know, public health is the art 
of incomplete information.” (GLO_2013-07-02-2, NGO/private foundation) 
“There was a leap of faith in terms of bringing the three conditions together.” 
(GLO_2013-07-08-2, bilateral agency) 
In the meantime, policy actors continued to engage in evidence building, through for 
example the Operational Research working group of the CCM Task Force and resulting 
outputs such as the 2012 American Journal of Tropical Medicine and Hygiene supplement 
(Young, Wolfheim et al. 2012). 
Common policy enterprise.  As the aforementioned conflicts were resolved, actors in the iCCM 
network were positioned to embark upon a common policy enterprise, with the ultimate goal 
of making progress toward the child survival MDG.  As with any global health policy, 
epistemic community members were faced with a set of choices:  whether the intervention 
would focus on the health sector or be multi-sectoral, whether an integrated approach to 
pathologies was merited, how simple or complex it would be, and where along the spectrum 
of care (health promotion, prevention, curative) the emphasis would be placed.    
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Multi-sectoral approaches had fallen out of favor after C-IMCI failed to launch (discussed 
further below), disfavoring the addition of activities related to poverty, agriculture and 
gender (GLO_2013-07-23, bilateral agency).  Furthermore, the question of separate versus 
integrated care for pathologies was resolved once malaria stakeholders accepted the 
implications of RDT-negative fever, a move embraced by other actors for clinical reasons 
and thanks to the promise of funding from the malaria side.  Malaria programs had been 
prime beneficiaries of a wave of vertical funding in the early 2000s, and other policy actors 
were eying malaria’s coffers: 
“[Malaria] brought a lot of resources, both from PMI and also from Global Fund. 
We basically decided that this was the star we needed to hitch to if we wanted to 
make iCCM go forward. So we groveled a little bit.” (GLO_2013-07-11-2, bilateral 
agency) 
Malaria stakeholders may have had their own incentives to make the strategic alliance 
following higher prices for the new artemisinin combination therapies compared to previous 
treatment regimes in the mid-2000s.   
Next, given the approaching deadline for the MDGs, members of the epistemic community 
focused on a simple, targeted approach to treating the three main pathologies that could be 
quickly implemented at scale.  And though actors agreed malnutrition was a common 
underlying cause of a substantial portion of child deaths, the interventions involved in caring 
for children with severe or moderate acute malnutrition were complex in their own right, 
and in many cases not suitable to be undertaken by CHWs with limited training 
(GLO_2013-07-11-2, bilateral agency).  For these reasons, epistemic community members 
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were inclined to exclude malnutrition from the iCCM policy enterprise, in the meantime 
creating space to resolve other disagreements.  As one respondent said, 
“There’s full recognition of the nutrition element of this, but also a concern that it 
might weigh down efforts to resolve disagreements over pneumonia.” (GLO_2013-
07-23, bilateral agency)  
Lastly, along the continuum of care, actors in the iCCM policy network were led to focus on 
curative care based on the objective of making rapid progress toward the approaching 
deadline for the MDGs (Druetz, Ridde et al. 2014).  And though significantly expanding 
curative care has far-reaching implications for countries’ health infrastructure and human 
resources, policy communities working on health systems remained separate from members 
of the iCCM epistemic community (GLO_2013-06-14, GLO_2013-08-15, academics), 
though some were performing highly relevant work regarding CHWs’ role in expanding 
access to child survival interventions (Haines, Sanders et al. 2007).  It is conceivable that the 
broader legitimation of task-shifting taking place in health systems policy communities may 
have seeped into the iCCM epistemic community, allaying concerns about using CHWs to 
provide curative services.  Our data do not permit us to verify this conjecture; however, 
these communities have subsequently been in more visible contact. For example, the Global 
Health Workforce Alliance (GHWA) funded recommendations on implementing iCCM and 
other community based interventions in conflict situations, as investigators involved in 
iCCM overlapped with GHWA (GHWA, UNCHR et al. 2011).  
4.4.3 How the iCCM epistemic community influenced policy development 
Once constituted, the iCCM epistemic community was poised to influence policy, and did so 
via the three causal dynamics outlined by Haas: 1) by relieving decision-makers’ uncertainty 
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about complex issues; 2) by interpreting data and observations; and 3) by institutionalizing 
preferred policy solutions. 
4.4.3.1 The epistemic community gains power by reducing uncertainty 
Policymakers seeking to address ongoing high rates of child mortality were in a difficult 
place in the early to mid 2000s.  C-IMCI, which aimed to reach children at community level, 
was vague on implementation details and not include curative care.  By the time the 2001 
Baltimore conference on C-IMCI provided a clearer path to implementation (BASICS, 
CORE_Group et al. 2001), the policy was “already dead,” partially due to limited support at 
Unicef, which had been assigned responsibility for supporting the policy (GLO-2013-07-08-
2, bilateral agency).  In 2003, health policy-makers at global and national levels were both 
dismayed and re-energized by a Lancet series highlighting ongoing high rates of child 
mortality worldwide and particularly in Africa (GLO_2013-6-14 and GLO_2013-6-20-2, 
academics; GLO_2013-6-20 and GLO_2013-7-31, multi-lateral agencies; GLO_2013-7-2-2 
and GLO_2013-7-10, NGO/private foundation).  The series made clear that fast action was 
needed and that previous policies had had disappointing results.  Evaluations of IMCI were 
also showing smaller than expected reductions in child mortality rates, mainly because 
children failed to reach facilities where IMCI was available (WHO, UNICEF et al. 2003; 
Bryce, Victora et al. 2005). Similarly, UNICEF’s Accelerated Child Survival and 
Development (ACSD) program, implemented in 11 west African countries between 2001 
and 2005, failed to substantially reduce mortality relative to comparison areas, in part 
because coverage of malaria and pneumonia treatment at community level was not 
sufficiently realized (Bryce, Gilroy et al. 2010).  
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As lessons from these programs accrued, national policy-makers understood that greater 
access to curative care was needed for children sick with a few specific illnesses; however, 
uncertainty remained around operational specifics regarding the CHW cadre. In this context, 
ongoing work by members of the iCCM epistemic community offered fairly specific 
guidelines and best practices for programs using CHWs, building on substantial groundwork 
by implementing partners who had reviewed their respective field experiences in forums 
such as the CORE Group.  Indeed, implementation of iCCM-like policies in sub-Saharan 
African countries occurred preceding and throughout policy development.  USAID’s 
BASICS program began implementing CCM-like strategies in the late 1990s through 2009, 
and facilitated three large African regional meetings on CCM with international agencies 
(Dakar 2005, DRC 2007, and Madagascar 2008).  ICCM-like strategies were further 
implemented in other countries after 2007, when the Canadian International Development 
Agency (CIDA) signed a C$ 100 million agreement with Unicef called the Catalytic Initiative, 
with additional funding by the Gates Foundation.  By the time global iCCM policy was 
issued in 2012, large-scale iCCM-like programs and implementation research funded by the 
Gates Foundation were underway in more than a half dozen countries in sub-Saharan Africa. 
This supported an increasingly precise conception of operational specifics, reducing 
uncertainty while at the same time offering initial proof of iCCM’s feasibility. 
4.4.3.2 Interpretation of evidence matches problem and solution 
In the case of iCCM, those responsible for designing policy were nearly all members of the 
epistemic community and vice versa. As a result, epistemic community members were not 
interpreting evidence for a separate body of policymakers.  As part of their analysis, 
epistemic community members used advanced modeling tools such as LiST (Lives Saved 
Tool), which estimates potential mortality impacts due to increases in coverage of specific 
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health interventions.  These analyses linked iCCM as a solution to the problem of child 
mortality in a convincingly “scientific” and data-driven way that measured the number of 
potential “lives saved” (GLO_2013-06-20-2, academic; GLO_2013-07-02, multi-lateral 
agency, GLO_2013-07-11-2, bilateral agency; GLO_2013-07-11-3, NGO/private 
foundation).  One respondent said, 
“We’ve known for 30 years that kids are dying in the community of diarrhea and 
malaria.  I mean, that’s really old … Quantifying the causes and risk factors, I think, 
was an important thing, and the more specific burden … It had a lot to do with the 
packaging of that information.” (GLO_2013-07-11-3, NGO/private foundation)   
Members of the epistemic community also relied on data that suggested iCCM as a solution 
via the Countdown Group’s country profiles (also known as “dashboards”), which charted 
coverage of key child survival interventions (Bryce, Terreri et al. 2006).  These dashboards 
seemed to imply an iCCM-like approach:   
“If you look at the indicators, the dashboard … if you read that carefully … with the 
thought of what do you do, what pops out of them is community case management, 
at least the way I see it.” (GLO_2013-07-11-3, NGO/private foundation)   
The emphasis on complex algorithms and highly technical interpretations is no doubt linked 
to the backgrounds of members of the epistemic community, a substantial portion of whom  
were medical doctors or held advanced degrees in epidemiology, public health, and related 
fields.  This disciplinary homogeneity permitted high-level discussions of the policy’s clinical 
content and projected epidemiological impact.  However, despite the substantial field and 
implementation work described above, there may not have been equal consideration of 
broader practical concerns related to scaling up iCCM, such as the health systems 
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implications of creating or rehabilitating cadres of health workers and the resulting financial 
burden for countries.  (For a synthesis of this point based on six country case studies of 
iCCM, see George et al., this issue). 
4.4.3.3 Institutionalization secures an imprimatur and resources 
Actors working on iCCM were quite often members of powerful institutions in global 
health; however, the policy initially lacked 1) the imprimatur of the main norm-setting body 
(WHO), 2) support from the main international agency with jurisdiction over the issue area 
(Unicef) and 3) sufficient resources to pursue policy development.  First, gaining the 
imprimatur of the main norm-setting body in global health, WHO, was critical, particularly 
for the controversial pneumonia component, as countries were unlikely to move forward on 
a policy they felt the world’s experts did not condone in terms of safety and efficacy.  In its 
role as the global norm-setting body, WHO had a necessarily cautious approach made more 
stringent in 2003 by new rules on the use of evidence in policy development (Oxman, Lavis 
et al. 2007).  Despite WHO’s release of a Joint Statement on pneumonia that supported 
community treatment in early 2004 (WHO/UNICEF 2004), further policy endorsement 
lagged at the agency. While the mechanisms of how WHO changed its position and began to 
support CCM for pneumonia are not fully elucidated by our data, by 2010 the policy can be 
said to have received WHO’s full imprimatur in the form a WHA resolution (WHA 2010). 
Second, even with the legitimacy conferred by WHO’s approval, the iCCM policy endeavor 
could not succeed without what Haas calls the “consolidat[ion] of bureaucratic power,” 
including support from the main international agency with jurisdiction over the issue area 
(Haas 1992).  Here, an important boost was provided by the revival of the child survival 
agenda at Unicef after a change in leadership in 2005 (GLO_2013-07-08, academic; 
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GLO_2013-07-02-3, NGO/private foundation).  This followed a period during which 
Unicef had followed a “human rights approach” that put less emphasis on reducing child 
mortality compared to other priorities, spurring criticism of the agency for abdicating its 
leadership role on child survival (Horton 2004).  After 2005, child survival once again 
became a top priority at Unicef, and Unicef officials would be key partners in the CCM Task 
Force and throughout policy formulation. 
The last component of successful institutionalization was the allocation of sufficient 
resources to pursue policy development in early 2010, when higher-level officials at Unicef 
and USAID agreed “CCM [was] an important priority for both agencies,” and followed up 
with specific institutional commitments such as assigning USAID’s MCHIP program as the 
Task Force’s secretariat (GLO_2013-07-11-4, bilateral agency).  At the same time, the 
financial prospects for implementation were looking rosier due to the malaria community’s 
involvement in the policy.  These partnerships enhanced the policy’s seeming viability as 
institutional partners began to understand that collaboration would result in a bigger pot to 
draw from:   
“Big global health siloed programs … [began] to cast this as a win-win rather than a 
Peter robbing Paul scenario, and that was … really important [in] providing a 
conducive environment for a mission such as iCCM.” (GLO-2013-07-31, multi-
lateral agency) 
4.5 Discussion 
ICCM was created by a community of international technocrats spanning different agencies, 
continents, and issue areas, who lent their focused attention to the problem of child 
mortality.  Members of the epistemic community were mainly technical health professionals 
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with higher-level degrees in medicine, public health, epidemiology and similar fields.   
Professional relationships in this group went back several decades as actors moved between 
agencies and topic areas, forming connections via “institutional junctions” such as research 
departments, conferences and meetings, and coordinating mechanisms (Stone 2004).  The 
epistemic community around iCCM evolved as members resolved outstanding conflicts on 
values/normative beliefs (about the ability of CHWs to safely prescribe antibiotics), causal 
beliefs (malaria versus pneumonia as the leading cause of child deaths in Africa), notions of 
validity (whether the evidence basis was sufficient to move forward on policy) and a 
common policy enterprise (including questions of intervention complexity, integration, etc.).  
These conflicts were resolved via structural changes in the network (the departure of key 
opponents, the decision to exclude malnutrition), negotiation (potential public health 
benefits overriding uncertainties about the evidence base), new technology and evidence 
(spurred by the advent of RDTs), and the existence of funding incentives (favoring 
integration of malaria).  Once constituted via the CCM Task Force after 2008, the epistemic 
community influenced policy content by answering uncertainties about technical details and 
offering operational guidance, interpreting complex evidence in a way that framed iCCM as 
the ideal solution, and securing support and resources from the most powerful institutions in 
global public health.   
One interesting feature of the iCCM epistemic community was the near total overlap 
between its membership and the set of policy actors assigned responsibility for creating the 
policy, whereas epistemic communities are usually conceptualized as one set of actors among 
others who influence policy decision makers.  As the epistemic communities framework has 
not frequently been applied to global health policy, it is difficult to assess how unusual or 
unique this situation may be.  However, there was no such overlap of the epistemic 
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community in a study of WHO’s 2005 adoption of the Framework Convention on Tobacco 
Control, which documents how a group of health researchers and scientists prevailed over 
opposing trade and industry representatives (Mukherjee and Ekanayake 2009). In another 
case in Bangladesh, members of a policy community working on neonatal mortality 
revitalized a dormant policy sphere, with its members invited into the policy-making process 
by the Ministry of Health (Shiffman and Sultana 2013).  Further application of the epistemic 
communities framework for global health policy is required to assess how much overlap 
tends to occur between technocrats and policymakers and whether such overlap is a positive 
feature for policy development. 
Our case study of the iCCM epistemic community offers insights into understanding how 
global health policies are formed and how policy-making processes affect policy content, for 
example when issue-area experts decide not just technical details but the broad shape of 
policy.  In this respect, our case study mirrors findings from a study on the use of evidence 
in WHO recommendations, which showed a heavy reliance on experts in a particular 
specialty, rather than on experts from relevant methodological areas or representatives of 
groups who would subsequently live with the recommendations (Oxman, Lavis et al. 2007). 
The finding recalls criticisms of Haas’ epistemic communities framework from within 
Science and Technology Studies holding that so-called “expertise,” including notions of 
validity, causal beliefs and so on, is socially constructed.  Thus, the shared perception of 
problems in epistemic communities may have less to do with problems’ essential “technical” 
nature than with the epistemic communities’ disciplinary orientations, political ideologies or 
discursive framing (Jasanoff 1996; George 2004).  In our case study, consensus was indeed 
achieved at times by excluding certain actors and setting issue-area boundaries, the better to 
63 
 
build on homogenous worldviews, dynamics that are elucidated but perhaps not fully 
problematized under the epistemic communities framework. 
The epistemic communities framework offered many insights; however, our data did not 
allow us to fully explain the controversy over allowing CHWs to administer antibiotics.  By 
the early to mid-2000s, numerous high-quality studies and two meta-analyses ought to have 
satisfied policy actors’ own standards of scientific validity about the safety and efficacy of 
CCM for pneumonia (Sazawal and Black 1992; Sazawal and Black 2003).  The articulated 
reason for some actors’ continued opposition was the fear of antimicrobial resistance, a 
serious consideration as it could lead to many common conditions becoming untreatable 
(Review_on_Antimicrobial_Resistance 2014).  However, unarticulated rationales are also 
worth considering.  One reason for the widespread popularity of Western medicines is 
because they are associated with authoritative professionals and represent the medical realm; 
“in them, healing is objectified” (van der Geest and Whyte 1989).  Such potent symbolic 
associations could explain the unspoken and perhaps unconscious proprietary feelings over 
antibiotics within the culture of clinically-trained policy actors (“the medical mafia”), who 
simultaneously articulated justifiable worries about the dangers of anti-microbial resistance.   
Finally, while the agencies involved in developing iCCM often had strong relationships with 
country offices (particularly at Unicef and USAID), the policy was forged by an epistemic 
community operating at the global level.  In other studies of global policies adopted by 
African countries, analysts observed a looped process by which treatment protocols were 
experimented with at the country level, “confirmed” at the global level and then filtered back 
down to countries (Ogden, Walt et al. 2003; Walt, Lush et al. 2004).  In Mozambique, 
country-level actors were observed to be more receptive to tuberculosis treatment guidelines 
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because they had already been involved in pilots (Cliff, Walt et al. 2004).  This type of back 
and forth between global and national policy-makers was not characteristic of iCCM and 
country case studies in this series suggest a disconnect between global policy-makers’ goals 
and the health systems implications and service delivery needs that national policy-makers 
would subsequently have to address [Juma et al, this issue; Chilundo et al, this issue].  
Similarly, a quantitative study of iCCM policy makers found divergences in research 
priorities between experts working in organizations headquartered in high-income countries, 
who prioritized technical questions on diagnostic and treatment algorithms, and those 
working in-country or regionally, who preferred research on CHW retention, motivation and 
supervision; determinants of non-use of iCCM by caretakers; and other operational concerns 
(Wazny, Sadruddin et al. 2014).  Thus, while global iCCM policy makers were highly efficient 
at sharing complex, detailed, high-level scientific information and data among themselves, as 
the epistemic communities framework demonstrates, this may also explain members’ 
observed detachment with issues of high priority for field workers, operational actors and 
others who subsequently have to implement the strategy. 
4.6 Conclusion 
In this case study, we analyzed a network of actors involved in developing global child health 
policy during the late 1990s and 2000s and how they formed an epistemic community 
framing iCCM as a solution to the problem of child mortality.  Our study underlines the 
importance of technocratic expertise in the relatively uncontested arena of child health and 
illustrates the relevance of the epistemic community framework for understanding global 
health policies. Further applications of the epistemic communities framework to health 
policies could help shed light on how these policies are formed and how policy-making 
processes affect policy content. 
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Chapter 5. Power and pro-poor policies: the case of iCCM in Niger 
5.1 Abstract  
Analyses of health policy in low- and middle-income countries frequently mention but rarely 
explore power dynamics, whether or not the policy in question targets the poor.  We present 
a case study in Niger of integrated Community Case Management (iCCM), a policy to 
provide basic care for poor rural children sick with malaria, diarrhea and pneumonia that has 
contributed to measurable reductions in child mortality. We focus on three dimensions of 
power in policy making: political authority, financial resources, and technical expertise.  Data 
collection took place March to August 2012 and included semi-structured interviews with 
policy actors (N=32), a document review (N=103) and contextual analysis.  Preliminary data 
analysis relied on process tracing methodology to examine why iCCM was prioritized and 
identify dimensions of power most relevant to the Nigerien case; we then applied theoretical 
categories of these power dimensions deductively to our data.  We find that political 
authorities, namely President Mamadou Tandja, created the underlying health infrastructure 
for the policy (“health huts”) as a way to distribute rents from development aid through 
client networks while claiming the mantle of political legitimacy.  Conditional influxes of 
financial resources created an incentive to declare fee exemptions for children under 5, a key 
condition for the policy’s success.  Technical expertise was concentrated among international 
actors from multi-lateral and bilateral agencies who packaged and delivered scientific 
arguments in support of iCCM to Nigerien policymakers, whose input was limited mainly to 
operational decisions.  The Nigerien case sheds light on the dimensions of power in health 
policy-making, particularly in neo-patrimonial African regimes, and provides insights on how 




Despite widespread declines in child mortality rates in recent years, an estimated 6.3 million 
children under 5 still die each year, many from preventable, treatable diseases including 
pneumonia (15% of deaths), diarrhea (9%), and malaria (7%) (You, Hug et al. 2014).  
Integrated community case management of childhood illness (iCCM) is an evidence-based 
strategy to provide life-saving curative care for these diseases to children in low- and middle-
income countries (LMICs), using health workers at the community level (Young, Wolfheim 
et al. 2012).  While not explicitly marketed as a “pro-poor” policy, iCCM primarily benefits 
poor rural populations, with few direct benefits to segments that already have access to the 
health system.  The World Health Organization (WHO) and Unicef promoted iCCM in a 
2012 Joint Statement (WHO/UNICEF 2012); powerful bilateral agencies and civil society 
actors such as USAID, the Canadian International Development Agency (CIDA, now 
DFATD), Save the Children and the Gates Foundation have also supported its development 
and implementation.  Nonetheless, a survey of Unicef country offices in sub-Saharan Africa 
found that while many countries had adopted policies supportive of community-level 
treatment of childhood illnesses, fewer had implemented integrated approaches to CCM at 
any scale (George, Young et al. 2012).   
In recent years, scholars of health policy in LMICs have observed that power dynamics can 
be decisive in policy outcomes, for example via the exercise of political power in priority-
setting processes and policy reform (Reich 1995; Shiffman and Garcés del Valle 2006; 
Shiffman and Smith 2007) and the ability of front-line health workers to limit or re-shape the 
implementation of decisions taken at higher levels (Lipsky 1980; Erasmus and Gilson 2008; 
Lehmann and Gilson 2012).  Nonetheless, the concept of power is often evoked without a 
specific theoretical exploration of what is meant by the term (Gilson and Raphaely 2008; 
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Buse, Dickinson et al. 2009).  A better understanding of the concept of power is necessary to 
understand how LMICs adopt and implement health policies, particularly those targeting 
poorer populations that are more likely to be powerless.   
In this paper, we provide an analysis of power in the policy process using a case study of 
iCCM development and implementation at the central government level in Niger.  Access to 
healthcare for Niger’s poor, rural populations has historically been extremely limited; the 
country’s health system has been described as one of “urban privilege” (Raynaud 1987; 
Körling 2011).  Nonetheless, in 2007, Niger became one of the first countries in sub-Saharan 
Africa to adopt iCCM and it remains one of the few where it has been implemented at a 
national scale.  Furthermore, effective implementation of iCCM and surrounding policies 
was found to contribute nearly a quarter of Niger’s 43% reduction in child mortality between 
1998 and 2009 in a study using the Lives Saved Tool (LiST) to calculate the impact of 
interventions on child mortality (Amouzou, Habi et al. 2012).  
To understand power in Niger’s iCCM policy development process, we first examine 
theories of power and select three dimensions of the concept based on preliminary analysis 
of case study data.  Next we describe data collection methods and apply an analytical 
framework for understanding power in the Nigerien case.  Finally, we discuss findings and 
the case’s significance for understanding how pro-poor health policies can be promoted in 
countries with similar political and economic contexts.  
5.3 Background 
The concept of power remains elusive both conceptually and empirically (Hyden 2008).  
Foucault called power the “most hidden” part of human relations and the very concept may 
be “essentially contested,” meaning the subjective assumptions needed to analyze it are 
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inherently value-dependent (Gallie 1955-6; Foucault 1994).  Stephen Lukes suggests the term 
itself is “polysemic” and can be defined to include or exclude a range of phenomena such as 
authority, influence, coercion, force, manipulation, and domination (Lukes 2004).  And while 
many analyses of power cite Robert Dahl’s classic definition, “A has power over B to the 
extent that he can get B to do something that B would not otherwise do,” others argue this 
formulation captures only overt, compulsory forms of power, ignoring more subtle 
phenomena such as those encompassed by Bertrand Russell’s power of “propaganda or 
habit” or Gramsciian “hegemonic ideas” operating unnoticed in the background (Russell 
1938; Dahl 1961; Gramsci 2012). 
Power is a fundamental if enduringly mysterious force in health policy as in all human 
endeavors and in recent years scholars have called for empirical studies of power in health 
policy to advance understanding and ultimately “tackle the global political determinants of 
health” (Buse, Dickinson et al. 2009; Marten, Hanefeld et al. 2014).  We started from a 
largely agnostic position on the dimensions of power most relevant to health policy making 
processes, considering theories encompassing both the sources of power (e.g. in personal 
charisma, procedural raison, physical force) and the mechanisms by which it is exercised in 
society (Russell 1938; Weber 1948; Giddens 1984; Foucault 2002; Lukes 2004). Given the 
theoretical cornucopia at our disposal – and early stage of the health policy literature in 
tackling this topic – we decided to focus on dimensions of power most relevant to the 
Nigerien case, as revealed by preliminary data analysis.  Three dimensions of power emerged 
as most salient and are discussed here in greater detail:  1) political authority, 2) financial 
resources and 3) technical expertise.   
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The first dimension of power, political authority, can influence policy development 
processes in both direct and indirect ways.  Possessors of political authority can directly 
advance or hinder specific health policies by drawing attention to issues, controlling financial 
resources and regulatory regimes, and selecting health policy actors and applying pressure on 
them (Shiffman and Garcés del Valle 2006; Croke 2012); furthermore, political cycles and 
incentives can be exploited by policy-makers to improve the chances of policy reforms 
(Reich 1995).  Forms of political authority can also have indirect impacts on policy making, 
for example by creating institutional incentives and constraints or setting up tradeoffs with 
competing priorities.  Such incentives and constraints are important insofar as they affect the 
choices made by those in possession of power, as power is “a dispositional concept, 
comprising a conjunction of conditional or hypothetical statements specifying what would 
occur under a range of circumstances if and when the power is exercised” (emphasis added) 
(Lukes 2004).  This ability to act or not act in favor of a policy (or anything else) is what 
Bachrach and Baratz call the “two faces of power” (Bachrach and Barazt 1970).  It is also 
important to consider less overt sources of power related to political authority, such as 
political legitimacy, which can provide leeway to actors possessing it or whose promise can 
motivate policy decision making. 
The second dimension of power, financial resources, is in some ways the simplest:  funding 
is the sine qua non of the policy enterprise, especially at the level of implementation.  Beyond 
the mere availability of financial resources for the policy in question, however, it is relevant 
to consider who possesses or controls these financial resources, as these actors have 
inherently greater advantages in the political (and policy) arenas (Wright Mills 1968; Buse, 
Mays et al. 2009).  Financial resources are thus inseparably linked to the power of political 
authority, in that revenue flows (stemming from sources both internal and external to the 
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state) bestow power on actors, who choose to expend funds among various policy options.  
Actors may also support the spread of policies through the “manipulation of economic costs 
and benefits” of choices, as has been observed in the international policy diffusion literature 
(Dobbin, Simmons et al. 2007).      
Third, technical expertise is intrinsic to government action in the modern era, and control 
over knowledge and information is a crucial dimension of power in policy making (Haas 
1992; Rose and Miller 1992).  Technical capacity to produce, interpret and disseminate 
knowledge and information is differentially distributed among actors within the policy 
sphere, particularly in LMICs, where powerful international actors often proliferate (Pallas, 
Nonvignon et al. 2015).  Actors’ technical education and training not only conditions the 
epistemic and normative frameworks guiding their practice, but also confers power in and of 
itself: in global health, Shiffman finds that holders of expertise claim authority based on a 
privileged relationship to the truth and a superior procedural way of moving towards the 
ideal policy outcome (Shiffman 2014).  At lower levels, actors can also exercise technical 
power via regulatory and operational decision making (Lipsky 1980; Erasmus and Gilson 
2008; Lehmann and Gilson 2012).  Finally, since Foucault, we understand knowledge itself 
to be the product of power relations in the society that created it, meaning the way problems 
are presented and the scientific or technical arguments used to support policy positions must 
be reflected upon critically (Foucault 1994). 
Nigerien context 
Since independence in 1960, Niger has experienced alternating periods of autocratic rule and 
democratic governance, punctuated in the past two decades by coups d’état in 1996, 1999 and 
2010.  Political authority in Niger conforms to classic models of neo-patrimonial governance 
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in Africa, characterized by a strong executive branch, reciprocal clientelism and extensive 
patronage systems (Bratton and van de Walle 1994; Therkilsden 2005; Bach 2012). Power in 
such regimes “is concentrated and personalized, entailing discretionary control over broad 
realms of public life” (Lewis 1996). In countries with multi-party electoral systems, as in 
Niger, large partisan operations are marshaled in the service of reciprocal clientelism (Olivier 
de Sardan 2004; Tidjani Alou 2012).  When public finances and government services are 
weak, as in Niger, rulers are further incentivized to cultivate electoral support via patronage 
instead of promises of future programming, as voters view skeptically the government’s 
ability to deliver on said promises (Kaufman, Kraay et al. 2008; Kelsall 2011).   
Neo-patrimonial political authority is predicated on rent sharing (via patronage); however, 
Nigerien authorities have historically had limited access to financial resources and few 
revenue-generating capabilities.  Niger’s tax-to-GDP ratio is well below the West African 
Economic and Monetary Union target of 17% and the extractive sector, a main source of 
government revenue, suffers from insufficient profit monitoring and diversion of funds 
(AFD 2011).  The resulting chronic fiscal weakness and recurrent deficits have been 
mitigated by large aid flows; as a result, government policy-makers in all sectors are heavily 
dependent on aid to finance basic programming.  Table 5 shows Niger’s main sources of 
revenue from 2005 to 2007, the only years for which tax revenue data is available (these 
years also coincide with the period during which iCCM policy was tested and adopted).  
These figures demonstrate Niger’s advanced level of aid dependence, particularly as 
Goldsmith has suggested countries with overseas development aid (ODA) greater than 10% 




Table 5 Nigerien government revenue during iCCM policy development (2005-2007) 
 2005 2006 2007 
Gross National Income (GNI) 
(thousands of US$) 3,396,604 3,645,126 4,290,093 
Tax revenue (thousands of US$) 323,295 363,813 415,957 
Tax revenue (% of GNI) 9.5 10.0 9.7 
Net official development assistance 
(ODA) (thousands of US$) 604,460 611,060 565,150 
Net ODA (% of GNI) 15.4 14.9 12.7 
External resources for health (% total 
expenditure on health) 34.9 32.8 31.6 
Source: Based on World Bank data 
Compared to other LMICs, Niger has limited technical capacities in health policy making, 
with a small tertiary education system drawing from a population with a low literacy rate 
(29%) (UNESCO 2012).  While the uranium boom in the 1970s financed the creation of a 
relatively strong public administration, structural adjustment policies in the 1980s and 90s 
caused a major degradation in institutional planning capacities.  At the same time, there was 
attrition of the technocratic class, whose brightest members were lured by significant salary 
differentials at aid organizations.  The result was prolonged technocratic atrophy in the 
government sector, whose effects are apparent today in the degraded planning capacity of 
state agencies (Lavigne Delville and Abdelkader 2010).  Currently, international organizations 
continue to employ large numbers of Nigerien and international technical staff, with human 
and material resources that often dwarf their government counterparts;  the Unicef campus 
in Niamey alone counts over 55 technical experts (including 25 local and 30 international 






Case study methodology is useful for reconstructing phenomena holistically to reveal 
underlying processes (Yin 1994). We used a document review, semi-structured interviews 
and contextual analysis to document the iCCM policy process in Niger and analyze how 
three dimensions of power – political authority, financial resources and technical expertise –
contributed to policy outcomes.   
Primary data collection took place February to August 2012 and included 1) an extensive 
document review and 2) interviews with Nigerien and international officials involved in 
formulating iCCM (Table 6).  For the document review (N=103), we combined close 
reading of documents on iCCM from sources such as government ministries, international 
organizations and public sources, with systematic data extraction across such categories as 
the document’s type/purpose, authorship, justifications put forward, budgetary data (when 
available) and scientific or technical argumentation. In-depth semi-structured interviews 
(N=32, n= 28 in country) were conducted with individuals involved with the iCCM policy 
process and identified through the document review and snowball sampling.  Interviews 
were conducted in French and transcribed in-country.  We complemented these data sources 
with secondary analyses of Nigerien political economy, political history and quantitative 






Table 6 Primary data collection 
Document review 
 N Examples 
Official policy 22 - National strategies for child survival, family health practices, malaria control 
- Policy declarations or directives in the area of health 
- Human or health sector development strategies (Health Development Plan, Poverty 
Reduction Strategy...)  
- Training manuals for health workers 
“Gray” 
literature 
29 - Preliminary or draft versions of health policies 
- Internal documents (meeting minutes, PowerPoint presentations from workshops, 
supervision reports...) 
- Project proposals/ funding requests for donors 
- Reviews of IMCI in Niger and region (WHO, WAHO, UNICEF ...) 
Scientific data 
/ evidence 
31 - Articles in international journals on health programs or policies in Niger  
- Doctoral students' dissertations in health / public health 
- Surveys from Nigerien statistics agency or external organizations 
- Socio-anthropological research on the Nigerien context 
- Action research studies (for example on family health practices) 
Other 21 - Laws and regulations 
- Cooperation agreements between Nigerien government and external actors 
- Articles published in Nigerien newspapers, other newsletters or publications 
- Historical documents on the implementation of IMCI 
TOTAL 103  
Semi-structured interviews 
 N Examples 
Government 
sector 
19 - Senior and mid-level Ministry officials in departments of reproductive and child 
health, community health, health education, nutrition, etc. 
- Officials at regional health offices and the national malaria program (PNLP) 
- Clinicians at national reference hospitals and maternities & IMCI trainers 




10 - WHO-Niger program officers (child/reproductive health) 
- Unicef–Niger program officers on child survival, health communications, etc. 
- USAID staff working on BASICS, BASICS II and AWARE-RH programs 
- International consultants hired for research, training, report writing, etc. 
NGOs & 
civil society 
3 - Country staff at international & local development NGOs 
- Members/leaders of health worker professional associations 
TOTAL 32  
 
For preliminary data analysis, we used process tracing to combine multiple sources of 
information establish causality, reveal political and social processes and minimize bias when 
describing events and processes in the policy cycle (Yin 1994; Shiffman, Stanton et al. 2004).  
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As such, we compiled a timeline of iCCM policy development using information gleaned 
from interviews, the document review and secondary analyses of the Nigerien political 
context.  Interviews were coded on categories related to the policy actors, processes and 
content; political and financing issues; technical expertise and scientific argumentation; and 
mentions of power using NVivo 9 (QSR 2010).  We then interrogated our data using 
questions and theoretical categories drawn from the literature on power discussed above, 
focusing on the dimensions of power that emerged as most relevant during preliminary data 
analysis (Table 7).  Our analytical strategy was thus both inductive (selecting dimensions of 
power to focus on based on preliminary analysis) and deductive (applying theoretical 
concepts drawn from the political economy and health policy literatures to the data).    
This research was approved by Niger’s national ethics committee (Comité consultative national 
d’éthique) and Ministry of Higher Education and Scientific Research; it was deemed exempt 
from ethical review as part of a multi-country study of iCCM policy formulation in Africa by 
the Johns Hopkins Bloomberg School of Public Health. 
Study limitations 
This study has some limitations.  Not all targeted stakeholders, particularly high officials 
within the Ministry of Health (MOH), were able to be interviewed and some key documents 
were unavailable due to the destruction of WHO-Niger servers by fire in 2007; budgetary 
data were difficult to obtain.  As in any qualitative study, respondents may have sought to 
portray events strategically; we triangulated between respondents and other data sources to 
understand how a respondent’s position might affect his or her words, remaining vigilant for 




Table 7 Framework on power for a policy analysis of iCCM in Niger 
 Concept Questions to guide inquiry & analysis 
Political 
authority 
Systems of governance 
 
- Which persons or groups hold decision-making power? What rules condition 
its use? 
- By what mechanisms is political authority exercised? Is the political system 
presidential, parliamentary, authoritarian, etc.? 
- What forms of political participation exist and are effective? 
- What interests & factions exist within the state?  
Institutional incentives 
& constraints 
- What demands (financial are otherwise) are put on political authorities?  What 
are the institutional limits of political authority? 
- What incentives do political authorities have to align themselves with 
segments of the population? What disincentives?  
- What accountability mechanisms exist and are enforceable? 
- Is power in the political regime viewed as legitimate?  What is the basis of this 
legitimacy (electoral, redistributive, rhetorical, etc.)? 
State capacity/ 
weakness 
- To what extent are official channels of authority respected or challenged?  
Does the state control what happens within its borders? 
- In which areas is state capacity most limited? 
Financial 
resources 
State sources of revenue - What are the main sources of state revenue and in what proportion?  
o Internal sources: tax base, extractive or other sectors, etc. 
o External sources: trade flows, aid intensity and/or dependence 
 Loci of control over 
resources  
- Which actors or groups control financial resources?  In what other spheres do 
they have leverage?   
- Which actors have the ability to manipulate the economic costs and benefits 
of policy decisions?  
 Availability of 
resources for the policy 
- Which resources could potentially be used for the policy in question?  How 
liquid and/or fungible are they? 
- What other priorities compete for the same resources?   
- What trade-offs come with accessing available financial resources? 
Technical 
expertise 
Technical capacity - Which actors or groups are best equipped to produce, interpret and 
disseminate technical knowledge?  Which are less well equipped? 
- What is the relative level of capacity of state and non-state actors?   
- Who are the main sources of knowledge and how is knowledge transmitted 
within and between policy circles?   
- What potential biases might stem from technical education/training, 
disciplinary backgrounds, etc.?  
 Decision-making 
autonomy 
- What is the role of technical staff in health policy decision-making? 
- What is the relationship between health policy actors and holders of political 
authority? 
- What operational & regulatory levers & constraints exist and who is affected 
by them? 
 Nature of technical 
knowledge 
- What are the origins of the frameworks, norms and ideas that shape technical 
inquiry? 
- How are issues framed?  What is the stated problem to be addressed? What 
arguments are used during discussions? 





The elusive, contested and value-laden nature of power analysis gives rise to particular 
challenges.  Prior to and throughout data collection and analysis, we kept detailed “reflexivity 
memos” to interrogate our assumptions and values and how these could impact data 
collection, analysis and findings.  We also used regular debriefings to confront the analytical 
perspectives of authors from different “power perspectives,” namely those from Western 
institutions and West African researchers more intimately versed in local political dynamics 
and cultural norms.   
5.5 Results 
5.5.1 Origins & policy precedents of iCCM in Niger 
The development of iCCM in Niger can be traced from the late 1990s to its full 
implementation in 2011 (Figure 6).  Historically and into the 1990s, Niger suffered from 
extremely high rates of child mortality (estimated at 226 deaths per 1000 live births in 1998) 
which, combined with high fertility rates, meant that most Nigerien families could expect to 
lose at least one child (Amouzou, Habi et al. 2012).  Efforts to introduce policy to combat 
this situation in the 1990s were challenged by ongoing political instability; however, in 1997 
MOH adopted and began implementation of a major child survival program, IMCI 
(Integrated Management of Childhood Illness).  IMCI included three components: clinical 
case management, health system strengthening and a “community” component to 
strengthen links between health facilities and the communities they served. 
78 
 
Figure 6 Timeline of iCCM policy development 
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IMCI was designed to improve child survival rates; however, its implementation in Niger 
was mainly limited to health facilities and thus failed to reach a large portion of Niger’s 
children, who lacked access for economic, geographic and social reasons.  And though 
political stability returned to Niger with the advent of the Fifth Republic in 1999, creating a 
more favorable environment to pursue policy enterprises, implementation of “community” 
IMCI remained stalled, even following a national orientation workshop in August 2002 and 
initial training sessions in 2003-2004 in Madarounfa and Matamèye.  By 2007, only 10 of 42 
health districts had initiated any activities on the community component (Hamsatou 2008): 
“At that time there were no funds, there was nothing for IMCI. Much later we got 
funds from Unicef and WHO to conduct the first activities.” (NIG-2012-7-12-2, 
IMCI officer, government sector) 
Not only were funds missing to train personnel and carry out activities, community IMCI 
was meant to be operated out of a new type of health structure, the case de santé (“health 
hut”), created by ministerial decree in 1999.  However, few health huts had been built by the 
time community IMCI stalled as a policy in the early 2000s.  
5.5.2 Creating the infrastructure for iCCM: Tandja’s health huts 
The community-level health infrastructure onto which iCCM would be grafted began to be 
constructed in 2001 under the aegis of the “Special Program” of President Mamadou Tandja, 
elected in 1999, re-elected in 2004 and deposed by the Nigerien military in 2010 after an 
attempt to extend his rule known as “Tazartché” (“continuation” in Hausa).  Tandja’s 
“Special Program,” created in 2001 to administer funds following Niger’s admission to the 
Heavily Indebted Poor Countries (HIPC) initiative, financed and oversaw the construction 
of over 2,000 health huts, with construction advancing quickly under the supervision of 
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officers reporting directly to the president (NIG-2012-7-11-1, NIG-2012-5-17-1) (Bensaid and 
Mistycki May 2011).  Funds were disbursed not through the government agencies but 
directly to Tandja’s “friends,” merchants and entrepreneurs who executed development 
projects including the building of schools, dams, wells and the health huts (Olivier de Sardan 
2010; Körling 2011).  Investments under the Special Program won Tandja support from 
farmers in rural areas home to four-fifths of the population, and would be used by Tandja’s 
supporters as an argument in favor of Tazartché. 
In the health sector, a number of respondents spoke with grudging admiration of Tandja’s 
decision to create the health huts (“a courageous and salutary act”) and attributed him sole 
credit for the decision (NIG-2012-6-16, senior manager, international agency): 
“Tandja got the idea of health huts. The MOH was called upon [afterward].” (NIG-
2012-5-17-1, senior manager, government sector)      
At the Ministry, however, opposition to the health huts was widespread among leadership 
and personnel, who would have preferred to extend the “official” health system rather than 
offering “inferior medicine” to the poor (NIG-2012-7-11-1, NIG-2012-7-3-2). However, 
some respondents had a less conflictual view: 
“There wasn’t a problem, because the MOH is answerable to the presidency; the 
MOH doesn’t have its own separate policy.  Its policies come from the president.  
It’s what the country wants and what the MOH implements.” (NIG-2012-6-14, IMCI 
trainer, government sector) 
Nonetheless, respondents suggested health huts were under-utilized in the early years of 
their construction (they had a reputation of being used to house donkeys and other 
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livestock) and the workers staffing them were not officially integrated into the MOH 
personnel hierarchy, suggesting possible contestation to Tandja’s unilateral act among 
Ministry leadership and personnel (NIG-2012-7-3-2). 
5.5.3 ICCM policy arrives in Niger 
From 2001 to 2005, health huts were built at a rapid clip; however, the training of the 
community health workers to staff them lagged behind in terms of both the number of 
workers trained and the quality of training they received (NIG-2012-7-3-2, NIG-2012-6-4).  
At the same time, global-level actors were beginning to coalesce around and promote 
integrated community-based strategies resembling iCCM, focusing a number of early efforts 
in West Africa; the West African Health Organization (WAHO) would also identify iCCM as 
a “best practice” to promote in November 2005 (AWARE 2008; Dalglish, George et al. 
2015).  In April 2005, a WAHO consultant traveled to Niamey to perform a situation 
analysis for iCCM on the basis of several criteria, and notably the existence of “engaged [in-
country] partners” ready to mobilize resources and share costs (Sall 2005; AWARE 2008).  
The same month, USAID’s Action for West Africa Region – Reproductive Health 
(AWARE-RH) project sponsored a large meeting in Dakar along with Unicef, WHO and 
WAHO, inviting officials from a dozen countries to discuss a common regional approach to 
treating common childhood illnesses and learn from a Senegalese project on pneumonia 
(AWARE 2008).  At that meeting,       
“Every country presented what they intended to do at the community level. Niger 
stated that it will not limit itself to [pneumonia] case management … but will rather 
implement IMCI as it is learnt at the clinical level and implement it at the community 
level.” (NIG-2012-5-18, clinician)       
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Following the Dakar meeting, AWARE and other partners including WHO, Unicef and 
WAHO traveled to Niger for a follow-up visit to advocate for iCCM, and were met with a 
“convergence of viewpoints” by Ministry officials (AWARE 2008).  Respondents disagreed 
as to whether Ministry or external actors had provided the impetus to move forward:   
“[W]e had the idea to develop an iCCM module ... with support from WHO, Unicef 
and the USAID AWARE project.” (NIG-2012-5-17-1, senior manager, government sector)   
“I don’t think there was any difficulty … We paid a visit to all the key officials at the 
MOH and explained to them what iCCM is, and they all accepted it.” (NIG-2012-7-
12-3, IMCI officer, international agency)       
In any case, a field trial was organized in Madarounfa district shortly thereafter, with 
financial and technical support provided by partners.  Following the template of the 
Senegalese experience in community-level pneumonia care, international donors had initially 
favored training a non-professional cadre of community health volunteers known as relais 
communautaires or mères éducatrices. However, the relais were volunteers with no official 
existence in MOH texts and were thus ineligible to receive financial compensation, supplies 
and medicines via the health system, effectively blocking their participation in iCCM 
(AWARE 2008).  International donors entered into discussions with Ministry officials to 
bring relais into the system; MOH “didn’t refuse but didn’t say yes” (NIG-2012-5-24, senior 
manager, international agency). Reluctant to hang iCCM on so tenuous a peg, donors relented to 
use community health workers, the cadre of health workers previously created to staff the 
health huts.  This was the policy that Nigerien officials decided to scale up in January 2007 
following positive results from the pilot’s mid-term evaluation (NIG-2012-5-24, NIG-2012-6-
6) (AWARE 2008; Hamsatou 2008).   
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Aside from the necessity of a pilot project, Nigerien government respondents rarely 
mentioned the scientific evidence-building process leading up to iCCM, quite possibly since 
iCCM was seen as previously scientifically “validated” by external actors such as WHO, 
Unicef, WAHO and USAID.  When prompted, Nigerien respondents said nonetheless that 
the decision to adopt iCCM was based on strong scientific evidence and that the policy was 
“proven,” often invoking the 2003 series on child survival in the Lancet as justification – a 
French-language summary of which Unicef had distributed to Nigerien government partners 
(NIG-2012-5-30, senior manager, international agency).  Indeed, Nigerien policy makers’ access to 
the scientific literature appears to have been largely mediated by international agencies such 
as WHO and Unicef, who introduced studies and technical guidelines to “important 
professors and influential people” (NIG-2012-8-2, international consultant): 
“Unicef is very powerful with respect to community-based components … They say, 
‘Here are the guidelines,’ and I think that the Ministry just complies. In Niger the 
Ministry is not very tough, not tough at all. When evidence is provided, it complies.” 
(NIG-2012-6-6, IMCI officer, international agency)  
This influence could originate in the superior technical capacity of outside agencies 
compared to Nigerien government offices (recall Unicef’s 55 technical experts, far more than 
in the Ministry’s child health office); further, Nigerien government documents tended to cite 
few or no articles from the scientific literature.  Alternatively or additionally, state actors may 
have been influenced by the financial resources external actors could bring to bear to fund 
implementation of recommended policies (see below for a further discussion of this point).   
5.5.4 User fees exemptions render care financially accessible 
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The steadily increasing number of health huts and decision to adopt iCCM were important 
steps toward making care available for children sick with common killer diseases; however, 
user fees for visits and medicines constituted an insurmountable financial barrier for many 
poor Nigerien families.  This situation changed in 2006, when Tandja abolished user fees for 
pregnant women and children under five years of age, which he called his “gift to the 
women and children of Niger,” a decision that greatly increased the number of children able 
to benefit such improved care:     
“Now what is the relationship between the health hut and fee exemptions? I would 
say that it is the opposite, it is fee exemptions that led to the boom of [the health hut] 
....” (NIG-2012-5-24, senior manager, international agency) 
Among health care workers as well, a large majority agreed that the abolition of user fees 
significantly boosted utilization and health-care seeking behavior among families of sick 
children (Ridde and Diarra 2009).  
Far from originating among Nigerien health policy-makers at MOH or elsewhere, the 
abolition of user fees for children under five appears to have been a World Bank 
conditionality for releasing budgetary assistance during negotiations with the Nigerien 
Ministry of Finance in April 2006 (Ousseini 2011).  Tandja was particularly sensitive to such 
inducements following the 2005-06 food crisis, which also created a crisis of government 
legitimacy (Körling 2011).  Nigerien health authorities did not learn of the decision until a 
senior MOH official was pulled out of a meeting to quickly write up and sign the ministerial 
order (Ousseini 2011).  Such hasty decision making meant that planning for the reform was 
essentially non-existent, and today the state’s reimbursement system for health facilities 
remains highly dysfunctional, plagued by double-billing and poor record keeping, and is in 
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arrears up to 20 billion CFA (US$42 million) (Ousseini 2011; Ousseini and Kafando 2013).  
Respondents said such insufficient technical and managerial preparation for policy change 
was not unique to the decision on fee exemptions:   
“You know, here [in Niger], political decisions always come before technical 
decisions.” (NIG-2012-7-6, high official, government sector) 
Similar cases of government sensibility to outside funding incentives were also reported 
under current President Mahamadou Issoufou: 
“[T]he government is very sensitive to the World Bank’s suspension of the subsidy.  
That’s why no later than last week, the President of the Republic decided to unblock 
an envelope of 800 million [CFA] to buy medicines, mosquito nets and quinine to 
cope with the [malaria] high-transmission period.”  (NIG-2012-7-19, senior manager, 
government sector) 
5.5.5 Financing & implementation 
Funding for implementation arrived in October 2007 with the signing of a co-financing 
agreement between Unicef and CIDA as part of the global Catalytic Initiative (CI/IHSS), 
which focused on strengthening health systems to deliver high impact and cost effective 
interventions at the operational level.  CIDA pledged US$ 10 million for iCCM over six 
years (2007-2013), which was matched and administered in Niger by Unicef.   A massive 
training campaign for community health workers took place in 2008-2009 and by 2012 over 
3,000 health workers had been trained (MSP/DGSP/DOS 2012).  The supply of essential 
drugs was provided by Unicef and delivered to the district level (NIG-2012-5-24).  As a 
result, the number of operational health huts increased from 1,666 in 2007 to 2,501 in 2011, 
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with all districts implementing iCCM by the end of the period (Oliphant, Amouzou et al. 
2011).   
Alongside the state’s contributions to iCCM in the form of Tandja’s network of health huts 
and payment of health worker salaries, the provision of external resources to fund specific 
training and medicines suggests an interplay between government and external actors when 
deciding who pays for what.  Just before the arrival of iCCM, in the 2005-2009 Health 
Development Plan, Ministry staff recommended formulating the health budget such that 
reproductive and child health programs existed as separate entities, rather than integrating 
them into regular Ministry functioning (MSP 2005).  “These [programs] will certainly require 
specific funding,” the document states, presumably referring to funding from external 
sources and later invoking the supposed availability of Unicef funding for IMCI 
programming over the 2004-2007 period.  The same year (2005), Nigerien government 
expenditure on health per capita was at a relative low at $4.2, whereas the country was 
experiencing an influx of development aid toward maternal, newborn and child health, 
which increased by 209% per live birth and 474% per child between 2003 and 2008 
(Amouzou, Habi et al. 2012).  While only circumstantial, this suggests Nigerien policymakers 
may have waited to see how donors would direct funds before acting themselves, though no 
specific evidence of strategizing or negotiating is contained in our data. 
5.6 Discussion 
Over a period of a decade, Nigerien policy-makers and their international partners 
cooperated to successfully prioritize, develop and implement iCCM, a policy benefiting 
mainly the poor, contributing to a significant reduction in child mortality.  Previous policies 
had not significantly reduced child deaths because of Niger’s limited health system, under 
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which many or even most families did not have access to basic curative care.  In 2001 
President Tandja began using an influx of HIPC funds to rapidly build over 2,000 health 
huts, simultaneously distributing patronage and gaining support among rural voters.  
Beginning in 2005, influential global-level partners working on child survival in West Africa, 
including USAID, Unicef, WHO and WAHO, found in Niger’s Health Ministry a willing 
partner to move forward on a new “best practice,” iCCM, whose technical content and 
“evidence-based” bona fides originated mainly outside of Niger.  During a pilot test in 2006-
2007, Ministry personnel re-oriented the policy with respect to important operational details, 
notably the choice of health care worker and link to Tandja’s health huts.  
Contemporaneously, President Tandja acceded to a World Bank conditionality that Niger 
adopt fee exemptions for children under 5, making iCCM accessible to many more Nigerien 
families.  Finally in late 2007, large sums of money from international donors became 
available to pay for health care worker training and essential medicines, allowing iCCM to be 
scaled up nationally.   
An analysis of three dimensions of power in health policy making in the Nigerien case helps 
link these events and provide causal explanations.  Power dynamics emerged from the 
political economy of the Nigerien state, including governance structures that underpinned 
Tandja’s political power through enabling strongly centralized and personalized rule, his 
dependence on external financial resources, and the political imperative of distributing rents 
through patronage. In terms of technical expertise, we found domination by international 
actors over “scientific” expertise, whereas Ministry officials’ contributed operational or 
health systems expertise. Actors and organizations external to the state were influential when 
exercising power derived from financial resources and technical expertise; many policy 
decisions related to iCCM originated at the interface between state and non-state spheres.  
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The dimensions of power also overlapped in ways that were difficult to separate, for 
example the mixed technical and financial power of external norm-setting agencies like 
WHO and Unicef.  
Our case study of Niger focused on a country with a neo-patrimonial system of political 
economy, features of which warrant highlighting for our analysis to take on its full meaning.  
First, West African neo-patrimonial states are characterized by a confusion between public 
and private spheres, whereas in the West the separation between the two provides the 
foundation of procedural forms of power and governance (Olivier de Sardan 2004).  Indeed 
neo-patrimonial states only appear to operate according to Weberian rational-legal principles 
in the form of modern bureaucracy, while instead being driven by the logic of patronage and 
reciprocal clientelism (Bratton and van de Walle 1994; Therkilsden 2005; Bach 2012).  This 
presents special challenges for researchers, who find that in state business the “formal” and 
the “real” hardly coincide, official organograms mask real-life power relationships and 
budgets are “pure fiction” (Olivier de Sardan 2004).  In our case study, we observed that 
procedural power held little sway in that the MOH was often excluded from health policy 
decision making and that powerful actions took place outside of the usual government 
channels, as with the Special Program.   
Indeed, key decisions around iCCM were highly personalized (in the case of Tandja) and 
strategically oriented toward his political longevity, notably because they 1) enabled the 
smooth functioning of his patronage machine, and 2) allowed him to credibly claim political 
legitimacy.  First, the Special Program has already been discussed as an efficient patronage 
distribution system under Tandja’s control, which he used in part to create the underlying 
infrastructure for iCCM.  However, Tandja’s reliance on external resources to fund 
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government and political activities meant he was vulnerable to conditionalities set by external 
actors able to offer financial backing or relief.  Indeed, with a ratio of development aid to 
total government expenditure as high as 91% in some years, Nigerien authorities relied on 
outside financial resources for everyday government expenditures, including patronage 
(Moss and Subramanian 2005).  Times of crisis can exacerbate this dependency:  in 2006, 
Tandja badly needed funds to quell unrest following the 2005-06 food crisis and tax 
increases on food, water and electricity, perhaps rendering him especially amenable to the 
World Bank’s conditionality on fee exemptions for children under five (Körling 2011; 
Ousseini 2011).     
Second, Tandja sought to further his career by establishing political legitimacy beyond the 
“instrumental legitimacy of systematic patronage,” a difficult task in a neo-patrimonial states 
because their ruling mechanisms are imported from the West and thus not linked to 
traditional African forms of governance and legitimacy (Englebert 2000).  To this point, 
when Tandja called the user fee exemptions his “gift to Niger’s women and children,” we see 
resonance with the “Father-Chief” archetype of African political authority, who gains 
legitimacy by taking care of the nation/family, notably its most vulnerable members (Kelsall 
2011).  Tandja’s decision to build the health huts (along with other development projects 
under the Special Program) was further cited by supporters as evidence of “how much 
[Tandja] has invested himself in improving life conditions for the average Nigerien” and 
used as an argument for extending his rule under Tazartché (Guede 2006).  Here, similarly, we 
see Tandja positioned as the chief who is entitled to eat well only “if his children are [not] 
suffering” (Kelsall 2011).   
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Such rhetorical orientations are not incidental, and indeed cannot be divorced from 
governance systems in operation, offering clues about conditions under which the poor are 
most likely to benefit (Kelsall 2011).  In neo-patrimonial states, positive development 
outcomes for poor populations may be more likely to occur when leaders 1) centralize rent 
seeking and rent management and 2) are oriented toward the long term (Kelsall 2011).   Our 
results are fully in line with these findings:  health huts for the poor were built under 
Tandja’s centralized rent management scheme (the Special Program) and his long-term time 
horizon (Tazartché, continuation) was clearly stated.  If these forms of governance seem in 
conflict with tenets of Western-style democracy, it is because they are; hence calls for global 
policy-makers to “go with the grain” of implementation countries and work within their 
cultural and institutional contexts (Commission_for_Africa 2005; Kelsall 2011).  Indeed, 
calls to improve governance in African countries and other LMICs often do not recognize 
the range of institutions that can support better development performance (Wild, Booth et 
al. 2015).  
One feature of this case study was the relatively small role for Ministry of Health technical 
expertise beyond operational and regulatory decisions.  Ministry officials gleaned scientific 
information from international agencies connected to large transnational networks of experts 
working to synthesize research evidence; the core technical content of iCCM was imported 
from a pre-existing model.  Further Ministry technical staff were entirely left out of several 
major policy decisions underlying iCCM, learning about the fee exemptions only when asked 
to issue the ministerial order; many also opposed the health huts at their debut.  Nigerien 
government officials did organize implementation of iCCM, with subsequent evaluations 
showing good quality of care; they also exercised power in linking incoming funds from the 
Catalytic Initiative to the health huts and resisting the use of relais in favor of paid 
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community health workers, a key factor in ensuring iCCM’s geographic reach and 
sustainability within the health system (Seidou 2008; Bensaid and Gali 2009).   
Our case study of power in policy making in Niger reveals iCCM to be founded on political 
conditions favoring positive outcomes for the poor, well-timed injections of external funds 
(the HIPC monies and CIDA/Unicef implementation financing), a (sometimes unstated) 
pro-poor agenda at external agencies, and the ability of Ministry officials to complement 
“scientific” evidence with operational and health systems expertise.   Among others, the UK 
Department for International Development (DFID) and the Swedish development agency 
(Sida) have used power analyses to inform policy initiatives; however many development 
programs fail to consider such issues and, we argue, risk squandering their resources.  Health 
policies in particular tend to be more context-specific than other policies, as they involve 
political, social, economic and cultural considerations (Walt and Gilson 1994) – but while 
accounting for political and contextual dynamics “might seem obvious … it is rarely the 
norm” (Wild, Booth et al. 2015).  Researchers and proponents of pro-poor health policies in 
LMICs should consider placing more attention on understanding individual country 
contexts, particularly as policies are unlikely to be successfully transferred when they conflict 
with national power structures (Reyna 2007).    
5.7 Conclusion 
In the literature on health policy reform, power is frequently invoked to explain outcomes 
but more rarely defined or analyzed, especially in studies focusing on LMICs.  We identify 
dimensions of power relevant to a case study of iCCM in Niger – political authority, financial 
resources, and technical expertise – and apply these to show why this pro-poor health policy 
was successfully developed and implemented in Niger.   
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Understandings of power in policy making in LMICs would be strengthened by multiple 
case studies, which are needed to strengthen theoretical claims; however, the deep 
understanding of national context required makes such research practically difficult to 
undertake.  Case study series and international collaborations by researchers interested in 
questions of power may provide a way forward in exploring power, an important if 




Chapter 6. Research utilization and knowledge translation in low-
resource environments: a case study of child survival policy in 
Niger 
6.1 Abstract 
Recent years have seen calls to enhance the use of scientific evidence in international health 
and development policy to optimize scarce resources and create maximally beneficial 
policies.  However, proposed analytic frameworks for understanding how knowledge and 
research evidence are translated into policy were created using data and observations mainly 
from Western countries and may not account for dynamics specific to policy environments 
in low- and middle-income countries (LMICs).  With these considerations in mind, we 
examine processes of health policy development in Niger, a low-income West African 
country that adopted and implemented integrated community case management (iCCM) 
beginning in 2007, resulting in measurable declines in child mortality.  Data collection 
included in-depth interviews with policy actors in Niger (N=32), document review (N=103) 
and direct observation of policy forums related to iCCM (N=3); we analyzed data using 
process tracing methodology and an Aristotelian definition of “knowledge” as consisting of 
1) episteme (facts), 2) techne (skills) and 3) phronesis (practical wisdom), while also applying a 
critical perspective to understand issues of power and domination.  We find sharp 
differentials in policy-makers’ possession and use of codified forms of knowledge (episteme), 
Nigerien policy officers access to which was highly mediated by actors at bilateral and multi-
lateral agencies; similarly, these latter had greater skills and capacity (techne) to produce and 
interpret research evidence.  Practical wisdom (phronesis) was more evenly distributed among 
actors, who used ethical arguments, attention to operational details and historical reasoning 
to make decisions later found to be key to iCCM’s success.  Researchers seeking to move 
forward theoretically and conceptually on research utilization and knowledge translation 
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should examine policy environments in LMICs, which differ from Western countries due to 
their limited health infrastructure and human resources coupled with large aid flows, 
conditions that provide external actors significant leverage in policy discussions and 
decisions-making. 
6.2 Introduction 
The key benefit of evidence-based policy-making is that it is believed to produce higher 
quality policies, with correspondingly better outcomes for populations (UK Department of 
Environment Food and Rural Affairs 2006).  When it comes to child survival policy, the 
stakes are incredibly high: each year an estimated 6.3 million children under 5 die, nearly all 
in low- and middle-income countries (LMICs), with three leading causes of death being 
pneumonia (15% of deaths), diarrhea (9%), and malaria (7%) (Liu, Johnson et al. 2012).  
Policies to increase access to prompt and effective treatment of childhood illness are crucial 
to reducing child mortality; as a result, global actors developed integrated community case 
management of childhood illness (iCCM), an evidence-based strategy to provide life-saving 
care for these three diseases (Young, Wolfheim et al. 2012).  To date, nearly all African 
countries have adopted some form of iCCM, including CCM for malaria, diarrhea or 
pneumonia or some combination thereof (Rasanathan, Muñiz et al. 2014).  
In recent years there have been calls to move toward evidence-informed decision-making in 
global health and public policy, following observations in the 1990s and early 2000s that 
health policies did not reflect evidence as much as they could and that stores of useful 
research were going to waste (Davis and Howden-Chapman 1996; Lavis, Ross et al. 2002; 
Hanney, Gonzalez-Block et al. 2003). Concurrently, there have been new directions in the 
kinds of evidence considered necessary and appropriate as a basis for health policy, with a 
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growing consensus that earlier definitions of evidence as “statistical inference about events 
in populations that are studied prospectively” were far too narrow, and should be expanded 
to include observational and qualitative studies and health policy and systems research 
(HPSR) (Black 2001; Sturm 2002; Fox 2005).  Following a 2004 Mexico City summit on 
translating evidence into practice, WHO issued a resolution “to establish or strengthen 
mechanisms to transfer knowledge in support of evidence-based public health and health-
care delivery systems” and began giving greater attention to the issue of evidence utilization 
including in LMICs (WHO 2004).  Today, there are a number of groups focusing on 
generating, synthesizing and communicating relevant research findings, including the WHO 
Alliance for HPSR and the Evidence-Informed Policy Network (EVIPNet), as well as tools 
like SUPPORT and SURE, which combine policy briefs, research syntheses and analyses of 
policy options and potential consequences and are aimed at health policy decision-makers, 
including in LMICs (Rosenbaum, Glenton et al. 2011).   
In this article, we consider existing models of research utilization and knowledge translation 
with respect to health policy and extract theoretical categories relevant to LMICs, then apply 
these to a case study of iCCM policy creation in Niger, a low-income West African country 
that historically has had very high rates of child mortality.  We first provide a brief overview 
of the literature and reflect upon issues that arise when studying evidence use and policy 
development in LMICs.  Next we provide a case study of research utilization and knowledge 
translation processes for iCCM in Niger.  Finally, we discuss lessons learned and suggest 






In the fields of public health, public policy, political science and international relations, there 
are broad literatures on the related concepts of research utilization, with its “many 
meanings,” and knowledge translation, often defined as “the exchange, synthesis and 
effective communication of reliable and relevant research results” for the purposes of policy-
making (Weiss 1979; Mills, Bennett et al. 2004).  Within these literatures there is a 
proliferation of models describing under what circumstances policy-makers utilize research 
evidence and how they translate knowledge into specific policies.  While containing many 
insights, the research on these topics has suffered from epistemological and conceptual 
difficulties related to the intersection of disciplinary standpoints used to study these topics, 
and a nearly exclusive focus on Western countries and corresponding lack of research in 
LMICs.  In this section, we examine these issues, then offer theoretical directions for 
examining research utilization and knowledge translation in health policy making in LMICs, 
to be applied during our case study of iCCM in Niger. 
First, the concepts of research utilization and knowledge translation exist at an intersection 
of disciplines, giving rise to conflicting theoretical understandings about the nature of 
knowledge and the processes by which policy makers make use of knowledge to develop 
policy (Stone 2004; Greenhalgh and Wieringa 2011).  Of particular note is the 
epistemological conflict arising between medical and health services research, which tends to 
have an objective view of knowledge as pre-existing and “untouched by human hands,” and 
those coming out of disciplines such as sociology, organizational management, and 
international relations, which view knowledge as “constructed” by human actors, and thus 
embedded in human reality with all its societal complications.  Most often, researchers in 
public health have adopted the former perspective, and are “imbued with the ideal model of the 
97 
 
natural sciences” (Walt 1994), whereas the international relations and sociology literatures use a 
broader definition of knowledge and emphasize the spread of norms influencing how 
knowledge is translated (Stone 2004).  Indeed, some analysts argue the theoretical difficulties 
encountered in the “evidence-based policy-making” paradigm have everything to do with its 
origins in the highly objectivist “evidence-based medicine” movement (Behague, Tawiah et 
al. 2009) and commentators in the public health literature have frequently argued that 
models of evidence-based policy-making rest too much on a rational view of policy-making 
(Hanney, Gonzalez-Block et al. 2003; Morgan-Trimmer 2014).     
Despite this lively conceptual debate, relatively few studies have been published on research 
utilization and knowledge translation in LMICs as they relate to health policy development.  
While articles in the literature do apply models of evidence to case studies of health policy in 
LMICs (Rodriguez, Shearer et al. 2015), existing studies tend to focus on the lack of research 
utilization or perceived failures in knowledge translation, such as the under-use of relevant 
evidence or data to inform decision-making (Gupta, Zurn et al. 2003) or specific barriers to 
using research (Aaserud, Lewin et al. 2005; Mubyazi and Gonzalez-Block 2005; Woelk, 
Daniels et al. 2009).  Several studies discuss political factors as barriers to evidence-based 
health policy-making in LMICs, including a multi-country case study on the introduction of 
magnesium sulfate for pre-eclampsia, in which respondents in LMICs cited a lack of political 
will and poor understanding and involvement of policymakers and public authorities, factors 
discussed much less frequently in high-income countries (Aaserud, Lewin et al. 2005; 
Hunsmann 2012).  Despite these difficulties, policymakers in LMICs nearly universally cite 
evidence as being crucial to making good policy decisions (Burchett, Mounier-Jack et al. 
2012).   
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Translating research knowledge into policy is a context sensitive process and it behooves us 
to consider the ways in which health policy making environments in LMICs differ from the 
Western countries in which most studies on research utilization and knowledge translation 
have taken place (Woelk, Daniels et al. 2009).  First and foremost, LMICs by definition have 
comparatively fewer resources to devote to the health policies they select, as well as higher 
levels of constraints in terms of the service delivery that can reasonably be expected of 
health systems.  LMICs also have comparatively fewer human resources, quantitatively and 
often qualitatively, resulting in lesser capacity to assess evidence and incorporate it into 
policy in the first place.  In sub-Saharan Africa, research capacity in both health and the 
social sciences is hampered by under-investment in research and universities, resulting in a 
small number of researchers, dilapidated libraries and infrastructure, and lack of status or 
consideration for teachers and researchers  (Olivier de Sardan and Tidjani Alou 2012). 
Furthermore, a substantial portion of what human resources do exist are lost to higher-
income countries: Kasper and Bajunirwe estimate that in half of sub-Saharan African 
countries, more than 30% of physicians trained locally are “lost” to migration (Kasper and 
Bajunirwe 2012).  At the same time, alongside massive aid flows, there are substantial 
numbers of qualified human and material resources at external organizations such as bilateral 
and multi-lateral agencies and non-governmental organizations (Pallas, Nonvignon et al. 
2015).   
Importantly, the “knowledge” available to be used towards policy making in LMICs is both 
limited in amount and frequently conditioned by viewpoints external to the national actors 
who will use them to create policy.  First, the mismatch between investments and needs in 
health research has been characterized since the 1990s as the “10/90 gap,” which refers to 
the Global Forum for Health Research’s finding that only 10% of worldwide expenditure on 
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health research goes toward problems primarily affecting the poorest 90% of the world’s 
population (Currat, de Francisco et al. 2004).  A comparison of the number of medical and 
social science publications annually by world region and income group in 2013 demonstrates 
the ongoing predominance of publications by authors affiliated with Western institutions, to 
the extent that a logarithmic scale is required (Figure 7).  Similarly, the most influential 
publications in the scientific literature as measured by citation frequency are rarely produced 
by authors affiliated with institutions in LMICs:  of the top 100 most cited articles in the 
Science Citation Index, the United States, Canada and the United Kingdom accounted for 89 
and none had a first author from an LMIC (Uthman, Okwundu et al. 2013).  
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Furthermore, what research on LMICs that does exist is often “the fruit of external logics,” 
meaning that it most often initiated and financed, not to mention undertaken and 
interpreted, by actors not physically located in the countries that are the subject of their 
research (Olivier de Sardan and Tidjani Alou 2012).  In LMICs, the vacuum of domestically-
produced research is filled by studies that are initiated, produced and published by 
researchers based outside the country and/or financed by bilateral or multi-lateral aid 
agencies:  as Oliver de Sardan and Tidjani Alou put it with respect to social science research 
in African countries:  “African states allocate very small budgets to research.  Research in 
these countries is most often financed by bilateral or multilateral aid agencies, which indicate 
their priorities and their expectations. They considerably influence research topics 
corresponding to their specific priorities” (Olivier de Sardan and Tidjani Alou 2012).  Thus, 
the construction of knowledge available for policy making in LMICs is already encoded with 
assumptions, normative positions and prioritization schemes that external not just to the 
government but to the entire national context to a much greater extent than in Western 
countries. 
In some ways, the confluence of theoretical and epistemological disorder and lack of 
research in LMICs on the topics of research utilization and knowledge translation opens a 
conceptual window, inviting us to re-define our terms while broadening the analysis to 
include a wealth of new cases differing substantially from those previously studied.  
Greenhalgh and Weiringa offer a number of new directions to move beyond the current 
conceptual difficulties, such as breaking down the implied separation between knowledge 
and practice encompassed in formulations such as the “know-do gap” and the term 
“knowledge translation” itself (Greenhalgh and Wieringa 2011).  Instead, they propose using 
an Aristotelian view of knowledge based on three components: the episteme (facts or explicit 
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knowledge, including notably the scientific literature), techne (skill or practice) and phronesis 
(situation-specific practical wisdom).  Phronesis is perhaps the slipperiest component of the 
Aristotelian conception of knowledge, usually called “practical wisdom,” more traditionally 
translated as “prudence,” and sometimes defined as the ability to apply general rules to 
particular situations (Montgomery 2006).  It is different from techne in that it is not a pure 
skill but also involves ethical and practical considerations about which ends to pursue.  For 
the purposes of studying research utilization in LMICs, this framework is appealing, as it 
calls upon us to consider forms of knowledge beyond those that are codified in the episteme, 
such as policymakers’ practical wisdom (phronesis), as well as look at issues of capacity and 
quality under the rubric of techne.   
Greenhalgh and other analysts further call on researchers to adopt a critical perspective and 
examine the role of power in research utilization, all the more so given stark power 
differentials outlined in discussion of health policy-making environments in LMICs above 
(Behague, Tawiah et al. 2009; Greenhalgh and Wieringa 2011; Shiffman 2014). A  critical 
perspective of policy-making processes requires the analysis of both hard forms of power, 
such those derived from resource imbalances, and softer forms of power which pervade via 
norms, cognitive frameworks, and ideas as seemingly elementary as what is “true” or 
“rational” (Morgan-Trimmer 2014).  These “softer” forms of power were a major theme of 
the Frankfurt School of neo-Marxist social theorists, who pointed to forms of domination 
exercised through ideology, social or intellectual norms, and criticized positivism as an 
ahistorical and insufficiently political philosophy and methodology that failed to sufficiently 
problematize the concept of knowledge (Haas 1992).  For the purposes of studying research 
utilization in LMICs, this perspective brings us to ask how “knowledge” is defined and by 
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whom, the identities of the producers of accepted forms of knowledge, and structures that 
reproduce the norms that define how knowledge should be used.   
6.4 Methods 
This study relies on case study methodology, a form of research useful for reconstructing 
processes holistically to examine the processes at work (Yin 1994). Our sources of data were 
in-depth semi-structured interviews, a document review and direct observation of policy 
forums, all of which are techniques useful in unraveling complex situations, appropriate to 
studies of policy made at the national level, and widely used in studies on research utilization 
(Hanney, Gonzalez-Block et al. 2003).   
Data collection took place in Niamey, Niger from February to August 2012.  For the 
document review, we consulted 103 documents of several types related to iCCM policy, 
including:   
• Official expressions of policy:  policy documents, implementation tools, training manuals, 
national strategies (n=22); 
• Internal documents or “gray” literature: draft reports, internal reports and memos, 
PowerPoint presentations from meetings, funding requests, field evaluations, 
midterm reports (n=29); 
• Scientific articles, research or data: articles from the scientific literature, doctoral 
dissertations, statistical surveys, action research studies (n=31); 
• Other: laws and regulations, press articles, newsletters, cooperation agreements 
between Niger and external actors (n=21). 
 
Documents were subjected to close reading; we systematically extracted information on 
authorship, the purpose of the document, arguments and justifications put forward, and the 
nature and quality of scientific or technical argumentation. 
103 
 
Interviews were conducted with 32 individuals involved in iCCM policy formulation, 28 of 
which occurred in country; the average length of interviews was 57 minutes.  Key individuals 
were identified through the document review and snowball sampling and included: 
• Directors of the Ministry of Health’s child health office between 1996 and 2012; 
• Senior and mid-level Ministry officials; 
• Staff at donor and technical assistance bodies in Niger including WHO, Unicef, 
USAID; 
• Representatives of professional associations, clinicians, and national pediatric health 
trainers; 
• Members of local and international NGOs and international consultants. 
Interviews were conducted in French and transcribed in-country.  Finally, we observed three 
national policy forums on issues related to iCCM and child health in Niamey1; in so doing, 
we were able to observe interviewees and other policy actors in real-life situations of policy 
discussions and negotiations, conditions that tend to reveal existing power relations and help 
identify controversial issues (Hunsmann 2012). 
Data analysis was based on process tracing, a technique to combine multiple sources of 
information to “minimize bias, establish common patterns of causality, and reveal social and 
political processes” (Yin 1994; Shiffman, Stanton et al. 2004). In the context of our study, 
process tracing can be used to demonstrate patterns of evidence sharing and directionality in 
flows of information, following the spread of knowledge for policy-making among groups of 
actors (Lee and Strang 2006). To perform process tracing we compiled a timeline of policy 
development in Niger as a basis for analysis from interview and document data.  Interviews 
and notes from participant observation were coded for categories related to knowledge and 
practice, including different types of evidence or knowledge and their utilization; process 
                                                 
1 The three forums were 1) a validation workshop to approve the new minimum package of care for health 
posts (Niamey, June 2012), 2) a national workshop to share results of a pilot program on neo-natal care 
(Niamey, July 2012), and 3) a workshop on home malaria care (Niamey, July 2012).  
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such as learning, argumentation, and framing; and political factors and power dynamics in 
policy-making using NVivo 9 (QSR 2010).  Following this descriptive analysis, we analyzed 
our data using the theoretical categories discussed above, namely by using an Aristotelian 
definition of “knowledge” and applying a critical perspective to understanding the 
knowledge translation process.  
This research was part of a larger multi-country study of iCCM policy formulation in Africa; 
it was deemed exempt from ethical review by the Johns Hopkins School of Public Health 
and was approved by Niger’s national ethics committee and Ministry of Higher Education 
and Scientific Research. 
6.5 Results 
The development of child survival policies leading up to iCCM in Niger can be traced from 
predecessor policies such as Integrated Management of Childhood Illness (IMCI) in the late 
1990s to the beginning of policy discussions in 2005, the adoption of iCCM in 2007, and 
finally its full implementation by the end of 2011.  Policy discussions on iCCM began in 
earnest leading up to April 2005, when representatives of Niger’s Ministry of Health (MOH) 
participated in a meeting sponsored by USAID’s AWARE-RH project in Dakar to learn 
from a Senegalese project on community-based management of pneumonia (AWARE 2008).  
The Nigerien delegation’s presentation at that meeting proposed an integrated approach to 
community level care including malaria, diarrhea and pneumonia, an initiative that gained 
momentum when AWARE and other partners traveled to Niger for a follow-up visit to 
discuss iCCM with MOH officials in August of the same year.  Shortly thereafter a field trial 
was organized in Madarounfa district, led by MOH with the necessary implementation tools 
developed in partnership with technicians from AWARE-RH, WHO and Unicef.  In January 
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2007, the results of the mid-term evaluation proved satisfactory and Nigerien officials 
decided to scale up iCCM, with funding for implementation arriving in October 2007 
following the signing of a co-financing agreement between the Canadian international 
development agency (CIDA, now DFATD) and Unicef (AWARE 2008; Hamsatou 2008).   
6.5.1 Episteme: Codified knowledge “comes” from outside 
Three main types of “facts” potentially available to policy-makers during issue identification 
and iCCM policy formulation were: 1) the scientific literature (including clinical and 
epidemiological studies but also health systems and policy research, qualitative studies, etc.) 
2) international technical directives and guidelines2, and 3) epidemiological and demographic 
data and statistics.  Nigerien government officials more frequently described using data and 
statistics to understand the country’s needs and tailor international guidelines to the country 
context, whereas external actors cited the scientific literature as the basis for child survival 
policies in Niger; furthermore Nigerien government officials’ access to the episteme was often 
mediated by international actors. 
First, Nigerien government officials often mentioned relying on international norms, 
directives, and technical guidelines to guide policy choices, which international agencies such 
as WHO and Unicef promoted by, for example, introducing them to “important professors 
and influential people” (NIG-2012-8-2, international consultant).  Nigerien government 
respondents viewed guidelines as being based on the latest and best scientific research, and 
therefore essentially “facts,” though facts in need of adaptation to the country context: 
                                                 
2 Some readers may question our inclusion of international directives and guidelines in the episteme, judging that 
they are not “pure” knowledge in that they represent an institutional or somehow specific point of view.  Our 
rejoinder, borrowed from the constructivists, is that all types of knowledge are similarly encoded with their 
origins; as such guidelines are merely another codified form of knowledge within the episteme. 
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“We base ourselves on international norms.  Because there are international norms 
that come, international directives that come.  And we, we take them and adapt them 
to our context.” (NIG-2012-5-21, mid-level child health officer, MOH)  
“They are universal practices developed by WHO and Unicef. Then the countries 
take them and adapt them at their level.”  (NIG-2012-5-11, mid-level child health officer, 
MOH) 
To this end, government stakeholders also frequently mentioned data and statistics about 
Niger’s demographic and epidemiological profile, including the low density of Niger’s 
population, high percentage of rural dwellers and improvements in the child mortality rate 
following policy implementation (NIG-2012-5-18, NIG-2012-5-21).  Such data was from 
sources such as the annual child mortality surveys led by WHO, Unicef, the World Bank, 
and others (NIG-2012-5-30) and the Demographic and Health Surveys (DHS) funded by 
USAID (NIG-2012-5-21).   
Scientific studies of any kind were rarely spontaneously evoked by government respondents, 
and brought up somewhat more frequently by officials at bilateral and multilateral partner 
organizations.  This is perhaps due to the fact that government stakeholders had limited 
access to the scientific literature, as one Nigerien respondent who had worked both at MOH 
and an international agency described:  
“With scientific data, it’s a continual learning process.  At any time I can get the 
information [here at the international agency]. But when I was at the Ministry from 
2000 to 2004, internet was not so advanced.3  I have better access to information 
                                                 
3 Nor is it today. – SD 
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here than there.  Science evolves.”  (NIG-2012-6-4, child health specialist, international 
agency) 
Government officials nonetheless stayed current on the latest scientific information via 
international conferences on child health and related issues, with their participation most 
often paid for by international partners: 
“It helps tremendously. When they go to major conferences they always come back 
with updated knowledge.” (NIG-2012-6-16, senior manager, international agency)        
The only specific studies brought up by respondents appeared in the Lancet, specifically its 
series on neo-natal and child survival (mentioned by two Nigerien and two international 
respondents).  One Nigerien said, 
“It was only through the Lancet that we came to know that to save the life of a 
newborn, [sophisticated material] is not necessary … Well, I think that it has been 
very influential; it was a ‘cry from the heart’ as we say, and it was an awareness raiser 
at the global level about massive newborn mortality.” (NIG-2012-6-7, clinician)       
Influential articles such as these were often circulated by WHO and other agencies, who 
made French-language summaries, for example of the 2003 Lancet series on child survival, 
which Unicef “didn’t [translate] … but took elements of” (NIG-2012-5-30, NIG-2012-6-16).  
In this way, access to the scientific literature was often mediated by international actors, 
whose interpretations government actors accepted because of the perceived authority and 
legitimacy of the former: 
“The role of evidence is that there is no point reinventing the wheel. These are 
things that are immediately applicable because they have proven their worth. They 
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do not need to be tested anymore and this makes you move faster to achieve a 
reduction in child mortality and morbidity.  So … we don’t reinvent the wheel of 
history, it’s already done, so now we must consume.” (NIG-2012-6-7, government 
clinician)  
6.5.2 Techne: In-country capacity no match for international agencies 
Elements of techne, defined here as the skills needed by policy-makers to produce, interpret 
and communicate relevant research, evidence or knowledge, again revealed a divide between 
the resources and capacities of Nigerien and international stakeholders.  On the one hand, 
government offices are under-staffed drawing upon a severely restricted pool of qualified 
policy-makers: 
“[W]hen we started [in the 1980s], Niger had no more than three or four 
pediatricians. Today, there are not many of them, but they exceed forty! Currently, 
they are trained here [in Niger], which will enhance the resource in terms of number 
and quality.” (NIG-2012-6-7, government clinician) 
In terms of the production of knowledge relevant to policy, beyond low Nigerien 
participation in the scientific literature (Figure 7), operational research also poses ongoing 
difficulties for government programs, as at a national workshop presenting results of a pilot 
project of iCCM for newborns (July 2012) during which numerous attendees expressed 
regret at the lack of baseline or reference group and subsequent impossibility of drawing 
meaningful conclusions.  “There were problems with respect to the data, it must be said; we 
have nothing to hide,” recognized one official linked with the research (NIG-2012-6-07).   
In terms of interpreting and analyzing research, government documents such as strategies, 
working papers and implementation tools frequently omit citations or refer to publications in 
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a vague manner (“according to a Kenyan study”), although poor citation habits do not 
necessarily indicate a failure to utilize research results (Zataka 2005; Hamsatou 2008; PNLP 
2012).  Government analytical capabilities also appeared to be limited with respect to 
language skills (few were comfortable in English, the language of the international scientific 
literature), as well as quantitative data and statistics – officials said they relied on data from 
DHS rather than from the national health information system because the former are “pre-
analyzed” in the accompanying reports: 
“Well, we have DHS, which is done every 10 years; we’re obliged to rely on that … 
The SNIS [national health information system] gives raw results, like that. It doesn’t 
allow one to formulate objectives.” (NIG-2012-5-21, mid-level child health officer, MOH) 
At the same time, international agencies staffed large child health offices with qualified 
Nigerien and international technical staff;  the Unicef campus in Niamey counts over 55 
technical experts (including 25 local and 30 international staff), not including consultants 
hired on a temporary basis, dwarfing the child health office at MOH (Touré 
personal_communication).  Furthermore, international agencies skim off the best and 
brightest of government technicians in Niger (and elsewhere) by offering substantially higher 
salaries, substantially weakening government planning capacity (Lavigne Delville and 
Abdelkader 2010).  Among those Nigerien experts who stay in the civil service, external 
influences are apparent in other ways, such as via the training and educational background of 
Nigerien clinicians, whose biases and viewpoints filter down to the generation of Nigerien 
clinicians they are training:  
“Because all these professors were educated overseas, it has been quite hard to get 
them to accept exclusive breastfeeding from 0 to 6 months, it has also been very 
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tough to get them promote home-made ORS by just mixing salt and sugar in water. 
These were revolutionary changes. Yet, their health facilities were reference facilities, 
supporting medical students and in-service training; therefore, when they are not 
convinced, it is hard.” (NIG-2012-8-2, international consultant)      
Nonetheless, Nigerien policy makers appeared to possess significant skills when it came to 
building on policy models from similar contexts, most notably countries in the sub-region, in 
processes that went beyond mere imitation.  Nigerien government respondents frequently 
mentioned nearby countries that had tested policy innovations similar to iCCM; the most 
pertinent examples, they said, were conducted in countries with similar epidemiological and 
socio-cultural profiles, which provided a model of success and facilitated the sharing of 
implementation tools, training modules and so on.  Respondents mentioned relevant 
experiences in Mali, Benin, Togo and especially Senegal, sometimes equating the importance 
of other countries’ experiences with that of scientific evidence in informing policy 
development: 
“There was scientific evidence showing that you can treat certain diseases at the 
community level. And there were other countries’ experiences.  Because Niger went 
to Senegal to see how it worked.” (NIG-2012-5-17-2, head of child health, government) 
As mentioned previously, Senegal’s pilot project was one of the first in sub-Saharan Africa to 
include community-level treatment of pneumonia – yet it inspired Nigerien officials to 
design an integrated curative package for the three main pathologies, which they presented at 
the 2005 Dakar meeting: 
“Every country presented what they intended to do at community level. So, Niger 
stated that it will not limit itself to [pneumonia] case management at community 
111 
 
level, but will rather implement IMCI as it is learnt at the clinical level and implement 
it at the community level. So the process should be the same, all the symptoms will 
be observed.” (NIG-2012-5-18, clinician, government sector) 
Thus, despite limited abilities to access and use the international scientific literature, Nigerien 
policymakers acted in intellectually entrepreneurial and innovative ways, making use of 
policy examples and extrapolating their relevance to the Nigerien context. 
6.5.3 Phronesis: International policy, common-sense Nigerien solutions  
Phronesis, often translated as “practical wisdom,” has also been defined as the ability to 
apply general rules to particular situations, an aspect of the concept particularly relevant to 
the translation of globally-produced health policies to local contexts (Montgomery 2006).  
We identify four types of practical wisdom potentially available for the iCCM policy-making 
process:  1) logical or common-sense arguments, 2) attention to operational details, 3) pilot 
projects, and 4) historical analysis.  First, Nigerien and international policy actors used logical 
arguments to connect the problem of child mortality in Niger to the solution of community-
level care. Nigeriens respondents frequently mentioned factors such as the geographic size of 
the country and the small number of health facilities to explain why children “died at home” 
and evoke the need to shift tasks to community health workers. One respondent said,  
“There are not enough pediatricians … If one says, it is necessary that pediatricians 
treat children, how many can he treat? [Laugh] It is not possible, the country is large 
and there is I believe 40% of the population who are children. … If one says it must 
be a pediatrician who treats them, we won’t get anywhere. But with task shifting, 
with small skills, they can save many lives.” (NIG-2012-7-11-2, IMCI officer, government 
sector)       
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Within both government and international agency offices, the most influential holdouts to 
task-shifting policies were often medical doctors, some of whom were trained abroad, and 
whose clinical perspective appears to have posed an initial obstacle to what were later 
accepted as “common-sense” arguments: 
“‘This is second-rate medicine, low-grade medicine. You are going to kill children, 
etc.’ After having said all this, we were told the number of children who die every 
day in the community. We think we see pediatric cases, in fact we don’t see anything: 
80% of children die in the community … Hey! Are you scratching your head, so, 
doctor, will you be the one to provide care for all these children? No? Will you let 
them die? No. So, what will you do? Discussions on the issue are now starting.” 
(NIG-2012-6-16, senior manager, multi-lateral agency) 
“The main argument for all these great professors was to say ,‘You are working in a 
facility that is well equipped with equipment, staff and material, but presently where 
do children go to seek care?’ Not necessarily in town.” (NIG-2012-8-2, international 
consultant)  
Second, Nigerien actors in particular paid attention to operational details in child health 
programming, a fact that was especially evident during direct observation of policy-making 
forums, which included much discussion of motorcycles, bicycles, donkeys and carts, 
specifics about how censuses and data collection would operate, and different incentives for 
health workers and other operational actors.  Lower-level health workers, those most 
familiar with operational details, were often represented at policy forums but rarely spoke up, 
perhaps intimidated by the dense scientific presentations that usually preceded question-and-
answer periods – meaning that their stores of practical knowledge and experience were rarely 
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tapped to inform the policy making process.  Typical was this interaction at a workshop on 
iCCM for newborns: a presiding officer, noting “quite the army of pediatricians and 
gynecologists who have spoken up till now,” called upon the community health workers 
(CHWs) present to comment; after one mumbled a few words, a member of the audience 
prompted, “What did you think of the project?”  “Well, there were a lot of problems related 
to post-natal care and delivery, but we also saw a lot of progress,” he responded, and the 
discussion moved on.  Finally it bears noting that such discussions of operational details 
during policy forums are rarely documented or recorded in writing and, in this case study at 
least, were an almost purely oral form of knowledge. 
Third, a pilot test was considered by all actors (and especially Nigerien ones) to be an 
essential step to demonstrating the feasibility of iCCM in the Nigerien context – yet its 
function was less about the formal creation of knowledge (no official evaluation was 
undertaken) than about a practical testing of the concept. MOH, in consultation with 
AWARE, WHO and UNICEF conducted a pilot test in 2006-07 with two cadres of health 
workers, CHWs and community volunteers (relais communautaires), in Madarounfa health 
district. Following the pilot’s evaluation in early 2007, Ministry authorities decided to scale 
up iCCM using only CHWs, a cadre that was already integrated into the health system, more 
or less forcing international partners to follow, as they were reluctant or unwilling to support 
a program that would be in conflict with existing legal and regulatory norms.  This marriage 
of policy and context that would ultimately prove key to iCCM’s success (Dalglish, Surkan et 
al. 2015).  
Generally speaking, pilot projects tested only a limited number of child survival interventions 
in Niger, principally those that international agencies were willing to finance.  Indeed donors 
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sometimes used pilot projects as a tool to convince national stakeholders to adopt policies 
and programs, a fact government officials were not unaware of: 
“Because people say ‘yes, in India it happened, yes in Ethiopia it happened, in 
Rwanda it happened, that is OK; but in our country, how can we avoid things getting 
out of control?’ That is why for the KFPs [Key Family Practices] we preferred a 
pattern with which it will be said that ‘this is being implemented by people living in 
Niger, when you try it, it works’.” (NIG-2012-6-16, senior manager, multi-lateral agency)       
“[Ideas for pilot projects come] from the higher level, either from Unicef which is 
our major partner or from any other partner who is willing to invest in one area, in 
child health, in newborn health … They get in touch with us or with our leaders, and 
then things land here… Decisions are not made here, but we are the actors.” (NIG-
2012-7-11-2, IMCI officer, government sector)      
Fourth and finally, elements of the Nigerien historical context were taken into account 
during policy processes mainly in informal ways.  Niger was an early leader in community 
health programming, and for more than two decades beginning in the mid-1970s deployed a 
small army of secouristes-hygienistes (first aid workers), who dispensed chloroquine for malaria 
and other basic medicines.  Respondents in our study were well aware of the secouristes; 
however, their ability to gain practical wisdom from this experience was hampered a lack of 
any formal evaluation of the program, making it difficult to learn lessons from the past.  
Respondents provided a multitude of reasons to explain its ultimate failure, including lack of 
incentives for first-aid workers (NIG-2012-6-8-1, NIG-2012-5-30); the absence of monitoring 
and supervision (NIG-2012-7-3-3); difficulties in replenishing drugs stocks (NIG-2012-6-8-2); 
changes in the health system with the introduction of health posts; and lastly, the poor 
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performance of first-aid workers (NIG-2012- 7-3-1, NIG-2012-7-26), which are not mutually 
exclusive.  However, as one said, the lack of substantive documentation effectively 
consigned the experiment to “the dustbin of history” (NIG-2012-7-3-1, direct observation, 
workshop on home malaria care).   
6.6 Discussion 
In the iCCM policy making process in Niger, government and international actors drew on 
diverse types of knowledge and evidence to design and enact a policy that would measurably 
reduce the number of child deaths in Niger.  An Aristolian conception of knowledge brings 
forth ways in which actors’ knowledge and practice worked inseparably to bring iCCM, a 
policy created at the global level, into the Nigerien health system.  Beginning with codified 
knowledge (the episteme), the production, analysis and communication of articles in the 
scientific literature was undertaken primarily by external actors, including those at bilateral 
and multi-lateral agencies; Nigerien actors nonetheless drew on trends from the scientific 
literature and international guidelines and distilled them through data and statistics on Niger 
to adapt iCCM to the local context.  The technical skills (techne) needed to translate 
knowledge into policy were also unevenly distributed, with Nigerien government offices 
severely limited in human resources, whereas international agencies were comparatively 
awash with qualified personnel; however, Nigerien government actors possessed capabilities 
allowing them to grasp currents in the scientific literature, assess their pertinence to Niger, 
and furthermore navigate a complex policy environment to build support, adopt and 
implement iCCM.  The practical wisdom (phronesis) of both Nigerien and international actors 
was essential to iCCM’s success, and included ethical or philosophical appeals regarding the 
need for task-shifting, an attention to operational details, and an insistence on linking iCCM 
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policy with an already-institutionalized cadre of health workers (CHWs) in a decision that 
would prove key to iCCM’s success.   
The Nigerien experience with iCCM is relevant because it is a case in which an evidence-
based policy created at the global level was successfully adapted, adopted and implemented 
in a low-income, low-capacity setting, with measurable success.   Evaluations of iCCM have 
generally shown good quality of care in health huts (Seidou 2008; Bensaid and Gali 2009); 
more importantly, estimations using the Lives Saved Tool (LiST) found iCCM and 
surrounding policies to have contributed nearly a quarter of Niger’s 43% reduction in child 
mortality between 1998 and 2009 (Amouzou, Habi et al. 2012).  In this way, the case of 
iCCM in Niger represents the promise of evidence-based policies, fulfilled when they are 
properly adapted to country contexts and implemented by competent authorities and 
operational actors.   
Nonetheless, this success should not prevent us from problematizing research utilization and 
knowledge translation processes, the more so since the Nigerien case reflects aspects of 
policy environments that are typical or common in LMICs but more rarely found in high-
income countries.  For example, the policy environment in Niger was characterized by 
limited human resources at government agencies, coupled with greater numbers of staff and 
higher capacity at international agencies, at least in the area of child health.  Taken together, 
policy actors from WHO, Unicef, USAID, the West African Health Organization and others 
often outclassed – the word choice is deliberate – Nigerien government actors in terms of 
education, training, English language skills and other technical skills, a fact due in no small 
part to the fact that the most talented Nigerien technical staff sought positions in 
international agencies for understandable professional and practical reasons.  Personnel at 
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these agencies also had vastly superior access to the scientific literature, allowing them to 
dominate interpretations of codified forms of knowledge.  Nigerien actors accepted this, 
quite likely because of numerous competing priorities coupled with limited time and 
resources.  This may explain the seeming passivity that some Nigerien respondents 
expressed with respect to interpretations of codified forms of knowledge and high regard for 
WHO’s technical advice, as has been observed in other studies in sub-Saharan countries 
(Cruz and Walt 2013). While these conditions may not be found in all health policy 
environments in sub-Saharan Africa or LMICs (and certainly not in research powerhouses 
such as India, China, Kenya, South Africa, and so on), no comparable situation is found in 
high-income countries, where research on knowledge translation and research utilization has 
typically taken place.   
A critical take on the iCCM policy-making process in Niger brings us to highlight sources of 
power within the knowledge translation process, one of which was medical training and 
clinical knowledge, as when pediatricians blocked and then finally allowed the treatment of 
pneumonia by CHWs following logical and ethical arguments about the need for iCCM as a 
way to reach more children in need.  Among Nigerien government policy actors, a 
substantial number were clinicians and indeed medical professionals are a policy elite that 
traditionally has exercised significant power in health policy thanks to their special 
knowledge and authority, legally granted occupational monopoly, top position in health, and 
cultural authority (Clark 2014).  In Australia, for example, a network analysis found medical 
professionals to form a cohesive and central sub-network, lending them pervasive influence 
on policy despite decades of efforts to reduce medicine’s place in policy making and the 
recognition that many (non-medical) forms of knowledge (including social science research, 
health systems and policy research, etc.) are both useful and necessary to making good health 
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policies (Lewis 2006).  In the Nigerien case, we might note that while there is a strong body 
of qualitative and socio-anthropological research on the Nigerien health system, including as 
it relates to child heath, much of it in French, these types of studies do not appear to have 
had any impact on iCCM policy making processes despite their relevance to understanding 
historical policy precedents, current health system challenges, and care seeking behaviors 
(Kafando, Mazou et al. 2011; Körling 2011; Ousseini 2011; Oumarou 2013).   
At this point it is useful to pause and put these results into context, in terms of the 
determinants of policy choices beyond research, evidence and knowledge – even 
“knowledge” broadly defined.  The adoption of iCCM in Niger was an intensely political 
process, pursued by political actors driven by structural dynamics related to Nigerien forms 
of governance and economic (re-) distribution and the agendas of external actors (Dalglish, 
Surkan et al. 2015).  This leaves us to wonder whether political skills are not properly 
considered a form of knowledge in the policy-making process – not knowledge to be 
translated, but knowledge of how to translate, a nuance hearkening back to the Aristotelian 
refusal to separate knowledge and practice.  For the purposes of the present analysis, we 
decided it lay outside our scope – a decision that might be criticized (and perhaps rightly) as 
unduly technocratic by analysts arguing that “policy is political; our ideas about knowledge 
translation must be too” (Morgan-Trimmer 2014).  Indeed, while the evidence-based policy 
paradigm is influential in high-income countries as well, some analysts have pointed out that 
policy decisions in Western countries are often openly political, whereas stronger forms of 
the “evidence-based policy” paradigm (particularly as they relate to evidence from 
randomized trials) are more exclusively associated with the global South (Deeming 2013).  At 
the same time, theoretical categories of knowledge for policy-making must not become so 
broad as to be unwieldy and lose meaning – and policy actors and political actors represent 
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distinct if connected classes.  Further reflection and discussion on these points is no doubt 
needed.   
Our study has some limitations.  Some targeted stakeholders, particularly high officials, were 
unable to be interviewed; a few key documents were also unavailable due to the destruction 
of WHO-Niger servers by fire in 2007.  As in any qualitative study, respondents may have 
sought to portray events strategically, which we sought to mitigate by triangulating between 
respondents and other data sources.  Finally and importantly, this research was financed and 
in large part carried out by researchers from Western institutions, and thus necessarily 
reflects an outside perspective on the events it seeks to describe.  We have attempted to 
mitigate this bias and enhance validity in a number of ways, including by keeping 
“reflexivity” memos on investigators’ underlying values and possible sources of bias, 
“member checking” (we presented preliminary results at a workshop in Niamey in October 
2012), discussions of our analysis with local researchers, and extending our critical reflection 
to ourselves (Creswell 2007).   
Processes of research utilization and knowledge translation have primarily been studied from 
the standpoint of Western countries despite the fact that the most pressing health policy 
needs, as measured by the burden of disease, are located in LMICs.  Furthermore, analyses 
of evidence-based policy making continue to rely on theoretical frameworks arising from 
objectivist and frequently biomedical paradigms related to concept’s origins as an outgrowth 
of evidence-based medicine (Behague, Tawiah et al. 2009).  This study demonstrates the 
utility of addressing these two deficiencies in the literature in tandem, including new cases to 
expand theoretical categories.  Furthermore, the importance of a critical perspective, 
encompassing sources of power in financial resources, professional authority, and technical 
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skill, among others, emerges as a central concern.  Both researchers and policymakers in 
LMICs should consciously account for the diverse and multiple types of knowledge available 
for developing health policy in LMICs and take a more active and critical perspective to 






Chapter 7. Conclusions 
7.1 Summary of results 
Results for each paper are highlighted in Chapters 5-7.  Taken as a whole, this study 
elucidates forces at work in global and national health policy processes, showing how the 
transformation of knowledge and research evidence into policy is conditioned by broader 
social forces, including the preexisting (geo-) political order, international and domestic 
resource flows, historical precedents and social trends and interactions amongst policy-
makers and members of the society at large.  Power, a difficult but important concept in 
health policy making, emerged as an important factor at all levels, whether arising from 
professional authority, political control, or access to economic resources.  The role of power 
is especially important in this case study of iCCM, a pro-poor policy whose benefits target 
politically disenfranchised, socially isolated populations and geographically far-flung 
populations.  During policy making at the global level, the poor were the focus for not-quite-
technical reasons:  reducing child mortality rates in the poorest subsets of the population 
were a necessary pathway to reaching the policy objective, namely the child survival MDG.  
At the national level in Niger, the poor benefited from governance mechanisms linking 
political longevity to a sort of national stewardship by Tandja, the “Father-Chief,” as well as 
timely and consequential influxes of funds – and the aforementioned technical expertise. 
Beyond this, this study illuminated aspects of theory that may be useful for explaining health 
policy processes in LMICs.  In terms of the use of evidence, this dissertation puts another 
nail in the coffin of “rational” theories of the use of evidence in policy-making, especially as 
it concerns policy making at the national level.  While the research literature was a key focus 
of policy makers in the more technocratic spheres of global policy-making, wherein experts 
actually got into shouting matches about the weight of the scientific evidence, this was hardly 
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the case at the national level in Niger, where Ministry officials accepted interpretations of the 
evidence provided by international actors and where many major policy decisions were made 
with exactly zero input from government health policy actors, including major decisions 
about the structure and functioning of the health system.   
This research joins a growing body of literature on policy analyses in LMICs; however it may 
also have relevance for social epidemiology, a field that explores how societal structures and 
dynamics degrade or enhance population health.  Social epidemiologists’ focus on 
“upstream” (more distal) causes of disease hearken back to public health’s founding 
principles (Vichrow et al.), and indeed it is a continual theme in public health to criticize the 
“short-term nature and ultimate futility of … downstream endeavors” (McKinlay 1979).  In 
an influential 1995 article, Link and Phelan argued for understanding social conditions as 
“fundamental causes of disease,” which affect “multiple disease outcomes through multiple 
mechanisms” (Link and Phelan 1995).  These “social conditions” as conceptualized by Link 
and Phelan encompass material deprivation as well as social inequalities, and researchers in 
intervening years have proposed a number of mechanisms by which these conditions could 
affect health, including epigenetic pathways related to social surroundings, psychosocial 
stress, and Durkheimian social cohesion models.  To this list, this dissertation proposes policy 
as a mechanism for political economy and other upstream factors to act on health.    
7.2 Strengths and limitations 
Strengths and limitations for each paper are included in Chapters 5-7.  A major strength of 
this dissertation is its use of in-depth contextual analysis related to the main study site, Niger, 
relying on extensive consultation of documents on the country’s history, political system, 
economic situation, relationship with other countries and position in the international order, 
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as well as socio-anthropological research on the country’s health system, bureaucratic and 
political culture, and governance structures.  Other strengths of this dissertation include its 
strong theoretical basis, founded on concepts and theories from within the public health and 
public policy literature, alongside more philosophical readings on the nature of power and 
knowledge. 
One major limitation of this dissertation is the fact that data collection occurred as part of a 
multi-country study on iCCM, meaning that study questions and research instruments were 
designed for the purposes of the overall study and not specifically for this dissertation.  To 
ensure the validity of the present work, I chose research questions that could be addressed 
using available data, adding additional sources (notably contextual data) and selecting analysis 
methods capable of culling appropriate evidence from the document review and interview 
data.  Nonetheless, it would have been fruitful to consider including other data collection 
methods relevant for further elucidating the more “hidden” aspects of power dynamics 
(such as discourse analysis, although this might be challenging in French for a non-native 
speaker), as well as providing more granular information on actors’ policy choices and 
implied tradeoffs, for example using discrete choice experiments. 
7.3 Recommendations for future research 
Given the early stage of development of the health policy research in LMICs and to a lesser 
extent at the global level, many avenues for future research remain, and several 
recommendations for future research have been listed in Chapters 4-6.  A number of 
previous observers have called for increasing attention to the ways in which power shapes 
and determines health policy processes; however, this dissertation provides an appreciation 
for the difficulty of applying such a profound, multi-faceted and contested theoretical 
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concept.  From my experience writing this dissertation, I would argue that the need in the 
literature is currently less for empirical studies of power in policy-making, but rather for 
primary theoretical reflection to guide subsequent inquiry. 
Like other studies, this dissertation demonstrated the extent to which specific country 
context determines policy outcomes.  We attempted to provide an in-depth explanation of 
why Niger was the first and remains one of the only countries to have adopted and 
implemented iCCM.  Given the time it takes to assemble even a reasonable familiarity with a 
country context, one way forward seems to be in collaborations between researchers 
interested in studying the same questions.  For example, these could be linked under the 
“Power” cluster of the Health Systems Global group of researchers, who blog on health 
systems issues including research utilization, policy and implementation, and who gather 
under the aegis of thematic working groups on relevant issues such as social science research 
on health systems issues and translating evidence into action. 
In terms of my personal goals for future research, I would like to continue to build upon my 
acquired expertise in Niger and the Sahel region, and collaborate with the talented Nigerien 
researchers whom I’ve had the privilege to meet and work with.  As one of the world’s 
poorest, most aid-dependent states, Niger offers possibilities for understanding mechanisms 
of policy development in situations of limited autonomy in terms of national policy-makers.  
It also suffers from major health challenges, with among the world’s highest rates of fertility, 
child mortality, malnutrition, and a number of infectious diseases.  At the same time, Niger 
is, for the time being, a (relatively) safe and stable place to conduct research.  I hope I have 
more contributions to make on health policy and related topics in Niger.   
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Lastly, this dissertation did not take a position on the appropriateness of existing policy 
development mechanisms – including the large role international actors play in setting 
national policy – though normative discussions on this topic are no doubt warranted.  
Indeed, further work on this topic should arguably be not merely descriptive but 
prescriptive:  given the very high stakes, researchers should be permitted to have – and share 
–opinions on their findings in appropriate forums.  Public health is a discipline founded on 
notions of justice, equity and the search for the “good society” – policy is a crucial 
mechanism toward reaching these goals, and researchers should not be afraid to interpret the 
facts in a way that advocates for the health of the poor and the greater good.  
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Chapter 8. Appendices 
8.1 Global study 
8.1.1 Interview guide 
 
Policy Analysis of Integrated Community Case Management  
for Childhood Illnesses – Global Policy-making 
 
Semi-structured interview guide 
 
The aim of this study is to understand how and why the policy known as Integrated 
Community Case Management of childhood illness (iCCM) developed at the global 
policy-making level.  We would like to understand how different factors affect this 
process, such as actors, institutions, ideas, context and policy content.  We are also 
interested in how ideas and evidence were used by global policy actors and diffused 
within the policy community.  This research is part of a broader study of iCCM policy, 
which also looks at national iCCM policies in six countries in sub-Saharan Africa.  We 
hope you will help us understand how iCCM was created in the international health 
policy arena and how it was promoted or diffused to countries in sub-Saharan Africa. 
 
 





DEMOGRAPHICS:  TAKE NOTES (identifying information to be kept separate from 
interview transcripts) 
 
a. Participant’s name  & organization and email/ contact details (fill in beforehand if 
possible):  
 
b. Participant’s title: 
 
***REQUEST TO TURN ON RECORDER*** 
 
c. What are your primary responsibilities in this position? 
 
 What year did you start in this organization? What year did you start in this 
position?  Where were working before this organization?  
 








1. What is your understanding of the definition of iCCM for child health? 
• What services does iCCM include?  [PROBE: on malaria, diarrhea, 
pneumonia] 
• What kind of health workers are meant to provide iCCM services? 
 
2. What are the origins of iCCM policy at the global level?   
• How did iCCM build on previous health programs? [PROBE on IMCI, C-IMCI, 
home management of malaria and pneumonia, community-level care for 
malnutrition, etc.] 
• ICCM could perhaps be seen as closely related to C-IMCI; why was it given a 
different name? 
• How is the content of iCCM policy different from other similar policies 
related to community case management?   
• What was the rationale for these different policies or programs?  
• iCCM could be seen as a largely curative care package (for example it does 
not include bednets, handwashing/ sanitation, breastfeeding, rotavirus 
vaccine, malnutrition).  Why do you think it evolved in this way? 
• Do you think global policy-makers see iCCM as being connected to 
approaches in prevention? Why or why not? 
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• Was community case management for some pathologies better accepted 
than for others?  How accepted were CCM for malaria, diarrhea, and 
pneumonia, respectively?  
 
3. How did iCCM policy at the global level develop over time? 
• What events or milestones were critical in the formulation of iCCM 
policies/programs?   [PROBE on specific meetings, conferences, events, etc.] 
• What documents do you view to be the key expressions of iCCM policy at the 
global level? 
• During the formulation of iCCM policy, was anything different or unusual 
compared to how policies and programs are normally developed?  
• How has iCCM policy impacted other existing policies, guidelines  or 
recommendations at the global level? [PROBE: contracting NGOs, human 
resources for health, drug regulation]  
• How open and consultative was the process for developing iCCM policy?   
 
4. What actors were involved in the discussions to formulate global iCCM policy? 
• Which offices/agencies/departments or individuals participated in the 
formulation of iCCM and related policies?  What were their roles? 
• Who led the process for formulating policies about iCCM policy? 
• Which actors were most supportive of iCCM policies?  Which actors opposed 
the development of the iCCM? 
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• Did a small number of actors dominate discussions or were there are large 
number of voices involved? 
• How did actors get involved in iCCM policy? Why did they become involved? 
• How did actors’ positions vary according to different components of iCCM?  
[PROBE on malaria, diarrhea, pneumonia]  How did these positions on iCCM 
policy change over time? 
• Which actors had the most expertise or scientific knowledge about iCCM 
policy? 
 
5. What has been the nature of actors’ interactions around global iCCM policy? 
• In what contexts did actors interact with each other over iCCM policy? 
• Which actors have forged strong alliances and which did not?  Did they have 
a history of working together? 
• Which actors were in opposition to each other?  What were the main points 
of disagreement?  
• How have these relationships between actors shifted over time? 
• Which actors involved in the development of iCCM policy do you think were 
the most powerful?  In your opinion, what made them powerful? 
 
6. What was the role of ideas and evidence in creating iCCM policy? 
• How did you learn about ideas or evidence related to iCCM?   
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• What were the main ideas or principles motivating the creation of iCCM 
policy? [PROBE for tacit knowledge, values, ideas, administrative/health 
service data, research, past international guidelines or recommendations, 
etc.] 
• How has this information influenced the content of iCCM policy?  
• Were there any differences in the evidence available for the different 
components of iCCM? [PROBE on malaria, diarrhea, pneumonia] 
• What specific sources (articles, reports) do you remember being important or 
influential, and how? 
• Were there disagreements about what the scientific evidence said? 
• How did actors introduce this information into the process?  
• Which actors were most likely to use scientific evidence during policy 
discussions on iCCM?  How did other actors react to this? 
• Did policy-makers share evidence with each other?  If so, how? 
• How important were ideas and evidence compared to other factors in the 
policy process?  
 
7. How was iCCM policy diffused between the global, regional and national levels? 
• What kinds of interactions were global level policy actors having with 
regional and national actors around iCCM?   
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• What strategies did global-level actors use to share policy ideas around iCCM 
with regional and national-level actors?  How successful were these 
strategies? 
• In what other ways were global policy ideas on iCCM transmitted to different 
policy communities and levels of policy-makers? 
• What efforts were made to “market” iCCM to countries? 
• What types of funding did global policy actors offer to engage other 
stakeholders regarding the adoption and implementation of iCCM? What 
other incentives were proposed around iCCM? [PROBE for technical 
assistance, aid in writing policies, etc.] 
• How were understandings of iCCM modified as the policy diffused across the 
global, regional and national levels? 
• What factors do you think affected whether or not countries decided to 
adopt and/or implement iCCM?   To what extent are policies that are 
promoted by international agencies accepted by in-country governments?  
For iCCM specifically and more generally? 
• Are countries aware of their neighbors’ health policies and does this 
influence their policy decisions? 
 
8. What kind of funding have donors made available to support iCCM activities at the 
country level?  
149 
 
• Has this changed over time? [PROBE for differences between malaria, 
diarrhea, pneumonia and newborn] 
• To what extent did funding availability impact the formulation of the iCCM 
policy at the global level and at the country level?  
• What collaboration was there between potential sources of funding for 
formulating and implementing iCCM at the country level? 
• What are the longer term plans for financially sustaining iCCM programming 
in countries?  Who is thinking about these issues? 
 
9. Is there anything else significant about the development of iCCM policy that we 
have not discussed so far?  Is there anything else you would like to add? 
 
***ASK FOR RELEVANT DOCUMENTS AND NAMES OF OTHER POTENTIAL 
RESPONDENTS*** 
 
Thank you for participating in this study.  Your responses will be very helpful to our 




8.1.2 Codebook for qualitative analysis 
Global iCCM Policy Analysis: Codebook  
Version of August 28, 2013 [SD, SB, AG, JS] 
Orig ins & content   
Definition Definition of iCCM according to the respondent or a source cited 
by the respondent. 
CHW profile for iCCM Characteristics of different community health workers delivering 
iCCM services and their role in delivery.  Issues around 
relationships with other health workers, supervision and training 
for iCCM services, distribution of supplies, etc. 
Origins Describes ideas, policies, scientific currents, and events that relate 
to the beginnings or origins of iCCM policy. 
Rationale Justification for iCCM as a policy; reasons why it is an effective or 
appropriate strategy. 
Integration Includes all discussion of how and why iCCM evolved as an 
integrated policy with respect to the pathologies included.  Also 
refers to disparities in the acceptance of the pathologies included 
in iCCM by various stakeholders, the timing of their inclusion, etc. 
Process  
Timeline Evolution of different iCCM policy components, or events 
relevant to iCCM, including when iCCM started gaining traction at 
the global level. 
Issue identification Includes descriptions of the problems or issues iCCM is meant to 
address, how these evolved identification has evolved over time, 
and how iCCM came to be discussed as a policy option.  
Formulation of iCCM Description about how iCCM policy was formulated, including 
how typical the iCCM process was compared to other policy 
formulation processes, and how fast or slowly it has been 
formulated.   
Events Landmark or critical events at the international or regional levels 
that influenced the formulation of iCCM policy, including 
meetings, conferences, and discussions.  Can be formal or 
informal events. 
Context  
Overall context  The influence of political, social, historical, and technological 
factors on the development of iCCM policy.   
Related policies Includes any discussion of similar or related child health policies.  
May include other CCM, HMM, nutrition, and prevention 
strategies, as well as CHW policy and non-child health policies 
that are also relevant.  Also includes iCCM’s influence on the 
development or form of these policy instruments and how they 
may conflict with iCCM. 
IMCI Includes mentions of IMCI and C-IMCI as pre-cursor policies, as 
other interventions occupying the same policy space, their 
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relationship to iCCM, etc. 
Actors  
UN system Includes actors and organizations within the U.N. system, such as 
WHO, Unicef, UNFPA, and WFP, involved the formulation of 
iCCM policy.  Also includes sub-offices or departments within 
these organizations (e.g. CAH in WHO, etc.). 
Other multi-lateral organizations May include the World Bank, EU, and other multi-laterals 
involved in the formulation of iCCM policy. 
Bi-lateral organizations Includes USAID, CIDA, and any other bi-lateral aid organizations 
involved in iCCM.  Also includes sub-offices or departments 
within these organizations (e.g. MCHIP, etc.) 
NGOs Includes non-governmental organizations that played a role in 
developing iCCM policy, operating either independently or as a 
coalition (e.g. CORE Group, Save the Children). 
Academic Includes researchers, academics, think tanks, and other academic 
actors or organizations that contributed to formulating iCCM 
policy. 
Country-level actors  Actors or organizations working at the country level, but involved 
in global or regional-level iCCM policy-making or diffusion.  This 
code may coincide with other actor categories (e.g. UN agencies 
and NGOS).  
Miscellaneous actors Other actors and organizations not listed under other Actor 
categories, including foundations (e.g. BMGF), consultants, 
advocacy groups, etc. 
Formalized partnerships May include the iCCM Task Force, the Catalytic Initiative, and 
other temporary or permanent partnerships bringing together 




Participation / consultation Description of the nature of the policy formulation process for 
iCCM and how the process hindered or enabled participation.  
Includes discussions about openness, transparency, consultation 
and stakeholder involvement.  Also includes descriptions of the 
lack of participation and/or consultation, for example with 
different policy communities. 
Alliances / coalitions Description of (informal) alliances between actors, including 
whether actors have a history of working together, and whether 
alliances have shifted over time.  Also includes coordination 
within agencies (e.g. CAH and RBM).  Formal alliances are 
covered under Actors / “Formalized partnerships.” 
Personal relationships Includes mentions of ongoing personal relationships, either inside 
or outside the professional sphere, and how these influenced the 
development of iCCM. 
Leadership Examples of actors and institutions leading the process of 
developing iCCM policy and in policy diffusion.  Includes persons 
who played key leadership roles in moving the policy forward, as 
well as specific instances of leadership.  May also include instances 
of a lack of leadership or an unfulfilled need for leadership. 
Power Relative power and influence of different actors, including reasons 
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for why actors are/are not powerful, different sources of power 
(e.g. funding, political power, administrative position), and how 
power was used by actors in policy process. 
Coercion/conditionality Instances of one party (actor or organization) using its leverage to 
impose its own viewpoint, obtain concessions or impose 
conditions related to choices during iCCM policy formulation. 
Evidence  
Types of evidence  
- Scientific research & 
data 
Scientific research and data that have played a role in the 
development of iCCM policy, including research evidence, 
surveillance data, scientific articles, operational research, and meta-
analyses etc. 
- Field reports Specific examples of in-country CCM pilots, projects or programs 
that influenced the development of iCCM policy.  These may be 
published or unpublished. 
- Tacit knowledge The role of tacit knowledge, experience, personal beliefs, values 
and other, non-scientific sources of evidence in the development 
of iCCM policy.  (E.g my work at the district level taught me…)  
- Norms, values, 
principles 
Refers to any ideas based on moral or ethical judgments or 
philosophical reasoning rather than scientific data.  May include 
how these ideas become rationalized and how they influenced how 
policy-makers conceptualize iCCM. 
- Specific documents Used to code the mention of specific articles or documents that 
were influential in iCCM policy. 
- Pilot projects Any mentions of pilot projects. 
Evidence use Descriptions of how evidence is/was used and which actors have 
used evidence in the discussions about iCCM policy, including 
promoting or arguing against the inclusion of specific aspects of 
iCCM.  Also includes descriptions of how the use of evidence 
concretely influenced choices related to iCCM content or 
implementation, as well as when evidence was ignored or not 
taken into account. 
Introduction of evidence How evidence was introduced to discussions on and related to 
iCCM, including the type of evidence and actor it was introduced 
by.  Describes parties (actors and organizations) that were most 
active in introducing evidence into debates on iCCM and framing 
and interpreting that evidence.  Also includes the creation of new 
evidence, e.g. commissioning studies. 
Framing How actors have consciously framed the thinking around the 
problems that iCCM addresses and the potential solutions.  
Includes both internal framing (within a group of actors) and 
external framing (outward to other stakeholders). 
Lack of evidence Discussions of instances where there was insufficient scientific 
evidence to justify certain policies, decisions or viewpoints.  This 
lack of evidence may be real or perceived. 
Diffusion of iCCM  
Interactions with regional and 
national actors 
Interactions of global-level policy-makers with regional or 
country-level policy makers, and how iCCM was introduced at 
sub-global levels.  This refers to interactions specifically aimed at 
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introducing iCCM to sub-global levels. 
Strategies to diffuse Examples of specific strategies used by global-level policy-makers 
to diffuse iCCM to regional and country levels.  May include 
holding regional workshops, meetings, the creation of 
implementation documents, the presentation of supporting 
evidence, etc.  Also refers to inducements or incentives offered for 
regional or country-level actors to adopt iCCM policy, such as 
offers of funding, technical assistance, aid in writing policies, etc. 
Adaptations Includes any modifications, either formal or informal, of iCCM 
policy as it moved from global to regional or country levels. 
Country responses Describes contextual, procedural, or other factors making it more 
or less likely for countries to adopt (or reject) iCCM.  This may 
include the existence of specific implementation tools, whether 
neighboring countries have adopted iCCM, or offers of technical 
or financial support. 
Financing & 
implementation 
Overall financing issues Current issues around financing iCCM, and types of funding and 
the sources currently available. 
Implementation Overall impressions or observations about the extent of iCCM 
implementation, including actors and institutions that are 
responsible for implementation.  Also includes futures plans for 
implementation of iCCM.  
Other  
Biographical information Any biographical information about the career history or personal 
involvement in iCCM mentioned by the interviewee. 
Malaria Applied to any discussion of malaria as a distinct CCM 
component, the place of malaria care within iCCM, and how 
malaria-related considerations influenced the development of 
iCCM. 
Diarrhea Applied to any discussion of diarrhea as a distinct CCM 
component, the place of diarrhea care within iCCM, and how 
diarrhea-related considerations influenced the development of 
iCCM. 
Pneumonia Applied to any discussion of pneumonia as a distinct CCM 
component, the place of pneumonia care within iCCM, and how 
pneumonia-related considerations influenced the development of 
iCCM. 
Nutrition Any discussion of nutrition and related issues, either as a CCM 
component or as a related policy, including discussions of whether 
or not to include nutrition in iCCM. 
Newborn Any discussion of newborn care and related issues, either as a 
CCM component or as a related policy, including discussions of 




8.2 Niger study 
8.2.1 Interview guide 
L’ANALYSE DE LA POLITIQUE DE LA PRISE EN CHARGE INTEGREE DES 
MALADIES DE L’ENFANT AU NIVEAU COMMUNAUTAIRE 
GUIDE D’ENTRETIEN SEMI- STRUCTURE 
INTRODUCTION 
Cette étude a pour but de comprendre comment et pourquoi la politique de prise en 
charge intégrée des maladies de l’enfant au niveau communautaire (PCIME-C) s’est 
développée au Niger. En particulier, nous voudrions savoir comment les différents 
acteurs, institutions, et idées, ainsi que le contenu de cette politique, ont influé sur les 
processus d’élaboration. 
Dans le cadre de cette étude sur la PCIME-C, nous nous focaliserons sur : (i) le 
traitement de la pneumonie de l'enfance (avec des antibiotiques), (ii) le traitement de la 
diarrhée (avec du zinc et des sels de réhydratation orale), (iii) le traitement du paludisme 
(avec les CTA – combinaisons thérapeutique à base d’artémisinine – et d'autres 
antipaludiques), et (iv) le traitement de la septicémie néonatale (avec des antibiotiques). 
Ces soins sont généralement pris en charge par les agents de santé communautaires 
(ASC) au sein des ménages et/ou dans la communauté. 
DEMANDER LE FORMULAIRE DE CONSENTEMENT : Nous allons enregistrer 
cette entrevue par le moyen d’un enregistreur et aussi prendre des notes au cours de 
l’entretien. Vos réponses aux différentes questions, les notes prises lors de l’entretien et 
l’enregistrement audio resteront confidentiels et anonymes. Vous n’êtes pas tenu de 
répondre à des questions qui vous mettent mal à l’aise. Vous pouvez aussi demander à 
mettre fin à l’entrevue à n’importe quel moment.  
DONNEES DEMOGRAPHIQUES (A noter séparément sur une feuille) 
e. Nom du répondant, structure et adresses (email, téléphone) ;  
f. Titre et Poste du répondant et responsabilité principales, 
g. Depuis quand travaillez-vous au sein de cette structure ?_____ans _____mois 
h. Depuis combien de temps êtes-vous à ce poste ? _______ans _________mois  












1. Pouvez-vous décrire la stratégie nationale de PCIME-C au Niger?  
• Quels sont les services (soins) qui sont concernés par la politique ? 
[SONDEZ : le paludisme, la diarrhée, la pneumonie, les soins aux nouveau-
nés].  
• Dans quelle mesure, la stratégie nationale est-elle une politique intégrée? Et 
comment? (politique, formation, monitoring, mise en œuvre, etc.) 
• Y a-t-il d’autres politiques de prise en charge communautaire des maladies 
infantiles et néonatales qui existent ou qui ont existé au Niger ? (prise en 
charge à domicile du paludisme, campagnes de vaccination …)  Comment la 
PCIME-C est-elle différente de ces programmes ?  
• Pouvez-vous décrire les agents qui offrent ces services (soins) aux enfants et 
nouveau-nés au sein de la communauté ? Quel est leur profile? (formation, 
sélection, motivation, rémunération) 
  
10. Quelle est l’historique du traitement des maladies de l’enfance au niveau 
communautaire au Niger ? 
• Qu’est-ce qui a motivé la création de ces différents politiques et programmes? 
(manque de personnel sanitaire, survie de l’enfant, OMD, accès aux services 
de santé) 
• Concernant le traitement des différentes maladies de l’enfance, y a-t-il eu des 
phases différentes de mise en œuvre de programmes de prise en charge au 
niveau communautaire?  Par exemple, est-ce que le traitement du paludisme 
au sein de la communauté a connu une évolution rapide par rapport au 
traitement de la pneumonie?  
• Quelle est la part de la prise en charge communautaire des nouveau-nés au 
sein dans cette historique?  
• Quelle est l’historique des agents de santé communautaires ou des relais 
communautaires dans la prise en charge des maladies de l’enfance au niveau 
communautaire ? 
 
11. Comment est-ce que la politique de PCIME-C a été élaborée ?  
• Quelles étaient les phases déterminantes (cruciales) dans l’élaboration de la 
politique ? [SONDEZ : les différences entre le palu, la diarrhée, la pneumonie, 
les soins aux nouveau-nés au niveau national et international] 
• Qu’est-ce qu’il y a eu de particulier dans l’élaboration de cette politique par 
rapport aux autres politiques et programmes de santé au Niger ?  
• Est-ce qu’il était nécessaire de modifier des lois, des réglementations, ou 
d’autres politiques afin de mettre en place la PCIME-C ? 
• Comment la PCIME-C a-t-elle influé sur les autres politiques existantes 
(ONGs partenaires, personnel sanitaire, loi de régulation sur médicaments)? 
 
12. Qui étaient les acteurs les plus impliqués dans les discussions et les débats au 
moment de l’élaboration de la politique de la PCIME-C ?  
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• Quelles sont les structures du Ministère de la Santé Publique qui étaient les 
plus impliquées dans l’élaboration de la politique de PCIME-C ? 
• Qui a dirigé le processus d’élaboration de la politique ? 
• Quels autres acteurs ont été impliqués dans le processus d’élaboration en 
dehors du MSP ? A quel moment ont-ils rejoint ce processus?  
• Ce processus était-il inclusif et participatif, ou plutôt fermé et dirigé d’en haut 
? 
• Quel acteur a joué le plus grand rôle dans l’élaboration de cette politique? 
• Quels acteurs s’opposaient à la PCIME-C ou voulaient ralentir le processus 
d’élaboration ? 
• Y avaient-ils des acteurs qui étaient plus en faveur de certaines composantes 
de la PCIME-C que d’autres ? Par exemple les soins aux nouveau-nés, par 
rapport au paludisme, aux diarrhées, et aux pnéumonies. 
• Parmi les acteurs impliqués dans ce processus, selon vous, qui étaient les plus 
puissants ? Selon vous, qu’est-ce qui les a rendu puissants? 
 
13. Quelles étaient les modalités de travail entre les différents acteurs travaillant sur 
la politique de PCIME-C ?  
• Dans ce processus, quels acteurs ont créé des alliances ? Quels acteurs ne 
faisaient pas partie de telles alliances ? 
• Ces acteurs avaient-ils déjà travaillé ensemble auparavant ?  
• Quels acteurs s’opposaient à quels autres acteurs ?  
• Comment est-ce que ces relations de travail ont-ils évolué au cours du 
processus ?  
 
14. Quelles informations ou évidences ont influé sur la formulation et l’élaboration 
de la politique de PCIME-C ? 
• SONDER: savoir tacite, idées, données administratives ou sur la santé, études 
internationales ou locales, orientations/recommandations internationales, 
expériences des autres pays …  
• Comment ces informations ont-elles influé sur le contenu de la politique? 
[SONDER : différences entre paludisme, pneumonie, diarrhée, soins aux 
nouveau-nés.] 
• Quel type d’information a joué le plus grand rôle lors des discussions? 
Comment cette information a été introduite dans le processus? 
• Quelle a été l’importance des normes/directives internationales de 
l’UNICEF ou OMS? 
• Quelle a été l’importance des projets de prise en charge 
communautaire des maladies de l’enfance dans d’autres pays?  
• Comment avez-vous pris connaissance de ces informations ?  
• Dans le processus d’élaboration, quelle a été l’importance de ces informations 
comparativement à d’autres facteurs? 
 
15. Pouvez-vous décrire la situation de la mise en œuvre de la PCIME-C au Niger ?  
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• Quels ont été les obstacles majeurs à sa mise en œuvre ? [SONDER : 
différences entre palu, pneumonie, diarrhée, soins aux nouveau-nés et 
barrières politiques, capacités techniques et administratives, l’acceptation des 
professionnels de la santé et de la communauté, aspects techniques, etc.] 
• D’après vous, les difficultés de mise en œuvre sont-elles liées à la manière 
dont la politique a été élaborée? Comment? 
 
16. Quels sont les types de financement disponibles pour la politique de PCIME-C 
au Niger?  Comment est-ce que la disponibilité des financements a-t-il évolué au 
fil des années ? 
• Comment est-ce que la disponibilité des fonds a-t-elle influé sur l’élaboration 
de la politique ? 
• Souvent les fonds pour ce type de projet viennent de divers bailleurs.  Est-ce 
que c’est le cas pour la PCIME-C ?  Si oui, comment est-ce que cela a-t-il 
affecté la mise en œuvre de chacune des composantes de la PCIME-C ?  
• Quelles sont les perspectives à long terme pour pérenniser le financement de 
la PCIME-C ?  
 
 Enquêteur : Posez la question 9 seulement si le répondant n’a pas encore mentionné les 
soins des nouveau-nés dans le cadre de la PCIME-C.   
 
17. Quelle est la situation actuelle de prise en charge des nouveau-nés dans le cadre 
de la politique de PCIME-C au Niger ?   
• Quel est le niveau d’intérêt auprès des acteurs pour inclure les soins des 
nouveau-nés dans cette politique ?  
• Quelles sont les parties prenantes qui ont manifesté le plus grand intérêt en 
faveur de la prise en charge des nouveau-nés dans le cadre de la PCIME-C ? 
• Quelles sont les difficultés spécifiques liées à la prise en charge 
communautaire des nouveau-nés?  
 
18. Y a-t-il d’autres aspects sur l’élaboration de la politique de PCIME-C que nous 





JE VOUS REMERCIE TRES SINCEREMENT D'AVOIR ACCEPTE DE PARTICIPE 
A CETTE ETUDE.  
 
VOS REPONSES NOUS SERONT TRES UTILES POUR MIEUX COMPRENDRE 





8.2.2 Codebook for qualitative analysis 
Policy Analysis of Integrated Community Case Management 




Ref. Codes Definition Example 
CONTENT 
C1 Local definition 
Definition of iCCM in the country, including 
various forms of terminology (e.g. What is iCCM 
called?). 
 
C2 Components included 
Components included in current/planned iCCM 
policy, incl. treatment and other services for 
diarrhea, pneumonia, malaria in children and 
newborn.  May also include other services such as 
malnutrition, red-eye, etc. 
 
C3 Integration 
Discussions about integration or lack of integration 
between iCCM services, and between iCCM 
services and other packages of services, such as 







Difference between current/planned iCCM policy 
from other child health policies.  
C5 Other policy content 
Other issues relating to iCCM policy content not 
covered by other codes, such as reasons for selecting 
piloting or implementation sites, financing and 
remuneration decisions, human resources issues, etc. 
 
C6 Policy gaps 
Discussions about issues that should have been 
taken into account during the formulation of iCCM 
policy, including content missing from the policy, 





E1 Issue identification 
Describes how iCCM is discussed as a policy 
option, such as historical origins of the policy, 
including what issues iCCM is meant to address, 
and how issue identification has evolved over time.  
 
E2 Timeline 
Evolution of different iCCM policy components, 
including when iCCM started gaining traction at the 
policy level. 
 





P1 Formulation of iCCM 
Description about how iCCM policy was/is 
formulated, including how typical the iCCM 
process is/was compared to other policy 
formulation, how fast or slowly it has been 
formulated.  Does not include discussions specific 
to the participatory nature of the policy 
formulation. 
 
P2 National events 
Landmark or critical events at the national level 
that influenced the formulation of iCCM policy, 
including meetings and discussions.  Can be 
formal or informal events. 
 
P3 International events 
Landmark or critical events at the international 
level that influenced the formulation of iCCM 
policy, including meetings and discussions.  Can 
be formal or informal events. 
 
P4 Participation/Consultation 
Description of the nature of the policy formulation 
process for iCCM and how the process hindered 
or enabled participation.  Includes discussions 
about openness, transparency, consultation and 
stakeholder involvement.  Does not include 





X1 Political factors 
Political factors that have influenced the 
development of iCCM policy, and how they 
have influenced it (e.g. new government, 
decentralization, coup d’etat).  Includes the 
influence of political factors on the content, 
actors and process of iCCM policy. 
 
X2 Social/Historical factors 
Social and historical factors that have 
influenced the development of iCCM policy, 
and how they have influenced it (e.g. 
community empowerment, legacy programs).  
Includes the influence of social/historical 
factors on the content, actors and process of 
iCCM policy, such as acceptability of iCCM at 
the community level. 
 
X3 Technological factors 
Technological factors that have influenced the 
development of iCCM policy, and how they 
have influenced it (e.g. RDTs, blister packs of 
medicines).  Includes the influence of 
technological factors on the content, actors and 




X4 Laws / Policy instruments 
Laws and policy instruments that currently exist 
that in some way relate to iCCM, including 
MoH plans, directives, safety guidelines, etc.  
Includes laws that could facilitate or hinder 
iCCM in the future.  Can be conflicting policy 





A1 Government health sector 
Offices, agencies and departments from the Ministry 
of Health that have played a role in formulating 
iCCM policy.  Also, includes those who are 
responsible for iCCM, including the different 
components of iCCM (diarrhea, pneumonia, 






Government offices, agencies and departments 
outside the Ministry of Health who have/had a role 
in developing iCCM policy, including the different 
components of iCCM (diarrhea, pneumonia, 
malaria, newborn, CHWs). 
 
A3 NGOs 
NGO actors and organizations that have played a 
role in developing iCCM policy.  Only refers to 
NGOs, such as local NGOs, PSI, CARE, MSF, etc. 
 
A4 Funders 
Funding actors and organizations that have played a 
role in developing iCCM policy, such as bilaterals, 
multilaterals, foundations, and other donors, 
including the different components of iCCM. 
 
A5 Technical Assistance 
Actors and organization that have provided 
technical assistance during the formulation of iCCM 
policy, including consultants, long-term expatriate 
advisors, etc. 
 
A6 Miscellaneous actors 
Actors and organizations that are not under other 
Actor categories (Gov’t, NGO, funder, TA) that 
have played a role in formulation iCCM policy.  
Includes researchers/research institutions, 




Actors and institutions that led the process of 
developing iCCM policy.  Includes those that played 
key leadership roles in moving the policy forward. 
 
A8 Power 
Relative power and influence of different actors, 
including reasons for why actors are/are not 
powerful, and different sources of power (e.g. 
funding, political power, administrative position), 
how power was used by actors in policy process. 
 
A9 Alliances Description of alliances and non-alliances between  
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actors, including whether actors have a history of 
working together, and whether alliances have shifted 
over time. 
 
EVIDENCE & DATA 
D1 Data 
Scientific data that have played a role in the 
development of iCCM policy, including research 
evidence, surveillance data, HMIS, administrative 
data, etc. 
 
D2 Tacit knowledge 
The role of tacit knowledge, experience, personal 
beliefs, values and other, non-scientific sources 
of evidence in the development of iCCM policy.  
(E.g my work at the district level taught me…)  
 
D3 Learning from others 
iCCM projects or programs, both within the 
country and internationally, that influenced the 
development of iCCM policy.  Includes pilot 
projects. 
 
D4 Evidence use 
Descriptions of how evidence is/was used and 
which actors have used evidence in the 
discussions about iCCM policy, including to 
promote positions for or against aspects of iCCM. 
 
D5 Framing 
How actors have consciously framed the thinking 
around the problems that iCCM addresses and the 
potential solutions.  Includes both internal 
framing (within a group of actors) and external 




I1 Overall implementation 
Overall impressions of the extent of implementation 
of iCCM and how implementation is proceeding in-
country, including actors and institutions that are 
responsible for implementation.  Also includes 





vs. iCCM policy 
Issues with iCCM implementation that are related to 







How funding issues influenced iCCM policy 
formulation.  
F2 Overall financing issues 
Current issues around financing iCCM, and types of 
funding and their sources currently available.  
F3 Future funding 
Plans for future funding support of iCCM, including 
the predictability of external funding, and plans for 






COMMUNITY HEALTH WORKERS (CHWs) 
H1 CHW profile for iCCM 
Characteristics of different community health 
workers delivering iCCM services, and their role in 
delivery.   
 
H2 Linkages to health system 
Issues around relationships with other health 
workers, supportive supervision and training for 





CODE QUALIFIERS (Codes applied to portions of text that have been coded with a 
distinct code (e.g. financing, actors, etc.) that need to be qualified further) 
Q1 Barrier Factors 
Classification for any statements about barriers to 
iCCM, including content, formulation, actors, 
evidence, implementation, financing, CHWs, and 
others. 
 
Q2 Facilitator Factors 
Classification for any statements about facilitators to 
iCCM, including about content, formulation, actors, 




For any discussions that have an international 
aspect, including international actors or 
organizations, evidence from international sources, 
etc.  Also known as: International Sauce (that is 
used in conjunction with other codes). 
 
Q4 Newborn 
For any discussions about newborn-related issues, 
include issue identification, services offered at the 
community level, challenges specific to advancing 
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